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ABSTRACT
Characterization of SBIP68: A Putative Tobacco Glucosyltransferase Protein and Its
Role in Plant Defense Mechanisms
by
Abdulkareem Olakunle Odesina

Plant secondary metabolites are essential for normal growth and development in plants
ultimately affecting crop yield. They play roles ranging from appearance of the plants to
defending against pathogen attack and herbivory. They have been used by humans for
medicinal and recreational purposes amongst others. Glycosyltransferases catalyze the
transfer of sugars from donor substrates to acceptors. Glucosyltransferases are a
specific type of glycosyltransferases known to transfer glucose molecules from a
glucose donor to a glucose acceptor (aglycone) producing the corresponding glucose
secondary metabolite or glycone, in this case glucosides. It was hypothesized that
SBIP68, a tobacco putative glucosyltransferase-like protein glucosylated salicylic acid.
Salicylic acid is an essential plant defense secondary metabolite. SBIP68 was cloned
and heterologously expressed in both prokaryotic and eukaryotic systems. Results from
activity screening suggest that SBIP68 is a UDP-glucose flavonoid glucosyltransferase
with broad substrate specificity. Further studies are required to fully characterize
SBIP68.
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CHAPTER 1
INTRODUCTION
Plant disease refers to an abnormal condition that causes damages to a plant,
leading to a subsequent reduction in its productivity. The disease could be caused by a
biotic agent or abiotic factors (McMullen and Lamey, 2001). Given the importance of
plants and their products on our daily lives, the study of plant diseases is of utmost
importance. Between 1845 and 1852, the great famine in Ireland led to the starvation,
death of about one million people and caused one million more to emigrate from Ireland
(Ross, 2002). The famine was a result of Potato Blight Disease. In the United States
alone, an estimated $30 billion is lost every year as a result of plant diseases (Pimentel
et al., 2000; Pimentel and Burgess, 2014). The ever increasing world population and
resulting higher demands for food supplies makes the control of plant diseases even
more critical (Emmert and Handelsman, 1999). Various means have been employed to
prevent/control herbivory and plant diseases; among them is the use of chemicals
called pesticides. Fungicides, herbicides, insecticides and the like, are all pesticides
employed in the protection of plants (Rangwala et al., 2013). In the United States alone,
more than $10 billion is spent yearly on the use of pesticides (Pimentel et al., 1994;
Pimentel and Burgess, 2014). Pesticides play a major role in maintaining food
production globally, as it has been estimated that without the use of pesticides, there
would be a 10% increase in losses due to pests. The use of pesticides, however, may
not necessarily result in a decrease in crop losses (Pimentel et al., 1992). For instance,
in the United States, losses due to pests from 1945 to 1989 nearly doubled from 7% to
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13% despite the ten-fold increase in the use of insecticides (Pimentel et al., 1991;
Pimentel and Burgess, 2014).
In recent times, there have been concerns over the excessive use of pesticides
(Pimentel et al., 1992; Pimentel and Burgess, 2014). Approximately 355,000 people die
as a result of unintentional poisonings yearly (WHO, 2003). Pesticides and other toxic
chemicals have been strongly associated with two-thirds of these deaths (Goldman and
Tran, 2002; FAO/UNEP/WHO, 2004). Dibromo-chloro-propane (DBCP, a banned
pesticide) was found to cause testicular dysfunction in animals (Foote et al., 1986) and
associated with infertility in humans exposed to it (Potashnik and Yanai-Inbar, 1987).
Reports from animal studies have shown that pesticides can cause immune dysfunction
(Thomas and House, 1989). Chronic health problems have been linked to
organophosphorus pesticides (Ecobichon et al., 1990) resulting in irreversible
neurological defects (Lotti, 1984). Neurotoxic effects have been found to persist
following poisoning (Ecobichon et al., 1990). Other issues related to the use of
pesticides include: poisoning in bees and reduced pollination, destruction of crop and
crop products, contamination of surface and ground water and fishery losses among
others. Despite their negative effects, pesticides still remain valuable pest control tools
(Pimentel et al., 1992; Pimentel and Burgess, 2014).
Cultivated plants such as Chinese cabbage, cowpea, cucumber, melon, potato,
strawberry, tobacco, tomato, water melon, are known to be attacked by viral pathogens
such as cucumber green mottle mosaic virus (CGMMV), cucumber mosaic virus (CMV),
lettuce mosaic virus (LMV), melon necrotic spot virus (MNSV), potato virus X (PVX),
and tobacco mosaic virus (TMV), etc. (Shigematsu et al., 1978). These plant viruses are
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ubiquitous, occurring in plants, seeds, and soil, and readily infect plants by the suction
of plant juices by insects, contact with virus-containing soil during planting, and contact
with farm equipment, or humans (Shigematsu et al., 1978). A number of chemicals are
known to control these viruses, these include antibiotics and nucleic acid-like
compounds, both of which function by suppressing the proliferation of plant viruses
(Shigematsu et al., 1978). These substances however, are toxic to humans, plants, and
animals, and have not been applied practically except in the case of one chemical that
contains sodium alginate as its main component (Shigematsu et al., 1978).
Despite advances in agriculture, certain cultural practices have been known to
augment the devastating potential of plant diseases (De Waard et al., 1993). Some of
these practices include the growth of plant cultivars that are vulnerable to pathogens,
the propagation of genetically similar crop plants in monoculture, and the application of
inorganic fertilizers at concentrations that increase disease susceptibility (De Waard et
al., 1993). Crop losses due to pathogenic fungi are estimated at approximately 30 %
(Schwinn, 1992). The control of plant diseases is heavily dependent on fungicides to
attack the plethora of fungal diseases that threaten the productivity of agricultural crops
(Schwinn, 1992). For farmers, the obtainability of progressively effective fungicides has
varied remarkably in its impact. These benefits include the reduction of yield losses, and
the prevention of complete crop losses, e.g. the preservation of potato from
Phytophthora infestans in Western Europe (Schwinn and Margot, 1991).
Fungicides have been known to improve crop quality, enhancing marketability
and food safety (Ragsdale et al., 1991). Improved food safety is associated with the
reduction of mycotoxins and phytoalexins (De Waard et al., 1993). Mycotoxins are
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capable of being carried over from fungal infections of live plants to stored plant
material, and decomposing plant matter (De Waard et al., 1993). They constitute a
threat in food technology, greater than the misuse of fungicides (Natl Acad Sci, 1987).
Mycotoxins are ubiquitous, they include tenuazonic acid, patulin, fusarium toxins, ergot
toxins, and aflatoxins (Ragsdale et al., 1991; Schwinn, 1992). Certain phytoalexins
known to occur in potato and leguminous plants are toxic to humans and other higher
animals (Ragsdale et al., 1991). Fungicides are capable of preventing and/or
diminishing the production of these toxic compounds (De Waard et al., 1993). Without
doubt, fungicides play a significant role in the defense against plant pathogens,
however, there are emerging concerns on the use of fungicides.
Ethylene-bis-dithiocarbamate (mancozeb) is a widely used fungicide that has
been found to induce embryo apoptosis in mice (Paro et al., 2012). Mancozeb was
shown to affect oocyte meiotic spindle morphology, and impair the rate at which
fertilization occurs, even when used at very low concentrations (Paro et al., 2012). It is a
reproductive toxicant that affects the somatic cells of the mammalian ovarian follicles,
by inducing a premalignant-like status in both mouse and human granulosa cells (Paro
et al., 2012). The fungicide residues benomyl, dichlofluanid, iprodione, procymidone,
and vinclozolin found in red and white bottled wines, were shown to have a negative
effect on yeast growth, with dichlofluanid and benomyl being the most toxic (Calhelha et
al., 2006). In wheat seedlings, carbendazim was found to alter biochemical parameters
such as protein content, carbohydrate content, total chlorophyll, chlorophyll a,
chlorophyll b, and alkaline protease activity (Rangwala et al., 2013). An increase in
concentration of the fungicide brought about a decrease in the concentration of protein,
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carbohydrate, total chlorophyll, chlorophyll a, and chlorophyll b, and an increase in
alkaline protease activity (Rangwala et al., 2013). A maximum decline in the
concentration of protein (– 62.49%), carbohydrate (– 62.5%), total chlorophyll (57.44%), chlorophyll a (-47.89%) and chlorophyll b (-63.44%), and a maximum
elevation in alkaline protease activity (152%) was obtained at a fungicide concentration
of 2500 mg/l (Rangwala et al., 2013).
The fungicides azoxystrobin, boscalid, chlorothalonil, fenarimol, fludioxonil,
myclobutanil, pyraclostrobin, pyrimethanil, and zoxamide are emerging chemicals of
concern due to their increasing rates of use globally, the frequency at which they are
detected in surface waters, and their likely persistence in the environment (Elskus,
2014). Significant sublethal effects of fungicides on aquatic invertebrates and
ecosystems, fish reproduction and immune function, zooplankton community, metabolic
enzymes, and ecosystem processes such as leaf decomposition in streams, have been
observed (Elskus, 2014). Some of these effects are known to occur at concentrations
well below single-species acute lethality values, killing 50 percent of the organisms
within 48 to 96 hours (Elskus, 2014). This is an indication that single-species toxicity
values may be a misrepresentation of the toxic effects of certain fungicides (Elskus,
2014). Fungicides are also capable of showing synergistic effects when used in
combination with other fungicides and insecticides (Elskus, 2014). The frequency of
fungicide use is projected to increase drastically in the next few years (Troy, 2011),
making them an emerging concern in freshwater systems in the United States (Elskus,
2014).
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More recently, there’s been an increase in the use of nonchemical based pest
control methods commonly called “biological control” (Emmert and Handelsman, 1999),
as most of the synthetic pesticides are likely to lose their usefulness over time, arising
from revised safety regulations (Duke et al., 1993; Benbrook et al., 1996; NRC Report,
1996), development of resistance in pathogens (Russell, 1995), and negative effects on
non-target organisms (Felton and Dahlman, 1984; Guy et al., 1989; Dernoeden and
McIntosh, 1991; Elmholt, 1991). Biological controls, such as microbes, are much more
environmental friendly compared to the use of pesticides in controlling plant diseases.
Apart from being environment friendly, the rich diversity of microbes makes them a
seemingly endless resource and a better alternative to the use of pesticides (Emmert
and Handelsman, 1999). Some rhizobacteria that function as effective biocontrol
substances by suppressing a number of economically important plant pathogens usually
promote plant growth and yield, either when applied to crop seed or into the soil (Burr et
al., 1978; Kloepper et al., 1980a, 1980b; Kloepper et al., 1989; Brown and Surgeoner,
1991; Turner and Backman, 1991; Bashan, 1998). These bacterial strains promote plant
growth even in the absence of pathogens (Harris et al., 1994). They are referred to as
plant growth promoting rhizobacteria, PGPR (Kloepper et al., 1989).
In-depth analysis into various plant defense mechanisms and the biocontrol of
plant diseases is essential to the development of better and safer disease control
methods. The innate immune system otherwise referred to as the “non-specific immune
system” (Grasso, 2002) is the first line of defense against invading pathogens. Unlike
the adaptive immune system found in vertebrates, the innate immune system does not
keep memory of antigens / pathogens and therefore does not provide an organism with
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long-lasting immunity (Alberts et al., 2003). Because plants possess neither mobile
defender cells nor the adaptive immune system characteristic of mammals, they defend
themselves against pathogens using the innate immunity of individual cells and
systemic signals produced by infected cells (Dangl and Jones, 2001; Ausubel, 2005;
Chisholm et al., 2006; Bent and Mackey, 2007).
Plants respond to a number of chemical stimuli produced by the soil and plantassociated microbes (Pal and Gardener, 2006). These stimuli are capable of inducing
plant host defenses via biochemical changes that boost resistance against subsequent
infections by different pathogens (Pal and Gardener, 2006). Depending on the type,
source, and amount of stimuli, the induction of the host defense mechanisms could be
local and/or systemic (Pal and Gardener, 2006). Attempts are being made by plant
pathologists to fully characterize the components of pathways involved in induced
resistance triggered by biological control agents and other non-pathogenic microorganisms. Upon pathogen infection, large amounts of salicylic acid is produced,
leading to the expression of pathogenesis-related (PR) proteins (Yalpani et al., 1991).
PR proteins consist of a variety of enzymes with different modes of action (Yalpani et
al., 1991). Some PR proteins lyse invading cells, others reinforce the host cell wall, and
some trigger localized cell death (Pal and Gardener, 2006).
In hypersensitive response (HR; a form of innate immunity), pathogen attack
triggers rapid cell death at the site of infection and immediate surrounding cells (Agrios,
1988; Goodman and Novacky, 1994). HR can be triggered by an array of pathogens
and it occurs within a few hours upon pathogen contact (Morel and Dangl, 1997). In
addition to HR, plants have a form of secondary resistance referred to as systemic
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acquired resistance (SAR) (Morel and Dangl, 1997). SAR is an inducible defense
mechanism that is activated in the distal uninfected parts of plants in response to a local
infection by pathogens (reviewed in Shah et al., 2014). It confers non-specific and
prolonged levels of resistance in uninfected parts of a plant to secondary infections by a
wide range of pathogens (Ryals et al., 1996). SAR is triggered by pathogens that cause
cell death due to HR (Morel and Dangl, 1997). However, HR is not required to generate
the SAR signal (Mishina and Zeier, 2007). Plants defend themselves against pathogens
through an interconnection of signaling pathways involving three signal molecules:
ethylene, jasmonic acid and salicylic acid (Kunkel and Brooks, 2002).
Abscisic acid (ABA; Fig. 1), is a phytohormone that also plays an important part
in plant responses to environmental stress and in defense against plant pathogens

Figure 1: Chemical Structure of Abscisic Acid
(Swamy and Smith, 1999; Chinnusamy et al., 2004). ABA is known to play an essential
role in various coordinating cellular processes including seed germination, seed
development, dormancy, and growth with responses to environmental changes. These
involve complex regulatory mechanisms that regulate its biosynthesis, catabolism,
perception, and transduction (Xiong and Zhu, 2003). It is produced in response to
different forms of stress which include but are not limited to cold, salinity and drought
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(Wu et al., 1997). It reduces water loss due to transpiration by triggering the closing of
stomata (Schroeder et al., 2001). ABA’s glucose ester is gradually dispersed from
leaves recovering from water stress thereby maintaining abscisic acid levels for a period
of time after the leaves have regained turgor (Hiron and Wright, 1973). Apart from its
role in environmental stress, ABA-mediated signaling is also important in plant –
pathogen interactions (Seo and Koshiba, 2002). It is involved in increasing resistance to
pathogens by plants through its positive effect on callose deposition (Mauch-Mani and
Mauch, 2005). Wounding induces an increase in the synthesis of ABA.
Ethylene (Fig. 2), is a gaseous phytohormone with roles in various processes in
plants such as growth and development (Yang and Hoffman, 1984). It is also a regulator

Figure 2: Chemical Structure of Ethylene
of fruit ripening (Van Loon et al., 2006). Its biosynthesis in plants has been found to
increase rapidly following exposure to pathogens (Ecker and Davis, 1987). The increase
in ethylene biosynthesis in infected plants brings about a subsequent increase in
chitinase activity in these plants (Roby et al., 1986) and the deposition of hydroxyproline
in the cell walls of the infected tissues (Roby et al., 1985). Hydroxyproline rich
glycoproteins are the major structural proteins present in plant cell walls. Chitinases are
enzymes that are responsible for the breakdown of glycosidic bonds in chitin (Jollès and
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Muzzarelli, 1999) which is an important component of fungal cell-walls and the
exoskeleton of arthropods, thereby conferring protection against fungal attack and
attack from arthropods on plant cells. Ethylene effects the accumulation of mRNAs of
genes responsible for plant defense (Ecker and Davis, 1987). Ethylene has been found
to contribute to disease resistance in some interactions (Thomma et al., 1999; NormanSetterblad et al., 2000), while it is known to promote disease in other interactions (Bent
et al., 1992; Lund et al., 1998; Hoffman et al., 1999).
Jasmonic acid (JA; Fig. 3), is a phytohormone with a number of physiological
roles including regulation of growth and development and response to biotic and abiotic

Figure 3: Chemical Structure of Jasmonic Acid
stress factors (Creelman and Mullet, 1995). JA, derived from lipids (Schaller and Stintzi,
2009) is biosynthesized from linolenic acid (Creeman and Mullet, 1995). JA also
controls pollen maturation and wound responses (Turner et al., 2002). JA and its ester
methyl jasmonate (MeJA) promote senescence (cell death), acting as growth regulators
as mentioned earlier (Creelman and Mullet, 1997). Inhibiting the biosynthesis of JA in
Arabidopsis thaliana greatly increases plant susceptibility to a wide array of pathogens
(Staswick et al., 1998; Thomma et al., 1998; Vijayan et al., 1998; Norman-Setterblad et
al., 2000).
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Salicylic acid (SA; Fig. 4), is a phenolic phytohormone that is widely distributed in

Figure 4: Chemical Structure of Salicylic Acid
plants, with its basal levels differing by as much as 100-fold between different plant
species (Raskin et al., 1990). It has various roles in plants ranging from growth and
development, ion transport, photosynthesis, response to abiotic stresses including
drought (Munne´- Bosch and Penuelas, 2003; Chini et al., 2004), heat (Larkindale and
Knight, 2002; Larkindale et al., 2005), osmotic stress (Borsani et al., 2001) and heavy
metal tolerance (Metwally et al., 2003; Yang et al., 2003; Freeman et al., 2005). It is well
studied for its involvement in plant defense signaling against pathogen infections (Hayat
and Ahmad, 2007; Kumar, 2014) in which case it induces the production of PR proteins
(Hooft van Huijsduijnen et al., 1986). SA induces resistance in uninfected parts of plants
through SAR (Fig. 6). SAR induces resistance against pathogens in other nearby plants
too by gaseous diffusion of methyl salicylate (MeSA), a salicylic acid ester (Shulaev et
al., 1997). MeSA is likely converted into SA to induce resistance (Shulaev et al., 1997).
SA biosynthesis occurs through two differentiated pathways (Fig. 5), that make use of
different precursors: the phenylpropanoid (phenylalanine dependent) and the
isochorismate (non-phenylalanine dependent) pathways in the cytoplasm and
chloroplast, respectively (Rivas-San Vicente and Plasencia, 2011; Kumar 2014). The
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isochorismate pathway involves isochorismate synthase and isochorismate pyruvate
lyase, and is responsible for synthesizing most of the pathogen-induced salicylic acid in
Arabidopsis (Wildermuth et al., 2001), Nicotiana benthamiana (Catinot et al., 2008), and
tomato (Uppalapati et al., 2007). Upon infection, SA concentration increases at the
pathogen infection sites, leading to the formation of necrotic lesions from hypersensitive
response. This activates the SAR pathway (Ryals et al., 1996) and activation of SAR
produces a broad-spectrum systemic resistance (Hunt and Ryals, 1996;
Neuenschwander et al., 1996).

Figure 5: Salicylic Acid Biosynthetic Pathways. Enzymes are shown in italics. PAL,
Phenylalanina Ammonia Lyase; ISC, Isochorismate Synthase; BA2H, Benzoic Acid 2Hydroxylase; IPL, Isochorismate Pyruvate Lyase; SAGT, Salicylic Acid
Glucosyltransferase; SAMT, Salicylic Acid Methyltransferase; SABP2, Salicylic Acid
Binding Protein 2; MES, Methyl Esterase; SGE, Salicyoyl Glucose Ester; SAG, Salicylic
Acid O-β-Glucoside; MeSA, Methyl Salicylate (Figure adapted from Vlot et al. 2009).
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Figure 6: Schematic Representation of Systemic Acquired Resistance (SAR) in Plants.
Volatile MeSA diffuses to uninfected parts and neighboring plants to induce pathogen
resistance.

Salicylic Acid Binding Protein 2 (SABP2)
There are four proteins that currently are known to bind SA in tobacco and these
are collectively referred to as salicylic acid binding proteins (SABP) (Vlot et al., 2009),
although recent studies suggest the presence of additional new SABPs in Arabidopsis
(Kumar, 2014; Manohar et al., 2014). One of the SABP, salicylic acid binding proteins 2
(SABP2) has the highest affinity for salicylic acid (Du and Klessig, 1997). It is a 29 kDa
protein required for both local resistance and SAR after infection by tobacco mosaic
virus (TMV) (Kumar and Klessig, 2003). It catalyzes the synthesis of methyl salicylic
acid (MeSA) into SA to induce SAR (Forouhar et al., 2005). Exogenous application of
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SA or its analog acibenzolar-S-methyl (ASM) also induces SAR as SABP2 catalyzes the
conversion of ASM into acibenzolar which induces SAR (Tripathi et al., 2010). SABP2silenced tobacco plants neither express PR-1 proteins nor induce SAR expression to a
significant level when treated with ASM (Tripathi et al., 2010). Conversely, treatment of
the same type of plants with acibenzolar induces full SAR indicating that SABP2 is
required for induction of resistance (Kumar and Klessig, 2003; Tripathi et al., 2010).
SABP2 is feedback inhibited by reverse binding of the product of the reaction it
catalyzes, SA. This inhibition promotes the accumulation of the more volatile MeSA to
be translocated through the phloem to uninfected parts of the plant (Forouhar et al.,
2005; Park et al., 2007).
To better understand the role of SABP2 in inducing SAR, an attempt was made
to identify its interacting proteins. One of the best ways to identify interacting proteins is
to use a yeast two-hybrid screen (Y2H). Y2H is a technique used in the discovery of
protein–protein interactions (Young, 1998) and also protein–DNA interactions (Joung et
al., 2000; Hurt et al., 2003) by testing for physical interactions between two proteins or a
protein and a DNA molecule. Typically one of the proteins, the known one, is termed the
‘bait’ and the unknown one(s) the ‘prey’. Interaction between the proteins causes
activation of a reporter gene which could be detected by change of color, antibiotic
resistance growth on depleted minimal media. With the aid of Y2H using full length
SABP2 as a bait, a number of interacting tobacco proteins were discovered. These
interacting proteins have been collectively referred to as ‘SABP2 interacting proteins’
(SBIPs). SBIP68, the focus of this research, is one of the interacting proteins.
Bioinformatics analyses revealed that the partial amino acid sequence of SBIP68 is
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100% identical to an annotated putative UDP-glucose: flavonoid glucosyltransferase
from Nicotiana tabacum (Fig. 7), with NCBI accession number BAD93688.1. It is a B
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Figure 7: Amino Acid Sequence of NtGT4. The PSPG Motif is shown in bold,
amino acid residues numbers 355–398.
type (fold) glycosyltransferase with 496 amino acid residues in its primary chain (NCBI).
It is encoded by the NtGT4 gene with a protein coding region that is 1491 base pairs
long (NCBI).
SBIP68 has the 44 amino acid C-terminal signature motif characteristic of family
1 of plant GT’s (UGT’s), the plant secondary product glycosyltransferase (PSPG) box
(Fig. 7; amino acid residues numbers 355 - 398), which is thought to be responsible for
binding the glucose donor substrate, UDP-glucose (Hughes and Hughes 1994). Results
from the Y2H screening showing that SBIP68 interacts with SABP2, which has high
affinity for SA (Kumar and Klessig, 2003), and bioinformatics analyses predicting
SBIP68 to be a UGT, both indicate that SBIP68 might be involved in the glucosylation of
SA during stress responses in plants (Fig. 8).
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Figure 8: Possible Role of SBIP68 in Plants. SBIP68 might be involved in the
glucosylation of SA during stress responses.

UGTs, SA, and the Significance of Glucosylation
Based on bioinformatics analyses, SBIP68 shows similarity (24% - 52%
identity) with many UDP-glycosyltransferases in Arabidopsis. UGT group D family
includes 13 members in Arabidopsis and it also contains genes identified in other plant
species, including tobacco, to be involved in plant stress responses (Langlois-Meurinne
et al., 2005). However, different patterns of expression in response to pathogens and
defense signal molecules such as SA, MeJA and H2O2 have been observed (LangloisMeurinne et al., 2005). None of them are induced by MeJA even though UGT73B genes
(B1-B5) expression are induced upon wounding (Langlois-Meurinne et al., 2005). Only
three of them, UGT73B3, UGT73B5, and UGT73C1 have been found to respond to
H2O2 (Langlois-Meurinne et al., 2005). Most of them respond to SA treatment (LangloisMeurinne et al., 2005). UGT73C6, a UDP-glucose: flavonol glucosyltransferase
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belonging to the Arabidopsis UGT group D, has been found to glucosylate the 7-OH
position of kaempferol-3-O-rhamnoside and quercetin-3-O-rhamnoside, respectively
(Jones et al., 2003). Presently, it is the only Arabidopsis UGT group D enzyme for which
the endogenous substrates are known (Langlois-Meurinne et al., 2005).
Salicylic acid has been found to be glycosylated at both the hydroxyl and the
carboxyl groups (Song, 2006). In TMV or Pseudomonas syringae pv. phaseolicola inoculated tobacco (Nicotiana tabacum cv. Xanthi-nc NN genotype) leaves, newly
synthesized SA is converted primarily to SA 2-O-β-D-glucoside (SAG) by glucosylation
at the hydroxyl group, and to glucosyl salicylate (GS), a relatively minor metabolite, by
glucosylating the carboxyl group, implying this to be a general process in tobacco plants
(Lee and Raskin, 1998). GS is rapidly produced while levels of SAG increases gradually
over a longer period of time making it a more stable metabolite of SA (Lee and Raskin,
1998). Biosynthesis of GS and SAG are catalyzed by UDPG/SA carboxyl
glucosyltransferase (SACGT) and UDPG/SA 2-O-glucosyltransferase (SAGT),
respectively (Lee and Raskin, 1998).
Unlike methyl salicylate, the glucosylated conjugates of SA accumulate only in
and around inoculated (or infected) parts of the plants where hypersensitive necrotic
lesions are formed, as there are no detectable levels of glucosylated SA in phloem sap
or uninoculated areas of TMV-inoculated plants (Enyedi et al., 1992 ; Malamy et al.,
1992). This suggests that glucosylation is not necessary for long distance signaling
during systemic acquired resistance (SAR) (Lee and Raskin, 1998). Just as inoculation
of tobacco leaves with TMV causes the activity of β-GTase to increase significantly as a
result of increased SA biosynthesis, exogenous application of SA produces similar
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results, showing that tobacco does not differentiate between endogenously produced
SA and exogenously supplied SA with regards to compartmentalization and biological
activity (Enyedi and Raskin, 1993).
Like most other enzymes, glucosyltransferases show substrate specificity. Most
plant glucosyltransferases are specific for UDP-glucose and a given phenolic compound
(Bechthold et al., 1991: Sun and Hrazdina, 1991: Fukuchi-Mizutani et al., 2003). An
exception to this is UDP-glucose:cinnamic acid glucosyltransferase present in sweet
potato that is involved in the conjugation of a range of phenolic compounds (Shimizu
and Kojima, 1984). Tobacco UDP-glucose: salicylic acid 3-O-glucosyltransferase (βGTase) has been found to be specific for the UDP-glucose as sugar donor and SA as
glucose acceptor (Enyedi and Raskin, 1993).
Because tobacco leaves rapidly metabolize SA to β-O-D-glucosylsalicylic acid
(GSA), most of the SA in TMV-inoculated leaves of tobacco is present in the form of
GSA (Enyedi et al., 1992; Malamy et al., 1992). Induction of β-GTase activity by SA has
been found to be inhibited by RNA synthesis inhibitors applied to cell-suspension
cultures of M. japonicus (Tanaka et al., 1990) and roots of oat plants (Yalpani et al.,
1992) indicating that SA triggers the de novo synthesis of β-GTase (Enyedi and Raskin,
1993). However, high concentrations of SA may inhibit plant growth (Pareek and Gaur,
1973; Chou and Patrick, 1976) by SA-induced disruption of membrane and inhibition of
ion absorption (Glass, 1973; Harper and Balke, 1981; Macri et al., 1986). Conversion of
SA to GSA may be required for sequestering excessive SA in the vacuole (Ben-Tal and
Cleland, 1982), hence protecting plant tissues from excessive damage by SA. This
makes sense as SA is required in a certain amount for increased activity of β-GTase
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and a subsequent increase in GSA. GSA may also serve to store metabolized SA
during plant defense (Enyedi and Raskin, 1993).
In strawberry plants, the expression of FaGT6 and FaGT7 glucosyltransferases
were found to be induced by certain plant defense signals suggesting their involvement
in stress responses (Griesser et al., 2008). Both glucosyltransferases were found to
glucosylate a number of exogenous substrates which do not occur in strawberry fruits in
vitro, suggesting they may have a role in detoxification (Griesser et al., 2008).
In Picrorhiza, MeJA treatment resulted in the upregulated expression of UGTs
UGT86C4 and UGT94F2. UGT86C4 expression was observed to increase 8-fold 12
hours post-application of MeJA and the expression of UGT94F2 increased 15-fold 24
hours post MeJA application (Bhat et al., 2013). Upon application of SA, UGT94F2
displayed maximum increase by 10-fold, 12 hours after induction while a 16-fold
increase in expression levels occurred with UGT86C4, 6 hours after induction (Bhat et
al., 2013). The rapid increase in the transcript levels of these UGT genes post
application of MeJA or SA is indicative of a possible role for these UGTs in plant
defense responses (Bhat et al., 2013).
Glycosylation is just one of the many mechanisms involved in the maintenance
of cellular homeostasis in plants. Glycosides are known to perform a number of
functions in plants including but not limited to serving as high-energy donors and
signaling molecules. They are involved in the biosynthesis of plant cell walls (Ostrowski
and Jakubowska, 2014). UGT’s catalyze the conjugation of plant hormones, a
regulatory mechanism that may serve to check the concentration of physiologically
active plant hormones during growth and development (Ostrowski and Jakubowska,

30

2014). Mutations leading to loss of function in UGT genes are known to have adverse
effects on the phenotype of the plants involved (Ostrowski and Jakubowska, 2014).
The significant role of SA in plants responding to stress suggests that it makes
use of an important signaling molecule whose concentration must be strictly controlled
(Ostrowski and Jakubowska, 2014). Even though the biological importance of SA
conjugates is still not fully understood, it is assumed that some of them serve to
increase the polarity of SA, thereby enabling its accumulation in plant vacuoles and
protection from degradation (Ostrowski and Jakubowska, 2014). Based on these, SA
glucosides may serve to transport and store SA (Ostrowski and Jakubowska 2014).
Further studies on the role of UGT’s in plants will enable us to come up with ways to
better control plant diseases and improve crop yield, by enhancing the resistance of
plants to pathogens and diseased conditions and consequently improve the life of
animals and humans alike.
This research aims at cloning the full length SBIP68, expression and
purification using a heterologous system (E. coli and/or yeast) and functionally
characterizing by testing a number of potential substrates (including but not limited to
salicylic acid) with the recombinant purified protein in vitro. Attempts will be made to
understand the effect of interaction of SBIP68 with SABP2, effect of SA on SBIP68, and
its possible role (if any) in the plants defense signaling mechanism.
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Hypothesis
Hypothesis: SBIP68 is a UDP-glucosyltransferase which glucosylates salicylic acid.
Yeast two hybrid screening revealed that SBIP68 interacts with SABP2 which
has high affinity for SA (Kumar and Klessig, 2003), and bioinformatics analyses
predicted SBIP68 to be a UGT. Based on these, it was hypothesized that SBIP68 is a
UDP-glucosyltransferase which glucosylates salicylic acid. It is also possible that
SBIP68 does not glucosylate SA, instead it glucosylates other molecules with important
roles in SA-mediated defense signaling in tobacco plants and its interaction with SABP2
modulates its activity or vice-versa.
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CHAPTER 2
MATERIALS AND METHODS
Plant Materials
Nicotiana tabacum cv. Xanthi-nc NN (XNN) plants were utilized for the purpose
of this experiment. Soil containing peat moss (Fafard Canadian growing mix F-15,
Agawam, MA) was used to cultivate the plants. The soil was autoclaved for 20 minutes
and allowed to cool to room temperature, after which an average of 20 seeds were
sown in a 4 x 4 inch plastic container. The container with the seeds was placed in a
controlled environment, a growth chamber (PGW 36, Conviron, Canada) set at 16-h day
cycle and 22 °C, the plants would be maintained under these conditions through the
course of the experiment. After 14 days, seedlings were transferred to 4 x 4 inch pots (2
per pot), and maintained in these for 3 weeks. Young plants were then transferred one
per 8” pot. Fertilizer (nitrogen, phosphorus, and potassium; 21:5:20) was diluted and
applied to the plants 3 days after transferring to 8” pots. The plants were grown until
they were 6 to 8 weeks old before using them for the experiments.
Chemicals and Reagents
Agar (Acros organics), agarose (SeaKem), ammonium persulfate (APS),
ammonium sulfate (NH4)2SO4), benzamidine-HCl, ß-mercaptoethanol (ß-ME), bovine
serum albumin (BSA), chloroform, coomassie brilliant blue G-250, coomassie brilliant
blue R-250, ethylenediaminetetraacetic acid (EDTA), glycerol, glycine, imidazole,
isopropanol, magnesium chloride (MgCl2), methanol, phenylmethanesulfonyl fluoride
(PMSF), ponceau-S, sodium chloride (NaCl), potassium phosphate dibasic (K2HPO4),
potassium phosphate monobasic (KH2PO4), sodium dodecyl sulfate (SDS),
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tetramethylethylenediamine (TEMED), TRIS base, tween-20, ethidium bromide, phenol,
isoamyl alcohol, 100% ethanol, glacial acetic acid, yeast extract, yeast nitrogen base
powder, and all other standard chemicals were purchased from Fisher Scientific
(Pittsburgh, PA). Liquid nitrogen (Airgas, TN), proteose peptone 3 (Becton and
Dickenson), dithiothreitol (DTT), diethylpyrocarbonate (DEPC), TRI reagent, mouse
monoclonal anti poly-histidine antibody, HRP conjugated goat anti-mouse IgG, mouse
anti c-myc monoclonal antibody, lyticase enzyme from Arthobacter luteus, and acid
washed glass beads (0.5mm), were purchased from Sigma-Aldrich. Acrylamide solution
(30%), pre-stained low molecular weight marker, SDS sample buffer, and Gene Pulser
cuvettes (0.2 cm) were purchased from Bio-Rad, Hercules, CA. Pierce ECL Western
blotting substrate was purchased from Thermo Scientific, Rockford, IL. WesternSure
PREMIUM Chemiluminescent Substrate was purchased from LI-COR, Lincoln, NE.
Polyvinylidene fluoride (PVDF) membranes were purchased from Millipore, Billerica,
MA. Oligo dT-20, and Taq DNA polymerase were purchased from Invitrogen, CA.
RNAse free DNAse, recombinant RNAsin, and MMLV reverse transcriptase were
purchased from Promega. dNTP, 100 bp and 1 kb DNA ladders, and restriction
enzymes (New England Biolabs), and gel loading dye (Bio-Rad). ZeocinTM was
purchased from Research Products International Corps (Illinois). QIAprep Spin Miniprep
Kit, QIAGEN Plasmid Midi Kit, and QIAquick Gel Extraction Kit were purchased from
Qiagen (Valencia, CA). Advantage HF 2 PCR Kit was purchased from Clontech.
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Cells and Vectors
pGEM®-T easy vector was purchased Promega, pET-28a vector from Novagen,
and pPICZA vector from Invitrogen (Carlsbad, CA). X-33 strain of Pichia pastoris was a
gift from Dr. Cecilia McIntosh, East Tennessee State University (Johnson City, TN).
Oligonucleotides
All the primers used in this study were custom synthesized by Eurofins MWG
Operon (Huntsville, AL). The lyophilized oligonucleotides were re-suspended in
nuclease-free water and diluted to give a final concentration of 10 μM. Table 1 lists all
the primers and their respective uses.
Table 1: Primers Used in This Study
Primers
DK639
forward
DK640
reverse
DK641
forward
DK642
reverse
DK643
forward
DK644
reverse
DK645
reverse
DK551
forward
DK552
reverse

Sequence (5’ – 3’)

Tm

GCCTCGAGGTCATGGCAACTCAAGTGCAC 72.9
AAACTTCATTTCATACTATTC
GAGGGCCCTTTTTCCTTGTGATTTTGTTGC 72.1
TCAATGATGTCTTCAATCAG
60.6
GACTGGTTCCAATTGACAAGC
GCAAATGGCATTCTGACATCC
GGATCCATGGCAACTCAAGTGCACAAACT
TCATTTCATACTATTC
CTCGAGCTATTTTTCCTTGTGATTTTGTTG
CTCAATGATGTCTTC
CTCGAGTTTTTCCTTGTGATTTTGTTG
CTCAATGATGTCTTCAAT

60.6
70.2
69.3
68.4
56.7

GTAAAACGACGGCCAG

54.8

CAGGAAACAGCTATGAC
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Purpose
Cloning in P.
pastoris
Cloning in P.
pastoris
Sequencing
in P. pastoris
Sequencing
in P. pastoris
Cloning in E.
coli
Cloning in E.
coli
Cloning in E.
coli
Sequencing
Sequencing

Apparatus
Mastercycler (Eppendorf, NY), ND-1000 nanodrop spectrophotometer (Thermo
scientific), agarose gel electrophoresis apparatus (Fisher Biotech) and SDS-PAGE
apparatus (BIO-RAD), Gene Pulser (BIO-RAD), Western blot apparatus (BIO-RAD), gel
doc (UVP) system, pH meter (Beckman), high speed centrifuge (Sorvall RT6000
refrigerated centrifuge, DuPont, Waltham, MA), UV transilluminator (UVP Bioimaging
Systems), LI-COR C-DIGIT Western blot imager (LI-COR). Spectrophotometer, French
press (Thermo Sciencific), centrifuge (Beckman, model J2-21 or Sorvall RC5B),
sonicator, AKTA purifier 10 (GE) system, Beckman LS 6500 scintillation counter
(McIntosh lab, ETSU), Waters Breeze HPLC system (McIntosh lab, ETSU).
Methods
Cloning and Expression of SBIP68 in E. coli
To clone and express SBIP68 in E. coli, gene specific primers (DK 643, DK644
and DK645) were synthesized and used. All primers were designed with a restriction
enzyme site to enable cloning into an E. coli expression plasmid. The forward primer
DK643, had a BamHI restriction endonuclease site. Both the reverse primers, DK644
and DK645 had Xho I restriction endonuclease sites. The plasmid pET-28a (Figure 9)
used for cloning and expression of SBIP68 in E.coli has both an N- and C- terminal 6x
polyhistidine tag coding sequence to help ease purification of recombinant proteins. The
reverse primer DK644 was designed to have the original stop codon present in the
SBIP68 gene, in which case the expressed protein was expected to be fused to the Nterminal 6x polyhistidine tag of the pET-28a vector. Reverse primer DK645 on the other
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hand did not have the stop codon of the SBIP68 gene in it, the expressed protein in this
case was to be fused to either the C-terminal 6x polyhistidine tag or both the N and C terminal 6x polyhistidine tags of the pET-28a vector.

Figure 9: Map of E. coli Expression Plasmid pET-28a (Novagen). Bam HI and Xho I
restrictriction sites of the multiple cloning area were used to clone SBIP68 in E. coli.

Total RNA Extraction
To minimize degradation during total RNA isolation, all material used were either
disposable or sterilized by autoclaving. Fresh DEPC treated water (Appendix B) was
autoclaved and was used. Leaf discs were obtained from wild type tobacco XNN plants
with the aid of a cork borer. The discs were transferred into eppendorf tubes, and snap
frozen by dropping into liquid nitrogen. The frozen tissues were homogenized to fine
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powder using a mechanical grinder and liquid nitrogen. To the finely ground leaf powder
(~50-100 mg), 1 ml TRI reagent was added and vortexed. The sample mixture was
incubated for 5 mins at room temperature. Two hundred microliters of chloroform was
added to the sample mixture, mixed gently by inverting the tubes several times, and
incubated at room temperature for 3 minutes. Following incubation, the sample was
centrifuged at 12,000 x g for 10 minutes at 4 °C. The supernatant resulting from the
centrifugation step was transferred to a fresh eppendorf tube. To the supernatant,
500 μl isopropanol was added, mixed and followed by a 10 minute incubation period at
28 °C. The sample was centrifuged at 12,000 x g for 10 minutes at 4 °C and the
supernatant was discarded, while making sure the pellets remained in the tube. The
pellet was resuspended in 1 ml of 75 % cold ethanol (prepared with DEPC treated
water) and centrifuged at 7500 x g for 5 minutes at 4 °C. The supernatant was
discarded and the pellet was air dried for 5-10 minutes. The pellet was resuspended in
43 μl DEPC-treated (ribonuclease free) water and incubated at 37 °C for 5 minutes. Five
microliters DNase buffer and 2 μl DNase (RNase free) were added to the sample,
mixed, and incubated at 37 °C for 20 minutes. To the sample, 0.5 ml of TRI reagent was
added and vortexed, followed by a 5 minute incubation at room temperature. One
hundred microliters of chloroform was added to the sample, mixed very gently and
incubated at room temperature for 3 minutes. The sample was centrifuged at 12,000 x g
for 10 minutes at 4 °C and the resulting supernatant was transferred to a fresh tube. To
this, 250 μl isopropanol was added followed by a 10 minute incubation period at 28 °C.
The sample was centrifuged at 12,000 x g for 10 minutes at 4 °C. The supernatant was
carefully decanted. To the pellet, 0.5 ml of 75 % cold ethanol was added. The sample
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was centrifuged at 7500 x g for 5 minutes at 4 °C. The supernatant was discarded, the
pellet air dried for 10 minutes and resuspended in 20 μl DEPC-treated water. The
sample was incubated at 55 °C for 10 minutes after which RNA concentration was
determined using a nanodrop spectrophotometer at 260 nm. The purity of the sample
was also determined from the value of OD260:OD280 (>1.8 shows low protein
contamination).
cDNA Synthesis
In synthesizing first strand cDNA, 1 μl (0.5 μg/μl) of oligo-dT was added to 9 μl (1
μg) of total RNA. The sample was mixed and incubated at 75 °C for 10 minutes in a
thermocycler and then cooled to 4 °C for annealing to occur. In a separate tube, 10 μl of
RT (reverse transcriptase) reaction mix was made. The RT reaction mix constituted 3 µl
of DEPC-treated water, 4 µl of 5 x RT buffer, 1 μl of 10 mM dNTP, 1 μl RNasin (RNase
inhibitor), and 1 µl MMLV reverse transcriptase (RT) enzyme. Ten microliters of the RT
mix was added to 10 μl of the RNA/oligo-dT mix. This new 20 μl sample was briefly
vortexed and incubated in a thermocycler at 42 °C for 60 minutes and at 70 °C for 10
minutes for reverse transcription and inactivation of the RT enzyme to occur,
respectively. One microliter of the newly synthesized cDNA was used to carry out a
polymerase chain reaction (PCR) of the tobacco housekeeping gene EF1α to check the
integrity of cDNA. The 10 µl PCR reaction mix composed of 1 μl cDNA, 1 μl of 10 x Taq
polymerase buffer, 1 μl of 10 x dNTP mix, 0.2 μl of 10 μM forward primer, 0.2 μl of 10
μM reverse primer, 0.2 μl of Taq DNA polymerase, 6.4 μl of H2O. The PCR conditions
were as follows: hot start and initial denaturation at 94 °C for 2 minutes, 30 cycles of
denaturation, annealing, and elongation at 94 °C, 55 °C, and 72 °C, for 30 seconds, 30
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seconds, and 45 seconds respectively, and a final extension step at 72 °C for 5
minutes. The rest of the cDNA was preserved at - 20 °C for future use.
Polymerase Chain Reaction (PCR)
The SBIP68 gene was PCR amplified using cDNA prepared from tobacco leaves
and Advantage HF 2 PCR Kit (Clontech) following manufacturer’s instructions.
Advantage HF 2 polymerase contains a mixture of Taq DNA polymerase and a
proofreading enzyme. Each PCR reaction mix composed 3 μl cDNA, 5 μl of 10 x HF2
PCR Buffer, 1 μl of 50 x HF dNTP mix, 1 μl of 10 μM forward primer, 1 μl of 10 μM
reverse primer, 1 μl of 50 x Advantage HF polymerase mix, 40 μl of H2O. The PCR
conditions were as follows: hot start and initial denaturation at 94 °C for 4 minutes, 30
cycles of denaturation, annealing, and elongation at 94 °C, 55 °C, and 72 °C, for 30
seconds, 30 seconds, and 90 seconds respectively, and a final extension step at 72 °C
for 10 minutes. DK643 forward primer, and DK644 reverse primer (with the SBIP68 stop
codon) were used to facilitate cloning into E.coli with a 6xHis fusion tag at the 5’ end of
the gene. DK643 forward primer, and DK645 reverse primer (without the SBIP68 stop
codon) were used to facilitate cloning into E.coli with a 6xHis tag codon at both the 5’
and 3’ ends of the gene.
Agarose Gel Electrophoresis
Agarose gel electrophoresis was used to separate nucleic acids based on size
differences. The PCR products were analyzed by gel electrophoresis using 1.2 %
agarose gel containing ethidium bromide. Ten microliters of 6 x DNA loading dye was
mixed with 50 μl of PCR product. Eight microliters (25 ng/μl) of a 1 kb DNA ladder was
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loaded into the first well, and the samples were loaded into the other wells. The gel was
run at 80 volts for ~ 90 minutes and visualized on a UV transilluminator.
Purification of PCR Product
SBIP68 DNA bands were cut out and purified using Qiagen Gel Extraction kit
following the manufacturer’s instructions. The purified DNA was quantified using a
Nanodrop spectrophotometer at 260 nm and subsequently analyzed on a 1.2 %
agarose gel as previously described.
Construction of pGEMT-SBIP68 Clone
Taq DNA polymerase adds a single deoxyadenosine nucleotide base to the 3´ends of PCR amplified fragments, in a template-independent fashion (Zhou and GomezSanchez, 2000). Cloning into pGEMT easy vector (Promega) is made possible due to
these deoxyadenosine bases added to the PCR amplicons. The vector, pGEMT, is
provided as a linear plasmid with single terminal thymidine bases added to both 3´ ends
(Fig. 10). The single 3´-T overhangs present at the insertion site of the vector greatly
improve the efficiency of ligation of PCR amplicons having 3´-deoxyadenosine bases
into the plasmids by preventing recircularization of the vector and providing a
compatible overhang for these PCR products (Zhou and Gomez-Sanchez, 2000;
Promega). The plasmid, pGEMT allows for blue/white screening on indicator plates and
carries an ampicillin resistant gene (Promega).
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Figure 10: Map of pGEM-T Easy Vector (Promega)

A 10 µl ligation reaction was set up as follows: 5 µl 2 x rapid ligation buffer, 1 µl
pGEMT easy vector, 2 µl purified PCR product, 1 µl T4 DNA ligase, and 1 µl H2O. The 2
x rapid ligation buffer was vortexed vigorously before use. A control reaction which had
all the constituents of the standard reaction without the PCR products was also set up.
Ligation reactions were incubated overnight at 4 °C for maximum number of
transformants.
Preparation of Fresh Competent DH5α Cells
E. coli DH5α cells from a glycerol stock stored at -80 °C freezer were streaked on
an LB plate and incubated overnight at 37 ºC. The following day, single isolated
colonies from the plate were used to inoculate 3 ml of LB-broth and grown at 37 °C and
250 rpm until the cultures had an OD600 of ~ 0.45. The cultures were transferred to prechilled tubes (on ice) for 15 minutes. They were then centrifuged at 3000 x g for 10
minutes at 4 °C. The pellet was gently resuspended in 0.6 ml of ice cold sterile 0.1 M

42

CaCl2 and incubated on ice for 30 minutes. The bacterial suspensions were centrifuged
at 3000 x g for 10 minutes at 4 °C, the supernatants were discarded, and the pellet
resuspended in 120 μl of ice cold 0.1 M CaCl2. The resuspended cells (50 μl) were used
for transformation.
Transformation of E. coli DH5α with pGEMT-SBIP68 Plasmid DNA
The ligation reactions were vortexed briefly and 2 µl of each ligation reaction was
added to 50 μl of freshly prepared competent cells in a 1.5 ml tube. The tubes were
gently flicked and incubated on ice for 20 minutes. After 20 minutes, the cells were heatshocked for 50 seconds in a water bath at 42 °C and immediately returned to ice for 2
minutes. Following incubation, 950 μl LB medium was added to each tube containing
transformation mix. The samples were incubated for 90 minutes at 37 °C with shaking at
150 rpm. The transformation mix was centrifuged at 5,000 x g for 1 min and pellet was
resuspended in 200 μl LB medium (Appendix B). The resuspended transformation mix
was spread on LB/ampicillin/IPTG/X-Gal plates (Appendix B) using sterile glass beads
and incubated overnight at 37 °C. The following morning, white colonies were selected
for further analysis for the presence of insert using colony PCR.
Verification of pGEMT-SBIP68 Plasmid by Colony PCR
A colony PCR was performed to screen for positive clones containing SBIP68.
Single isolated white bacterial colonies were picked using sterile tips from the plates
and streaked on a fresh LB/ampicillin plate. Each colony was assigned a number for
future reference. Following streaking, each tip was put in a 0.2 ml PCR tube containing
40 μl of sterile water and pipetted up and down a few times to suspend the remaining
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bacteria. Ten microliters bacterial suspension from each colony was used as template in
the PCR reaction. Each PCR reaction mix was composed of 10 μl bacterial suspension,
2 μl of 10 x PCR Buffer, 2 μl of 0.1 M dNTP mix, 0.8 μl of M13 forward primer, 0.8 μl of
M13 reverse primer, 0.5 μl Taq DNA polymerase, and 3.9 μl sterile H2O. The PCR
conditions were as follows: 94 °C for 4 minutes, 30 cycles of denaturation, annealing,
and elongation at 94 °C, 55 °C, and 72 °C, for 30 seconds, 30 seconds, and 90 seconds
respectively. The PCR products were analyzed by agarose gel electrophoresis as
described earlier.
Plasmid DNA Isolation from pGEMT-SBIP68 Clones
Positive clones following confirmation by colony PCR, were selected for plasmid
purification. Corresponding colonies from master plate were used to inoculate 3 ml LB
broth containing ampicillin (100 μg/ml). The bacterial cultures were grown at 37 °C and
250 rpm overnight. Plasmid DNA’s were isolated from the overnight cultures using the
QIAprep Spin Miniprep kit according to the manufacturer’s instructions. The
concentration and purity of the isolated plasmids were determined using a nanodrop
spectrophotometer at 260 nm. The quality of the plasmid DNA was also checked using
a 0.8 % agarose gel as described earlier.
Sequencing of pGEMT-SBIP68 Recombinant Plasmid
The purified plasmid DNA (0.5 – 1.0 μg each), were sent to the DNA Analysis
Facility at Yale University to be sequenced. The Sanger DNA Sequencing method was
employed in sequencing the pGEMT-SBIP68 constructs. The plasmids were sequenced
using M13 forward and M13 reverse primers. Analysis of the sequencing results helped
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in identifying clones with the highest similarities to the database gene sequence
(NtGT4). Of the 1,488 nucleotides in the protein coding sequence, there was only one
nucleotide difference, at position 552. This was a pyrimidine to pyrimidine (T to C) base
change and upon translation did not result in an amino acid change in the primary
sequence of the protein.
Cloning of SBIP68 into E. coli Expression Plasmid pET-28a
The positive pGEMT-SBIP68 clone following DNA sequence analysis was
selected for further cloning into pET-28a. To excise out SBIP68 from pGEMT, the
pGEMT+SBIP68 plasmid was restriction digested with BamHI and Xho I restriction
enzymes. Similarly, the destination plasmid pET-28a was also restriction digested with
BamHI and Xho I. The reaction mixture for the pGEMT-SBIP68 plasmids included: 10 μl
pGEMT-SBIP68 plasmid-DNA, 2 μl NEB buffer #3, 2 μl BSA (10mg/ml), 4 μl sterile H2O,
1 μl BamHI, and 1 μl Xho I. The digestion reaction for the pET-28a vector included: 5 μl
pET-28a vector, 2 μl NEB buffer 3, 2 μl BSA (10mg/ml), 9 μl sterile H2O, 1 μl BamHI,
and 1 μl Xho I. The reactions were incubated at 37 °C for 3 hours. The restriction
digested plasmid DNA were separated by running on a 0.8 % agarose gel. The DNA
band corresponding to SBIP68 was excised out and purified using QIAquick Gel
Extraction Kit according to the manufacturer’s instructions. Similarly the BamHI and Xho
I restriction digested pET-28a was also gel purified. Concentration and purity for SBIP68
and pET-28a were determined using a nanodrop spectrophotometer at 280 nm.
After gel purification, SBIP68 was ligated into pET-28a using T4 DNA ligase
following manufacturer’s instructions. Each reaction mixture consisted of 3 μl SBIP68-
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644 (24.1 ngμl-1) or SBIP68-645 (28.6 ngμl-1) DNA, 2 μl pET-28a vector (14.5 ngμl-1),
1 μl 10 x ligase buffer, 1 μl T4 DNA ligase, and 3 μl H2O. The reaction mixtures were
incubated at 16 °C overnight for ligation.
Transformation of E. coli BL21(DE3) pLysE with pET-28a-SBIP68 Plasmid
The ligated products from pET-28a-SBIP68 were used to transform E. coli BL21
(DE3) pLysE competent bacterial cells. The competent cells were prepared (as
described earlier) and stored at – 80 °C. Frozen competent cells were thawed by
placing them on ice for ~ 5 minutes. Two microliters of ligation products were added to
1.5 ml eppendorf tubes containing 50 μl competent cells. The contents of the tubes
were mixed gently and incubated on ice for 20 minutes. Cells were heat-shocked for 45
seconds using a water bath at 42 °C and the tubes were immediately returned to ice for
2 minutes. To the transformation mixture, 950 μl of LB broth was added and incubated
at 37 °C for 1 hour at ~ 150 rpm. Transformed bacterial cells were plated on
LB/Kanamycin (50 μg/ml) plates using sterilized glass beads as described earlier.
Plates were incubated at 37 °C overnight.
Test for Recombinant pET-28a-SBIP68 Protein Expression
Colony PCR using pET-28a specific primers was performed as described earlier
to test for clones containing the plasmid of interest. Positive clones were used to
inoculate 3 ml LB broth containing kanamycin (50 μg/ml). Cell cultures were incubated
at 37 °C with shaking at 250 rpm for 2 hours. One milliliter of each culture was
transferred into a 1.5 ml microcentrifuge tube and centrifuged at maximum speed for 3
minutes. The supernatants were discarded and the pellets (uninduced controls) stored
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at - 20 °C. To the remaining 2 ml cultures, 4 μl of 0.5 M isopropyl-beta-Dthiogalactopyranoside (IPTG) was added to a final concentration of 1mM for the
induction of recombinant protein expression. Induction was carried out at 37 °C and 250
rpm for 3 hours. After 3 hours, the bacterial cultures were centrifuged at 5000 x g for 3
minutes, the supernatants were discarded and the pellets stored at – 20 °C. The pellets
from both induced and uninduced samples were heated. They were analyzed by SDSpolyacrylamide gel electrophoresis.
Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS-PAGE)
SDS-PAGE was performed by mixing each protein sample with an equivalent
amount of 2 x SDS sample buffer containing 5 % βME added just before use. The
mixtures were placed in a boiling water bath for 5 minutes and centrifuged at 16,200 x g
for 10 minutes at room temperature. The samples were loaded on an SDS gel and run
using electrophoresis at 200 volts until the dye reached the bottom of the gel ~ 50
minutes. The gel was stained using coomassie blue stain for 20 minutes and
subsequently destained with a destaining solution (Appendix B) to remove the
background dye as much as possible to make separated proteins visible.
Western Blot Analysis
Upon the separation of protein samples using SDS-PAGE, the proteins were
transferred from the gel to a membrane by electroblotting. The membrane used
throughout this study was PVDF (polyvinylidene difluoride) membrane. Prior to
electroblotting, the PVDF membrane was incubated in 100% methanol for 15 seconds
after which it was rinsed with water for 2 minutes. The membrane was placed in 1x
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Western blot transfer buffer (Appendix B) and allowed to shake gently on a platform
shaker for 10 minutes. The foam pads and 3 mm Whatman papers were presoaked in
the 1x Western blot transfer buffer to be used for electroblotting. The gel and PVDF
membrane were sandwiched in between the Whatman papers which were sandwiched
between the foam pads. A roller was used to remove any air bubbles trapped in the
sandwich. The sandwich was placed in the gel cassette holder such that the gel was on
the black colored (negative) side of the gel cassette holder and the membrane was on
the clear side (positive) of the gel cassette holder. A small magnetic stir bar was placed
in the electrophoresis tank which was to be placed on a magnetic stirrer. A cold ice pack
was also placed in the electrophoresis tank. The cassette holding the gel and
membrane was placed in the electrophoresis tank such that the black colored side of
the cassette and the electrophoresis unit were in contact and the clear side of the
cassette was towards the red side of the electrophoresis unit.
Electroblotting was carried out at ~ 96 volts for 1 hour at 4 °C. After 1 hour, the
PVDF was taken out of the cassette, rinsed with methanol for 15 seconds, and allowed
to air dry for about 1 minute. The membrane was again rinsed with 100% methanol for
15 seconds and then placed in ponceau S stain (Appendix B) for 2 minutes to verify
protein transfer. The membrane was rinsed with deionized water and visualized for
protein transfer. Ponceau S stain was washed off with 1x PBS (phosphate buffered
saline, Appendix B). Once the membrane was clear of the ponceau S stain, the PBS
was discarded and blocking buffer (1 % non-fat dry milk, 3 % BSA in 1 x PBS, Appendix
B) containing mouse monoclonal anti-polyhistidine primary antibody (1:2,500) was
added to the membrane. The membrane with primary antibody was incubated on a
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rocking platform overnight at 4 °C. The next morning, the membrane was sequentially
washed twice with 1 x PBS, twice with1 x PBS containing 3 % tween 20, and twice with
1 x PBS for a duration of 5 minutes per wash step. The membrane was then incubated
with anti-mouse IgG conjugated with horseradish peroxidase in blocking buffer (1:5,000)
at room temperature for 2 hours on a rocking platform. The membrane was washed as
described above. After washing, the membrane was incubated in 2 ml of WesternSure
PREMIUM Chemiluminescent Substrate for 5 minutes at room temperature making sure
the entire surface area of the membrane was covered by the substrate. The membrane
was removed from the substrate and the excess substrate left on the membrane was
allowed to drip off. The membrane was placed protein side down in a C-Digit Blot
Scanner and a plastic wrap was placed on top of the membrane. The blot was scanned
for 12 minutes for maximum sensitivity and several pictures were captured. Following
scanning, the blot was stained with coomassie blue.
Recombinant pET-28a-SBIP68 Protein Solubility Test
To check if recombinant pET-28a-SBIP68 protein was present in soluble or
insoluble form, a solubility test was carried out. Positive bacterial colonies were used to
inoculate 3 ml of LB with kanamycin (50μg/ml). Cell cultures were incubated at 37 °C
with shaking at ~ 250 rpm for 2 hours. After 2 hours, 1 ml of each culture was
centrifuged and the pellets preserved at –20 °C to serve as uninduced controls. To the
remaining 2 ml cultures, 4 μl of 0.5 M isopropyl-beta-D-thiogalactopyranoside (IPTG)
was added to give a final concentration of 1 mM for the induction of protein expression.
Induction was carried out at 37 °C and 250 rpm for 3 hours. After 3 hours, the bacterial
cultures were centrifuged at maximum speed (18,800 x g) for 3 minutes, the
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supernatants were discarded and the pellets preserved at – 20 °C. The following day,
pellets from both induced and uninduced 1 ml samples were resuspended in 100 µl of
Ni-NTA binding buffer each. The samples were sonicated while placed on ice at an
amplitude of 10 % for 5 seconds and a 15 second interval for 3 times. The samples
were centrifuged at 16,200 x g for 5 minutes at 4 °C. Supernatants were transferred into
fresh microcentrifuge tubes and mixed with 2 x SDS sample buffer ratio 1:1. These were
placed in a boiling water bath for 5 minutes. The samples were centrifuged at 16,200 x
g for 2 minutes and analyzed using SDS-PAGE and Western blot. To the pellets derived
just before placing the supernatants in the water bath above, 200 μl of SDS sample
buffer was added to each. These were placed in a boiling water bath for 5 minutes after
which they were analyzed using SDS-PAGE and Western blot as described earlier.
Optimization of Conditions for Protein Solubility
Protein expression at 37 °C and 1mM IPTG concentration resulted in mostly
insoluble recombinant SBIP68 and a small amount of soluble protein. To increase the
solubility of recombinant SBIP68, the expression conditions were fine-tuned by lowering
the incubation temperature for expression to 17 °C and lowering the concentration of
IPTG (0.1 mM, and 0.01 mM). Induction at 37 °C and 1 mM IPTG concentration was
also performed simultaneously to serve as a control. Single colonies from the plates
were used to inoculate 3 ml LB/kan media which were incubated at 37 °C and 250 rpm
overnight. The following morning, 1 ml of each culture was used to inoculate 100 ml of
LB/kan medium each. One hundred milliliter cultures were grown at 37 °C and 250 rpm
until the OD600 was within 0.6 – 0.7. One milliliter samples were taken from each
culture to serve as uninduced controls. To the remaining 99 ml cultures, 198 μl, 19.8 μl,
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and 1.98 μl of 0.5 M IPTG were added to a final IPTG concentration of 1 mM, 0.1 mM,
and 0.01 mM, respectively, to induce SBIP68 expression. The 37 °C cultures were
incubated for 3 hours at 250 rpm, while the 17 °C cultures were incubated overnight at
250 rpm. Upon the completion of incubation, 1 ml of each culture was put in separate
1.5 ml tubes to be processed by Western blot analysis of SBIP68 solubility as previously
described. The remaining 99 ml cultures were transferred to separate tubes and
centrifuged at 21,000 x g for 10 minutes at 4 °C. The supernatants were discarded and
the cell pellets saved at - 20 °C until they were purified for recombinant SBIP68 protein.
Cell Lysis and Purification of Recombinant SBIP68 Protein
Each pellet from 100 ml culture was resuspended in 3 ml of 1 x Ni-NTA binding
buffer containing 30 μl PMSF (phenylmethylsulfonyl flouride – a protease inhibitor,
Appendix B), and 15 mM imidazole. Bacterial cells were lysed 3 times using a French
press mini cell (stored at 4 °C prior to use) at 20,000 psi and the lysed samples were
collected on ice. Samples were centrifuged at 21,000 x g for 15 minutes at 4 °C. The
soluble fractions (supernatants) were collected in fresh tubes and the pellets were
stored at - 20°C. Twenty-five milliliters of 1 x Ni-NTA binding buffer was used to
equilibrate 2 ml of Ni-NTA resin. Each soluble fraction was gently transferred to the
respective Ni-NTA column with the aid of a pipette and allowed to settle. The stop valve
was opened to collect flow-through and the column was washed with at least 15 ml of 1
x Ni-NTA wash / binding buffer (containing 15 mM imidazole). The bound 6xHis-tag
SBIP68 protein was eluted with 1 x Ni-NTA elution buffer (pH 8.0) containing 250 mM
imidazole at room temperature. The eluted proteins were collected in 0.5 ml fractions
which were stored at 4 °C. SDS-PAGE and Western blot analysis were performed to
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verify the presence of the protein of interest in the purified samples. Fractions with
highest recombinant SBIP68 were pooled, concentrated, and used for GT activity.
Analysis of Glucosyltransferase Activity Reaction Products using HPLC
GT activity assays were carried out using purified recombinant SBIP68 and
HPLC was performed to identify the products of the glucosyltransferase reactions
(Owens and McIntosh, 2009). Each 150 μl reaction mix consisted of 10 μl acceptor
substrate (100 nmol aglycone in ethylene glycol monomethyl ether), 100 μl assay buffer
(50 mM sodium phosphate buffer pH 7.5, 14 mM βME), 20 μl donor substrate (200 nmol
UDP-glucose), and 20 μl (34 µg, of which SBIP68 was about a tenth or less of this)
partially purified SBIP68 recombinant enzyme. The acceptor substrates used were
kaempferol, quercetin, naringenin, or hesperetin. The reaction mix was incubated with
gentle shaking at 37 °C for 120 minutes. After 120 minutes, 30 μl 6 M HCl was added to
the sample tube and mixed by vortexing briefly. Five hundred microliters of ethyl acetate
was added to the sample to separate the formed glucosides from unincorporated UDPglucose, the reaction tube was vortexed and centrifuged very briefly. Three hundred
microliters from the upper organic phase of the sample (containing the reaction
products) was transferred to a fresh tube. The reaction products were dried using
nitrogen gas. The dried components were redissolved in 60 µl of HPLC grade methanol
and 10 µl of this was run on a Waters Breeze HPLC system that consists of an in-line
degasser AF, a binary HPLC pump 1525 and a dual wavelength absorbance detector
2487 operated by Breeze software version 3.30 (Waters, Milford, MA). The mobile
phase was acetic acid:water (15:85) and a gradient of 95:5 acetonitrile:water was the
organic phase over a period of 28 minutes. Sample fractionation was performed at room
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temperature using a Nova-Pak® C18 (3.9 x 150 mm) column at a flow rate of 1.0
ml/min. The wavelengths used for detection were 290 and 365 nm. Kaempferol,
kaempferol 3-O-glucoside, quercetin, quercetin 3-O-glucoside, naringenin, naringenin 7O-glucoside, and hesperetin were used as standards in the identification of the reaction
products.
Cloning and Expression of SBIP68 in P. pastoris
Two gene specific primers, a forward primer DK639 and a reverse primer DK640
were utilized in the cloning of SBIP68 in P. pastoris. Both primers were designed to
carry a restriction enzyme site to enable cloning into an expression system. The forward
primer DK639, had an Xho I restriction endonuclease site, while the reverse primer
DK640 had an Apa I restriction endonuclease site. The vector pPICZA (Fig. 11),
containing a c-myc epitope tag coding sequence and a C-terminal 6x polyhistidine tag
coding sequence to facilitate the detection and purification of recombinant proteins
respectively (Invitrogen) was used for cloning and expression of recombinant SBIP68.
The reverse primer DK640 was designed without the stop codon present in the SBIP68
gene thereby making use of the stop codon just after the C-terminal 6x polyhistidine tag
in the vector.
PCR Amplification of SBIP68 for Cloning into pPICZA
SBIP68 was PCR amplified using a verified pGEMT-SBIP68 clone as a template.
The PCR reaction mix composed of 3μl pGEMT-SBIP68 plasmid DNA, 5 μl of 10 x HF2
PCR Buffer, 1 μl of 50 x HF dNTP mix, 1 μl of 10 μM forward primer, 1 μl of 10 μM
reverse primer, 1 μl of 50 x Advantage HF polymerase mix, 40 μl of H2O. The PCR
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conditions were as follows: hot start and initial denaturation at 94 °C for 4 minutes, 30
cycles of denaturation, annealing, and elongation at 94 °C, 55 °C, and 72 °C, for 30
seconds, 30 seconds, and 90 seconds respectively, and a final extension step at 72 °C
for 10 minutes.

Figure 11: Map of pPICZ Vector (Invitrogen). The restriction sites Xho I and Apa I
were used in cloning SBIP68 in P. pastoris

Purification of PCR Product
The products of the PCR reaction (SBIP68’) were analyzed using agarose gel
electrophoresis as described earlier. SBIP68’ DNA bands were cut out for purification
following gel electrophoresis. The bands were purified using Qiagen Gel Extraction kit
following the manufacturer’s instructions. The purified products were quantified using a
nanodrop spectrophotometer and subsequently analyzed on 0.8 % agarose gel.
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Construction of pGEMT-SBIP68’ Clone
Gel purified SBIP68’ was ligated into pGEMT easy vector and transformed into
competent DH5α cells as described earlier. The cells were plated on LB/ampicillin
containing IPTG/X-Gal and incubated overnight at 37 °C. The following morning, white
colonies were selected and streaked on fresh LB/ampicillin plates. The colonies were
also tested for presence of SBIP68’ using colony PCR as described earlier.
Recombinant Plasmid pGEMT-SBIP68’ Propagation and Isolation
Positive clones were propagated and used for plasmid purification using the
QIAprep Spin Miniprep kit. The concentration and purity of the isolated plasmids were
determined as previously described.
Sequencing of pGEMT-SBIP68’ Recombinant Plasmid
Each of the purified plasmids (0.5 – 1.0 μg) was sent to the DNA Analysis Facility
at Yale University to be sequenced. The plasmids were sequenced using M13 forward
(DK551) and M13 reverse primers (DK552). Analysis of the sequencing results helped
in identifying clones whose protein coding sequence were 100 % identical to pGEMTSBIP68 used for PCR amplification.
Digestion of pGEMT-SBIP68’ Plasmid and pPICZA Vector
pGEMT-SBIP68’ plasmid and pPICZA plasmid were both digested with Xho I and
Apa I. The digestion reaction for the pGEMT-SBIP68’ plasmids included in each tube:
10 μl pGEMT-SBIP68’ plasmid-DNA, 2 μl CutSmart buffer, 6 μl sterile H2O, 1 μl Xho I,
and 1 μl Apa I. The digestion reaction for the pPICZA vector included: 5 μl pPICZA
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vector, 2 μl CutSmart buffer, 11 μl sterile H2O, 1 μl Xho I, and 1 μl Apa I. All the
constituents of each of the reactions were added at the initial stage with the exclusion of
the Xho I enzyme. The samples were incubated at 25 °C (optimum temperature for Apa
I) for ~ 2 hours. After about 2 hours, Xho I was added to each sample and the samples
were incubated at 37 °C for 3 hours. Both enzymes were heat inactivated at 65 °C for ~
20 minutes. The digested samples were gel purified as described earlier. The
concentration and purity of digested DNA and vector was determined using a nanodrop
spectrophotometer as previously described.
Ligation of SBIP68’ into pPICZA
After purification, the products of the digestion reactions were ligated to create
pPICZA-SBIP68’ constructs. Each reaction contained a mixture of 10 μl SBIP68’ DNA,
1.3 μl pPICZA vector, 2 μl 10 x ligase buffer, 1 μl T4 DNA ligase, and 5.7 μl H2O. A
control reaction was also set up that had 1.3 μl pPICZA vector, 2 μl 10 x ligase buffer, 1
μl T4 DNA ligase, and 15.7 μl H2O. The reactions were incubated at 16 °C overnight.
Transformation of E. coli DH5α with pPICZA-SBIP68’ Plasmid DNA
The ligation reaction mix was centrifuged briefly and 2 µl was added to a sterile
1.5 ml tube on ice containing 50 µl of freshly prepared DH5α competent cells. All steps
were followed as described earlier. The cells were plated on low salt LB plates
(Appendix B) with 25 μg/ml zeocin and incubated overnight at 37 °C. The following
morning, colonies were streaked on fresh low salt LB/zeocin plates. The colonies were
tested for incorporation of the SBIP68’ plasmid using colony PCR.
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Verification of the Presence of pPICZA-SBIP68’ Plasmid by Colony PCR
A colony PCR was performed to screen for positive clones containing the
pPICZA-SBIP68’ target plasmid. Two hundred microliter PCR tubes containing 40 μl of
water each were numbered serially. Single isolated white positive colonies were picked
from the low salt LB/zeocin plate and streaked on fresh low salt LB/zeocin plates
divided into numbered sections, these were to be the master plates. It is important that
low salt LB media be used for efficient selection as zeocin is only active under
conditions of low salt concentration and a pH of 7.5 (Invitrogen). The colonies were
streaked using sterile micropipette tips. Each of the tips was put in a PCR tube
containing 40 μl of sterile water and pipetted up and down a few times to suspend the
bacteria. Ten microliters each of the bacterial suspensions would serve as cDNA
templates in the PCR amplification of pPICZA-SBIP68’ target plasmids. Each PCR
reaction mix was composed of 10 μl bacterial suspension, 2 μl 10x PCR Buffer, 2 μl
0.1M dNTP mix, 0.8 μl 5’ AOX1 (DK 641) forward primer, 0.8 μl 3’ AOX1 (DK 642)
reverse primer, 0.5 μl Taq polymerase, and 3.9 μl sterile H2O. The PCR conditions were
as follows: 94 °C for 4 minutes, 30 cycles of denaturation, annealing, and elongation at
94 °C, 55 °C, and 72 °C, for 30 seconds, 30 seconds, and 120 seconds respectively,
and a final extension step at 72 °C for 10 minutes. The PCR products were analyzed by
agarose gel electrophoresis using 0.8 % agarose gels as previously described.
Recombinant Plasmid pPICZA-SBIP68’ Propagation and Isolation
Positive clones from the master plate as confirmed by colony PCR were selected
for plasmid propagation and purification using the QIAGEN CompactPrep Plasmid Midi
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Kit according to the manufacturer’s instructions. The concentration and purity of the
isolated plasmids were determined as previously described.
Sequencing of pPICZA-SBIP68’ Recombinant Plasmid
The plasmids were sequenced using 5’ AOX1 forward and 3’ AOX1 reverse
primers. One hundred percent positive plasmids were used to transform P. pastoris.
Preparing pPICZA-SBIP68’ DNA for Transformation into Pichia pastoris
To transform P. pastoris, ~ 10 μg of pPICZA-SBIP68’ plasmid DNA was
linearized by digesting with the restriction enzyme Pme I. Linearization of plasmid DNA
prior to transformation is not obligatory but is strongly recommended as linear DNA is
capable of generating extremely stable transformants of Pichia pastoris via homologous
recombination between the transforming DNA and regions of homology present within
the P. pastoris genome (Cregg et al. 1985; Cregg et al. 1989). The digestion reaction
mix contained: 6 μl plasmid DNA, 1 μl 10 x CutSmart buffer, 1 μl Pme I restriction
enzyme, 2 μl autoclaved milliQ water. The reactions were incubated at 37 °C for 4
hours. After 4 hours, 1 μl of Pme I was added to each reaction and incubated at 37 °C
overnight. The following morning the enzyme was heat inactivated by incubating the
reactions at 65 °C for 20 minutes. To ensure complete linearization, the digested DNA
mixture were analyzed by running 2 μl of each on a 0.8 % agarose gel. Following
verification, the total volume of linearized DNA was adjusted to 300 μl using sterile
water. Three hundred microliters phenol:chloroform:isoamyl alcohol (25:24:1) was
added to each 300 μl of linearized DNA. This mixture was vortexed for 20 seconds, and
centrifuged at 16,000 x g for 5 minutes. The upper aqueous phase of each mixture was
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carefully transferred to a fresh tube making sure none of the middle layer (phenol) was
transferred with it. Ethanol precipitation was performed by adding 0.1 volume of 3 M
sodium acetate (Appendix B) and then adding 2.5 volumes of 100 % ethanol. Samples
were mixed and incubated at - 80 °C for 1 hour and centrifuged at 16,000 x g for 30
minutes at 4° C. The supernatants were carefully decanted without disturbing the DNA
pellets. To each pellet, 500 μl of ice cold 80 % ethanol was added, and they were
centrifuged at 16,000 x g for 15 minutes at 4 °C. The ethanol was discarded, and the
pellets were air dried and then re-suspended in 10 μl each of sterile deionized water.
DNA concentration and purity were determined using a nanodrop spectrophotometer.
DNA was used to transform P. pastoris.
Preparation of Electrocompetent Pichia pastoris X-33 Mut+ Cells
Pichia pastoris strain X-33 Mut+ glycerol stock was used to inoculate 5 ml of YPD
(Appendix B) which was grown at 30 °C and 250 rpm overnight in a 50 ml flask. The
following day, 0.2 ml of the overnight culture was used to inoculate 200 ml of fresh YPD
medium. The culture was again grown overnight at 30 °C and 250 rpm overnight in a 1
L flask until its OD600 was within 1.3 – 1.5. The cells were centrifuged at 1500 x g for 5
minutes at 4 °C. Cells were resuspended with 200 ml of ice cold sterile water and
centrifuged at 1500 x g for 5 minutes at 4 °C. Cells were resuspended with 100 ml of ice
cold sterile water and centrifuged at 1500 x g for 5 minutes at 4 °C. Cells were
resuspended in 8 ml of ice cold sterile 1 M sorbitol and centrifuged at 1500 x g for 5
minutes at 4 °C. Finally the cells were resuspended in 0.4 ml of ice cold sterile 1 M
sorbitol (Appendix B). The cells were kept on ice and used the same day.
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Transformation of P. pastoris
To transform P. pastoris with pPICZA-SBIP68’, both linearized and circular DNAs
were used in two separate transformation reactions. Transformation was achieved by
electroporation of freshly prepared electrocompetent P. pastoris. In one tube, 80 μl of
the cells was mixed with ~ 10 μg of linearized pPICZA-SBIP68’ DNA, while in the other
tube 80 μl of cells was mixed with ~ 40 μg of circular pPICZA-SBIP68’ DNA. These
were transferred to pre-chilled 0.2 cm electroporation cuvettes. The cuvettes with the
cells were incubated on ice for 5 minutes, after which they were each pulsed once at 1.5
volts using BIORAD Gene Pulser. Immediately after pulsing, 1 ml of ice cold 1 M
sorbitol was added to each cuvette. The contents of the cuvettes were each transferred
to separate sterile 15 ml tubes and were incubated at 28 °C for ~ 2 hours without
shaking. Transformed cells (10 μl, 25 μl, 50 μl, 100 μl, and 200 μl) were spread using
glass beads on YPDS/zeocin (100 μg/ml) plates (Appendix B). The plates were
incubated at 28 °C until colonies formed, at approximately 2.5 days.
Direct PCR Screening of P. pastoris Clones
Colony PCR was performed to screen for positive Pichia clones containing the
pPICZA-SBIP68’ target DNA. PCR tubes (0.2 ml), each containing 15 μl of sterile water
were numbered serially. Single isolated Pichia colonies were picked (and numbered for
identification purposes) from the YPDS/zeocin plates with the aid of sterile micropipette
tips. Each tip was dipped in each PCR tube containing 15 μl of sterile water and
pipetted up and down a few times to suspend the cells. Ten microliters of each cell
suspension was mixed with 5 μl of a 5 U/μl solution of the enzyme lyticase in TE buffer.
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These were incubated at 37 °C, - 80 °C, and 95 °C, for 30 minutes, 10 minutes, and 10
minutes respectively. The addition of lyticase to the cells and their subsequent freezing
and heating treatment are necessary to lyse the cells as yeast cells are known to have
tough chitinous cell walls. The 5 μl of each cell lysate (cell suspension with lyticase,
after cold and heat treatment) would serve as the DNA template to be amplified during
the PCR. Each PCR mix was composed of 5 μl cell lysate, 1 μl 10 x PCR Buffer, 1 μl
0.1 M dNTP mix, 0.5 μl 5’ AOX1 forward primer, 0.5 μl 3’ AOX1 reverse primer, 0.5 μl
Taq polymerase, and 1.5 μl sterile H2O. The PCR conditions were as follows: 95 °C for
5 minutes, 30 cycles of denaturation, annealing, and elongation at 95 °C, 50 °C, and 72
°C, for 30 seconds, 30 seconds, and 90 seconds respectively. A 0.8 % agarose gel was
used to analyze the PCR products using agarose gel electrophoresis. Clones that
tested positive were used to inoculate YPD/zeocin media and grown overnight at 30 °C
with shaking at 250 rpm. These overnight cultures were used in the preparation of
Pichia-SBIP68’ glycerol stocks.
Time Course Expression of Recombinant SBIP68’
Pichia pastoris containing SBIP68’ from glycerol stocks were streaked on
YPD/zeocin plates and incubated at 28 °C until colonies formed (~ 2.5 days). A few
single isolated colonies were each used to inoculate 3 ml of YPD/zeocin media and
grown at 30 °C in a shaker at 250 rpm overnight. To start a large scale liquid culture,
100-125 μl of the overnight grown cultures were used to inoculate 25 ml of BMGY
medium (Appendix B) each in a 250 ml baffled conical flask. BMGY cultures were grown
at 29 °C and 250 rpm until their OD600 = 2-6 (log-phase growth) approximately 15-18
hours. The cells were harvested by centrifuging at 2,500 x g for 5 minutes at room
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temperature. The supernatants were discarded and the pellets were washed to remove
all traces of glycerol from the BMGY medium. Cells were washed by resuspending each
cell pellet in 30 ml BMMY (Appendix B) media and centrifuging at 2,500 x g for 5
minutes at room temperature. The washing step was repeated once. Cell pellets were
resuspended in BMMY media to an OD600 of 1.0 (typical resuspension volumes were
between 75 - 250 ml) in 1 L autoclaved baffled flasks. One milliliter samples were taken
from the cultures to serve as 0 hour post-induction time points. The flasks were covered
with 2 - 4 layers of sterile cheesecloth and incubated at 29 °C and 250 rpm. Every 24
hours, 100 % methanol was added to each culture to give a final methanol
concentration of 0.5 %. One milliliter samples were taken from the cultures at different
times post-induction to determine the optimal post-induction time to harvest. Time point
samples were centrifuged at 16,200 x g for 3 minutes at room temperature,
supernatants were discarded, and pellets were frozen in liquid nitrogen and stored at –
80 °C until ready to assay. Pellets were later analyzed for protein expression using
SDS-PAGE and Western blot.
Preparing Samples for SDS-PAGE and Western Blot Analysis
Pichia- SBIP68’ cell pellets were removed from the – 80 °C freezer and placed
on ice briefly to thaw. Each 1 ml sample pellet was re-suspended in 100 µl of breaking
buffer (Appendix B). An equal volume of 0.5 mm acid-washed glass beads was added
to each sample. The samples were alternately vortexed for 30 seconds and rested on
ice for 30 seconds, this was repeated for a total of 8 times. The cell lysates together
with the pellets (total cell protein) were analyzed by Western blot.
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Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS-PAGE)
SDS-PAGE was performed by adding 200 µl of 2 x SDS sample buffer
(containing 5 % βME added just before use) to each sample. The samples were placed
in a boiling water bath for 10 minutes and 10 µl of each sample was loaded on an SDS
gel and run by electrophoresis at 200 volts.
Western Blot Analysis
Upon the separation of protein samples using SDS-PAGE, the proteins were
transferred from the gels to PVDF (polyvinylidene difluoride) membranes as described
earlier. After electroblotting, the PVDF membranes were taken out of the cassettes and
processed for Western blot analysis using anti-polyhistidine primary antibody as
described earlier.
Large Scale Expression of Pichia-SBIP68’
Pichia-SBIP68’ cells from glycerol stocks were streaked on an YPD/zeocin plates
and incubated at 28 °C until colonies formed, ~ 2.5 days. A few single isolated colonies
were each used to inoculate 3 ml of YPD/zeocin media and grown at 30 °C and 250 rpm
overnight. To inoculate 25 ml of BMGY medium each in a 250 ml baffled conical flask,
100-125 µl of overnight culture was used. BMGY cultures were grown at 29 °C and 250
rpm until their OD600 was within 2 – 6 (log-phase growth) approximately 15 – 18 hours.
The cells were harvested by centrifuging at 2,500 x g for 5 minutes at room
temperature. The supernatants were discarded and the pellets were washed to remove
all traces of glycerol from the BMGY medium. Cells were washed by resuspending each
cell pellet in 30 ml BMMY media (Appendix B) and centrifuging at 2,500 x g for 5
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minutes at room temperature. The washing step was repeated once. Cell pellets were
resuspended in BMMY media to an OD600 of 1.0 (typical resuspension volumes were
between 75 – 250 ml) in 1 liter sterile baffled flasks. One milliliter samples were taken
from the cultures to serve as 0 hour control. The flasks were covered with 2 - 4 layers of
sterile cheesecloth and incubated at 29 °C and 260 rpm. Every 24 hours, 100 %
methanol was added to each culture to give a final methanol concentration of 0.5 %.
Cells were grown for a total of 96 hours and harvested by centrifuging at 2,500 x g for 5
minutes at room temperature. Pellets were saved at – 80 °C until they were processed
for purification of target protein.
Purification of Recombinant SBIP68’ Protein Expressed in Pichia pastoris
Each pellet derived from the 530 ml culture was resuspended in 40 ml of 1 x NiNTA binding buffer containing PMSF. Cells were lysed using a French press 40K cell at
20,000 psi at least 5 times, and lysate was collected on ice. Sample was centrifuged at
20,000 x g for 15 minutes at 4 °C. The soluble fraction (supernatant) was collected in a
fresh tube and the pellet stored at – 80 °C. Soluble SBIP68’ was purified on Ni-NTA
column as previously described. After purification, the fractions with the highest
concentration of proteins were pooled and concentrated using a centrifugal filter unit
(Amicon Centricon Centrifugal Filter, 30 kDa cut off) at 4,700 x g and 4 °C until the
sample volume was reduced to 500 µl. Two milliliters of enzyme assay buffer was
added to the sample and centrifuged again until the volume was 500 µl. Western blot
analysis was performed to verify the presence of SBIP68’ in the eluted purified fractions
and in the concentrated sample. The concentrated Ni-NTA purified SBIP68’ was used
for glucosyltransferase activity assay.
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Purification of Recombinant SBIP68’ using Anion Exchange Chromatography
Fractions 7 - 13 containing SBIP68’ (as confirmed by Western blot analysis) from
the Ni-NTA affinity chromatography were pooled and desalted on a Hi-Trap Desalting
Column (2x5 ml) (GE Healthcare). The desalted sample (9 ml) was further purified using
a Mono-Q anion exchange column (Mono-Q 5/50 GL, GE Healthcare) on AKTA purifier
10. The bound proteins were eluted with a linear gradient of 0-500 mM sodium chloride
in potassium phosphate buffer pH 7.5 (Appendix B) and collected as 1 ml fractions.
Western blot was performed to determine which fractions contained SBIP68’.
Analysis of Glucosyltransferase Activity using Radioactive Method
Recombinant purified SBIP68 was screened for glucosyltransferase activity
following a method developed by McIntosh et al. (1990). Briefly, radioactive (14C) UDPglucose was used as the sugar donor substrate and the amount of radioactive

14C-

glucose incorporated into the reaction product was measured. Each 75 μl reaction mix
composed of 5 μl acceptor substrate (50 nmol aglycone in ethylene glycol monomethyl
ether), 50 μl assay buffer (50 mM sodium phosphate buffer pH 7.5, 14 mM βME), 10 μl
donor substrate (UDP-[U- 14C] glucose, 0.025 µCi, 19,670 cpm), 10 μl (34 µg, of which
SBIP68 was about a tenth or less of this) semi-purified and concentrated recombinant
SBIP68 enzyme. A control reaction with 60 µl assay buffer and no enzyme and
kaempferol was used as the acceptor substrate. Each reaction mix was incubated with
gentle shaking at 37 °C for 10 minutes. A total of 14 potential acceptor substrates were
tested, these are: salicylic acid, methyl salicylate, benzoic acid, azelaic acid, phydroxybenzoic acid, kaempferol, quercetin, hesperetin, naringenin, gossypetin, 4'-
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acetoxy-7-hydroxy-6-methoxyisoflavone, apigenin, luteolin, and fisetin. The reactions
were terminated by the addition of 15 μl 6 M HCl and mixed by vortexing briefly. Two
hundred and fifty microliters of ethyl acetate was added to each tube to separate the
formed glucosides from unincorporated UDP-[U- 14C] glucose, the reaction tubes were
vortexed and centrifuged briefly. A hundred and fifty microliters of the upper organic
phase of each sample was transferred to separate 7 ml scintillation vials containing 2 ml
of scintillation fluid each. The radioactive count for each reaction product was
determined using a scintillation counter (Beckman LS 6500).
Analysis of Glucosyltransferase Activity Reaction Products using HPLC
HPLC was performed to identify the products formed from separate
glucosyltransferase reactions involving kaempferol, quercetin, naringenin, hesperetin,
and salicylic acid as acceptor substrates (Owens and McIntosh, 2009). Each 150 μl
reaction mix composed of 10 μl acceptor substrate (100 nmol aglycone in ethylene
glycol monomethyl ether for flavonoid substrates, 100 nmol aglycone in water (pH 7) for
salicylic acid), 100 μl assay buffer (50 mM sodium phosphate buffer pH 7.5, 14 mM
βME), 20 μl donor substrate (200 nmol UDP-glucose), and 20 μl (68 µg, of which
SBIP68 was about a tenth or less of this) partially purified SBIP68 recombinant enzyme.
The reaction mix was incubated with gentle shaking at 37 °C for 120 minutes. For
reactions involving flavonoid substrates, after 120 minutes, 30 μl 6 M HCl was added to
the sample tube and mixed by vortexing briefly. Five hundred microliters of ethyl acetate
was added to the sample to separate the formed glucosides from unincorporated UDPglucose, the reaction tube was vortexed and centrifuged very briefly. Three hundred
microliters from the upper organic phase of the sample (containing the reaction
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products) was transferred to a fresh tube. The reaction products were dried using
nitrogen gas. The dried components were redissolved in 60 µl of HPLC grade methanol
and 10 µl of this was run on a Waters HPLC system that consists of an in-line degasser
AF, a binary HPLC pump 1525 and a dual wavelength absorbance detector 2487
operated by Breeze software version 3.30 (Waters, Milford, MA). The mobile phase was
acetic acid:water (15:85) and a gradient of 95:5 acetonitrile:water was the organic
phase over a period of 28 minutes. Sample fractionation was performed at room
temperature using a Nova-Pak® C18 (3.9 x 150 mm) column at a flow rate of 1.0
ml/min. The wavelength used for detection was 365 nm. Kaempferol, kaempferol 3-Oglucoside, quercetin, quercetin 3-O-glucoside, naringenin, naringenin 7-O-glucoside,
and hesperetin were used as standards in the identification of the reaction products. For
the reaction involving salicylic acid as substrate, after 120 minutes, 300 μl of ethanol
was added to the sample tube and mixed by vortexing briefly. The sample was cooled
to – 80 °C for 120 minutes, and centrifuged for 30 minutes at 21,000 x g and 4 °C. The
supernatant was transferred to a fresh tube and the volume was reduced to 60 µl using
a concentrator (Thermo Electron Corporation Savant ISS110 SpeedVac Concentrator)
with the drying rate set to low, and 10 µl of this was run on the Waters HPLC system as
described for the other reactions. Detection of reaction products was at 296 nm.
Salicylic acid was used as a standard in the identification of the reaction products.
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CHAPTER 3
RESULTS
Cloning and Expression of SBIP68 in E. coli
Bioinformatics Analyses of SBIP68
Previous work involving a yeast two-hybrid screening using SABP2 as a bait and
tobacco leaf proteins as prey led to the identification of several putative SABP2
interacting proteins. The nucleotide sequence (Fig. 12A) of one of the SABP2
interacting proteins, SBIP68, was translated to protein (Fig. 12B) and used to perform a
BLAST analysis using the NCBI database.
A.
AGGGGTAATAAAACTGCAATTGATAATCAAGATTGCTTGAAATGGTTAGATAATTTTGAAAC
AGAATCCGTGGTTTATGCAAGTCTTGGAAGTTTATCTCGTTTGACATTATTGCAAATGGTGG
AACTTGGTCTTGGTTTAGAAGAGTCAAATAGGCCTTTTGTATGGGTATTAGGAGGAGGTGAT
AAATTAAATGATTTAGAGAAATGGATTCTTGAGAATGGATTTGAGCAAAGAATTAAAGAAAG
AGGAGTTTTGATTAGAGGATGGGCTCCTCAAGTGCTTATACTTTCACACCCTGCAATTGGTG
GAGTATTGACTCATTGCGGATGGAATTCTACATTGGAAGGTATTTCAGCAGGATTACCAATG
GTAACATGGCCACTATTTGCTGAGCAATTTTGCAATGAGAAGTTAGTAGTCCAAGTGCTAAA
AATTGGAGTGAGCCTAGGTGTGAAGGTGCCTGTCAAATGGGGAGATGAGGAAAATGTTGGAG
TTTTGGTAAAAAAGGATGATGTTAAGAAAGCATTAGACAAACTAATGGATGAAGGAGAAGAA
GGACAAGTAAGAAGAACAAAAGCAAAAGAGTTAGGAGAATTGGCTAAAAAGGCATTTGGAGA
AGGTGGTTCTTCTTATGTTAACTTAACATCTCTGATTGAAGACATCATTGAGCAACAAAATC
ACAAGGAAAAATAGTATATTATGATTATTTTTTTTCTAATAAAAAAAAAAAAAAAAAAAAAA
AAAACAC

B.
RGNKTAIDNQDCLKWLDNFETESVVYASLGSLSRLTLLQMVELGLGLEESNRPFVWVLGGGD
KLNDLEKWILENGFEQRIKERGVLIRGWAPQVLILSHPAIGGVLTHCGWNSTLEGISAGLPM
VTWPLFAEQFCNEKLVVQVLKIGVSLGVKVPVKWGDEENVGVLVKKDDVKKALDKLMDEGEE
GQVRRTKAKELGELAKKAFGEGGSSYVNLTSLIEDIIEQQNHKEK

Figure 12: Nucleotide and Translated Amino Acid Sequence of SBIP68
Obtained from Yeast Two-Hybrid Screening. A. Nucleotide sequence. B.
Translated amino acid sequence of SBIP68.
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The bioinformatics revealed that SBIP68 showed 100% identity to the C-terminal
of a putative UDP-glucose: flavonoid glucosyltransferase with NCBI accession number
BAD93688.1, that has 496 amino acids (Fig. 13A) and is encoded by the tobacco
NtGT4 gene with an open reading frame that is 1,488 bp long (Fig. 13B). The
A.
MATQVHKLHFILFPLMAPGHMIPMIDIAKLLANRGVITTIITTPVNANRFSSTITRAIKSGLRIQIL
TLKFPSVEVGLPEGCENIDMLPSLDLASKFFAAISMLKQQVENLLEGINPSPSCVISDMGFPWTTQI
AQNFNIPRIVFHGTCCFSLLCSYKILSSNILENITSDSEYFVVPDLPDRVELTKAQVSGSTKNTTSV
SSSVLKEVTEQIRLAEESSYGVIVNSFEELEQVYEKEYRKARGKKVWCVGPVSLCNKEIEDLVTRGN
KTAIDNQDCLKWLDNFETESVVYASLGSLSRLTLLQMVELGLGLEESNRPFVWVLGGGDKLNDLEKW
ILENGFEQRIKERGVLIRGWAPQVLILSHPAIGGVLTHCGWNSTLEGISAGLPMVTWPLFAEQFCNE
KLVVQVLKIGVSLGVKVPVKWGDEENVGVLVKKDDVKKALDKLMDEGEEGQVRRTKAKELGELAKKA
FGEGGSSYVNLTSLIEDIIEQQNHKEK

B.
ATGGCAACTCAAGTGCACAAACTTCATTTCATACTATTCCCTTTAATGGCTCCAGGCCACATGATTC
CTATGATAGACATAGCTAAACTTCTAGCAAATCGCGGTGTCATTACCACTATCATCACCACTCCAGT
AAACGCCAATCGTTTCAGTTCAACAATTACTCGTGCCATAAAATCCGGTCTAAGAATCCAAATTCTT
ACACTCAAATTTCCAAGTGTAGAAGTAGGATTACCAGAAGGTTGCGAAAATATTGACATGCTTCCTT
CTCTTGACTTGGCTTCAAAGTTTTTTGCTGCAATTAGTATGCTGAAACAACAAGTTGAAAATCTCTT
AGAAGGAATAAATCCAAGTCCAAGTTGTGTTATTTCAGATATGGGATTTCCTTGGACTACTCAAATT
GCACAAAATTTTAATATCCCAAGAATTGTTTTTCATGGTACTTGTTGTTTCTCACTTTTATGTTCCT
ATAAAATACTTTCCTCCAACATTCTTGAAAATATAACCTCAGATTCAGAGTATTTTGTTGTTCCTGA
TTTACCCGATAGAGTTGAACTAACGAAAGCTCAGGTTTCAGGATCGACGAAAAATACTACTTCTGTT
AGTTCTTCTGTATTGAAAGAAGTTACTGAGCAAATCAGATTAGCCGAGGAATCATCATATGGTGTAA
TTGTTAATAGTTTTGAGGAGTTGGAGCAAGTGTATGAGAAAGAATATAGGAAAGCTAGAGGGAAAAA
AGTTTGGTGTGTTGGTCCTGTTTCTTTGTGTAATAAGGAAATTGAAGATTTGGTTACAAGGGGTAAT
AAAACTGCAATTGATAATCAAGATTGCTTGAAATGGTTAGATAATTTTGAAACAGAATCTGTGGTTT
ATGCAAGTCTTGGAAGTTTATCTCGTTTGACATTATTGCAAATGGTGGAACTTGGTCTTGGTTTAGA
AGAGTCAAATAGGCCTTTTGTATGGGTATTAGGAGGAGGTGATAAATTAAATGATTTAGAGAAATGG
ATTCTTGAGAATGGATTTGAGCAAAGAATTAAAGAAAGAGGAGTTTTGATTAGAGGATGGGCTCCTC
AAGTGCTTATACTTTCACACCCTGCAATTGGTGGAGTATTGACTCATTGCGGATGGAATTCTACATT
GGAAGGTATTTCAGCAGGATTACCAATGGTAACATGGCCACTATTTGCTGAGCAATTTTGCAATGAG
AAGTTAGTAGTCCAAGTGCTAAAAATTGGAGTGAGCCTAGGTGTGAAGGTGCCTGTCAAATGGGGAG
ATGAGGAAAATGTTGGAGTTTTGGTAAAAAAGGATGATGTTAAGAAAGCATTAGACAAACTAATGGA
TGAAGGAGAAGAAGGACAAGTAAGAAGAACAAAAGCAAAAGAGTTAGGAGAATTGGCTAAAAAGGCA
TTTGGAGAAGGTGGTTCTTCTTATGTTAACTTAACATCTCTGATTGAAGACATCATTGAGCAACAAA
ATCACAAGGAAAAATAG

Figure 13: Flavonoid Glucosyltransferase (NtGT4) Accession Number BAD93688.1.
A. Amino acid sequence, the underlined sequence shows 100% identity to the
SBIP68 sequence in figure 13B. B. Open reading frame of NtGT4 gene.
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smaller size and exact match of the SBIP68 to the C-terminus of NTGT4 indicated that it
is a partial sequence and lacks N-terminus.
Subcellular Localization of SBIP68
Various subcellular localization prediction software was used to predict the
subcellular localization of SBIP68 (Figs. 14-16). Most analyses predicted SBIP68 to be
Protein: SBIP68
Predicted Location: cytoplasmic: 0.5 extracellular: 0.12 peroxisomal: 0.11 Golgi
apparatus: 0.07 plasma membrane: 0.06 mitochondrial: 0.05 vacuolar: 0.04 ER: 0.03
nuclear: 0.01 chloroplast: 0.01

Figure 14: Subcellular Localization Prediction using MultiLoc2. This predicts that the
protein is most probably a cytoplasmic protein with the highest score of 0.5.

Name
Len
cTP
mTP
SP other Loc RC
---------------------------------------------------------------------SBIP68
496
0.018 0.046 0.469 0.118
S
4
---------------------------------------------------------------------cutoff
0.000 0.000 0.000 0.000

Figure 15: Subcellular Localization Prediction using Target v1.1. This indicates that
SBIP68 is most probably a secretory protein (SP) and neither a mitochondrial
transfer protein (mTP) nor a chloroplast transfer protein (cTP).

endoplasmic reticulum (membrane) --- Certainty= 0.550(Affirmative) < succ>
endoplasmic reticulum (lumen) --- Certainty= 0.100(Affirmative) < succ>
outside --- Certainty= 0.100(Affirmative) < succ>
microbody (peroxisome) --- Certainty= 0.100(Affirmative) < succ>

Figure 16: Localization of SBIP68 as Predicted by PSORT.

neither a mitochondrial nor a chloroplast localized protein. MultiLoc 2 predicted it to be a
cytoplasmic protein (Fig. 14), while Target v1.1 predicted it to be a secretory protein
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(Fig. 15) and PSORT predicted to be endoplasmic reticulum membrane localized
protein (Fig. 16).
RNA Extraction
Total RNA from young tobacco leaves was purified and quantitated using a
nanodrop spectrophotometer. The result is as shown in Fig. 17. The concentration of
the purified total RNA was 637.2 ng/μl and the A260/280 ratio was 2.01 which showed
high purity level.

Figure 17: Scan from Nanodrop Spectrophotometer.

cDNA Synthesis
The endogenous tobacco EF1α was amplified via PCR to check the quality of the
newly synthesized cDNA. Figure 18 shows agarose gel picture of the PCR amplified
EF1α with expected size of 550 bp. The other thick diffused bands at the bottom are
likely from primer dimers. Lane numbers 2 and 3 are duplicate samples of the same
cDNA preparation.
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100 bp
ladder

1517 bp

EF1
500 bp

100 bp
Lane #

1

2

3

Figure 18: PCR Amplification of EF1α. DNA ladder (100 bp) was used to compare
size of purified products.

PCR Amplification of SBIP68
To amplify full length SBIP68, PCR amplification was performed using primers
specific for SBIP68. Three separate cDNA preparations (lane #2, 3, & 4) were used
(Fig. 19). Full length SBIP68 (~1491 bp) was amplified but some unexpected products
were also amplified (lane #2) as shown in Figure 18. This was probably due to non-

100 bp
ladder

specific binding of the primers used for PCR, to templates other than SBIP68 cDNA.

1517 bp

SBIP68

1000 bp

500 bp

Lane # 1

2

3

4

Figure 19: RT-PCR Amplification of SBIP68. Ethidium bromide stained 1.2 %
agarose gel showing amplification of SBIP68 (~1491bp).
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Purification of PCR Product
The RT-PCR amplified SBIP68 was gel purified as described in material and
methods before using them for other downstream applications. Figure 20 shows

100 bp
ladder

aliquots of the gel purified PCR products.

1500 bp

SBIP68

500 bp

100 bp

Figure 20: Purified SBIP68 PCR Products. Ethidium bromide stained 1.2 % agarose
gel showing SBIP68 purified PCR produtcs. DNA ladder (100 bp) was used to
compare size of purified products.

Cloning SBIP68 in pGEMT Plasmid
The purified SBIP68 PCR amplified products were ligated into pGEMT plasmids
via TA cloning. Ligated products were transformed into freshly prepared competent
cells. Transformed cells were plated on selective media (LB/ampicillin), and incubated
at 37 °C overnight. Isolated colonies were tested for the presence of pGEMT-SBIP68
using colony PCR, and the PCR amplified products were analyzed by electrophoresis
on a 0.8 % agarose gel (Fig. 21). Several clones containing the expected size bands
(#2, 3, 4 and #6 -10 for DK644) (#3 - 6 and 8 -10 for DK645) were selected for plasmid
DNA isolation followed by DNA sequencing. Clones in lane #5 (Fig. 21A), and lane #2
and 7 (Fig. 21B) showed faint and smaller sized bands. The fact that these clones grew
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as white colonies on selective media meant two things: they were transformed by the
vector which conferred resistance to ampicillin, and they were not transformed by empty
vectors otherwise they would have shown up as blue colonies due to α-

1000 bp
ladder

complementation and the presence of X-Gal.

3000 bp
1500 bp

SBIP68
(DK644)

500 bp
1

2

3

4

5

6

7

8

9

10

1000 bp
ladder

Lane #

3000 bp
1500 bp
1000 bp
500 bp
Lane #

SBIP68
(DK645)
1

2

3

4

5

6

7

8

9

10

Figure 21: Screening of SBIP68 Inserts by Colony PCR. Agarose gel (0.8%)
showing PCR amplified SBIP68. Lane numbers 2 through 10 are individual clones.
Clones that tested positive for the inserts of interest have been underlined. A.
Shows colony PCR of 644. B. Shows colony PCR of 645 in pGEMT. Plasmid
specific M13 forward primer, and gene specific DK644 and DK645 reverse primers
were used for PCR amplifications.

Plasmid Isolation and DNA Sequencing of pGEMT-SBIP68
Ten clones (five each of pGEMT-SBIP68 (644) and pGEMT-SBIP68 (645)) were
selected for plasmid DNA isolation. Plasmid DNA was isolated and sequenced. Of the
ten clones, seven of them had good quality readable sequences. These were compared
to the NtGT4 sequence from the NCBI database. All clones showed over 90% identity to
the reference sequence (NtGT4). Four of these clones, C2, C15, C18, and C20, showed
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99% identity to NtGT4. These four clones differed from the reference sequence (NtGT4)
by one nucleotide change at base number 552 (Fig. 22). This single nucleotide
difference was a pyrimidine (T) to pyrimidine (C) change. Upon translation this resulted
in no change in amino acid (Fig. 23). C2 is pGEMT-SBIP68 (644) with the stop codon
as present in NtGT4, while C15, C18, and C20, are pGEMT-SBIP68 (645) without the
stop codon. Full length SBIP68 nucleotide sequence and translated amino acid
sequence are shown in Figure 24A and Figure 24B respectively. Figure 25 shows the
result of a protein blast performed on NCBI with full length SBIP68 protein, showing
SBIP68 to belong to the glycosyltransferase_GTB_type superfamily. It has a putative
GT1_Gtf_like conserved protein domain (276 - 464) and a putative UDP-glucoronosyl
and UDP-glucosyltransferase (UDPGT, 287 - 408) conserved domain. Full length
SBIP68 showed homology to enzymes of glycosyltransferase family 1(Fig. 26). It
showed 100 % similarity to a predicted: UDP-glycosyltransferase from Nicotiana
tomentosiformis (NCBI reference sequence: XP_009623864.1), which also has 496
amino acids and is yet to be characterized. This 100 % similarity did not come as a
surprise as N. tabacum (a tetraploid) from which SBIP68 was derived is supposedly a
hybrid of N. tomentosiformis and N. sylvestris (Ren and Timko, 2001; Sierro et al.,
2014). SBIP68 also showed 88 % similarity to a putative glycosyltransferase UGT73E5
from Lycium barbarum (GenBank: BAG80535.1) with 503 amino acids (Noguchi et al.,
2008). UGT73E5 was cloned alongside other LbGT’s including UGT73A10 (49 %
similarity to SBIP68). UGT73E5 and UGT73A10 belong to the same phylogenetic
cluster and UGT73A10 has been shown to be a flavonoid: UDP-glycosyltransferase with
regiospeciﬁc activity towards ﬂavan-3-ols (Noguchi et al., 2008). UGT73A10 is highly
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speciﬁc for the donor substrate UDP-glucose has broad acceptor substrate speciﬁcity
with the highest preference for naringenin (Noguchi et al., 2008).
SBIP68 also showed 58 % similarity to a putative flavonoid UDPglucosyltransferase 2 from Citrus paradisi (GenBank: AIS39471.1) with 491 amino acids
(Devaiah et al., in review). A previously characterized salicylic acid glucosyltransferase,
UDP-glucose: salicylic acid glucosyltransferase (SA GTase) from Nicotiana tabacum
(GenBank: AAF61647.1) with 459 amino acids showed only 29 % similarity to SBIP68
(Lee and Raskin, 1999). SA GTase uses UDP-glucose as the sole sugar donor to
glucosylate SA forming SA 2-O-beta-D-glucoside (SAG) and glucosyl salicylate (GS)
and has broad acceptor substrate specificity to simple phenolics. SA GTase mRNA is
also induced by SA and incompatible pathogens. “Currently, PSPG function and
specificity cannot be fully predicted based on sequence information alone” (Noguchi et
al., 2008).
C15
C18
C20
NtGT4
C2
C15
C18
C20
NtGT4
C2
C15
C18
C20
NtGT4
C2

GGATCCATGGCAACTCAAGTGCACAAACTTCATTTCATACTATTCCCTTTAATGGCTCCA
GGATCCATGGCAACTCAAGTGCACAAACTTCATTTCATACTATTCCCTTTAATGGCTCCA
GGATCCATGGCAACTCAAGTGCACAAACTTCATTTCATACTATTCCCTTTAATGGCTCCA
------ATGGCAACTCAAGTGCACAAACTTCATTTCATACTATTCCCTTTAATGGCTCCA
GGATCCATGGCAACTCAAGTGCACAAACTTCATTTCATACTATTCCCTTTAATGGCTCCA
******************************************************
GGCCACATGATTCCTATGATAGACATAGCTAAACTTCTAGCAAATCGCGGTGTCATTACC
GGCCACATGATTCCTATGATAGACATAGCTAAACTTCTAGCAAATCGCGGTGTCATTACC
GGCCACATGATTCCTATGATAGACATAGCTAAACTTCTAGCAAATCGCGGTGTCATTACC
GGCCACATGATTCCTATGATAGACATAGCTAAACTTCTAGCAAATCGCGGTGTCATTACC
GGCCACATGATTCCTATGATAGACATAGCTAAACTTCTAGCAAATCGCGGTGTCATTACC
************************************************************
ACTATCATCACCACTCCAGTAAACGCCAATCGTTTCAGTTCAACAATTACTCGTGCCATA
ACTATCATCACCACTCCAGTAAACGCCAATCGTTTCAGTTCAACAATTACTCGTGCCATA
ACTATCATCACCACTCCAGTAAACGCCAATCGTTTCAGTTCAACAATTACTCGTGCCATA
ACTATCATCACCACTCCAGTAAACGCCAATCGTTTCAGTTCAACAATTACTCGTGCCATA
ACTATCATCACCACTCCAGTAAACGCCAATCGTTTCAGTTCAACAATTACTCGTGCCATA
************************************************************

Figure 22 (continued on next page)
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AAATCCGGTCTAAGAATCCAAATTCTTACACTCAAATTTCCAAGTGTAGAAGTAGGATTA
AAATCCGGTCTAAGAATCCAAATTCTTACACTCAAATTTCCAAGTGTAGAAGTAGGATTA
AAATCCGGTCTAAGAATCCAAATTCTTACACTCAAATTTCCAAGTGTAGAAGTAGGATTA
AAATCCGGTCTAAGAATCCAAATTCTTACACTCAAATTTCCAAGTGTAGAAGTAGGATTA
AAATCCGGTCTAAGAATCCAAATTCTTACACTCAAATTTCCAAGTGTAGAAGTAGGATTA
************************************************************
CCAGAAGGTTGCGAAAATATTGACATGCTTCCTTCTCTTGACTTGGCTTCAAAGTTTTTT
CCAGAAGGTTGCGAAAATATTGACATGCTTCCTTCTCTTGACTTGGCTTCAAAGTTTTTT
CCAGAAGGTTGCGAAAATATTGACATGCTTCCTTCTCTTGACTTGGCTTCAAAGTTTTTT
CCAGAAGGTTGCGAAAATATTGACATGCTTCCTTCTCTTGACTTGGCTTCAAAGTTTTTT
CCAGAAGGTTGCGAAAATATTGACATGCTTCCTTCTCTTGACTTGGCTTCAAAGTTTTTT
************************************************************
GCTGCAATTAGTATGCTGAAACAACAAGTTGAAAATCTCTTAGAAGGAATAAATCCAAGT
GCTGCAATTAGTATGCTGAAACAACAAGTTGAAAATCTCTTAGAAGGAATAAATCCAAGT
GCTGCAATTAGTATGCTGAAACAACAAGTTGAAAATCTCTTAGAAGGAATAAATCCAAGT
GCTGCAATTAGTATGCTGAAACAACAAGTTGAAAATCTCTTAGAAGGAATAAATCCAAGT
GCTGCAATTAGTATGCTGAAACAACAAGTTGAAAATCTCTTAGAAGGAATAAATCCAAGT
************************************************************
CCAAGTTGTGTTATTTCAGATATGGGATTTCCTTGGACTACTCAAATTGCACAAAATTTT
CCAAGTTGTGTTATTTCAGATATGGGATTTCCTTGGACTACTCAAATTGCACAAAATTTT
CCAAGTTGTGTTATTTCAGATATGGGATTTCCTTGGACTACTCAAATTGCACAAAATTTT
CCAAGTTGTGTTATTTCAGATATGGGATTTCCTTGGACTACTCAAATTGCACAAAATTTT
CCAAGTTGTGTTATTTCAGATATGGGATTTCCTTGGACTACTCAAATTGCACAAAATTTT
************************************************************
AATATCCCAAGAATTGTTTTTCATGGTACTTGTTGTTTCTCACTTTTATGTTCCTATAAA
AATATCCCAAGAATTGTTTTTCATGGTACTTGTTGTTTCTCACTTTTATGTTCCTATAAA
AATATCCCAAGAATTGTTTTTCATGGTACTTGTTGTTTCTCACTTTTATGTTCCTATAAA
AATATCCCAAGAATTGTTTTTCATGGTACTTGTTGTTTCTCACTTTTATGTTCCTATAAA
AATATCCCAAGAATTGTTTTTCATGGTACTTGTTGTTTCTCACTTTTATGTTCCTATAAA
************************************************************
ATACTTTCCTCCAACATTCTTGAAAATATAACCTCAGATTCAGAGTATTTTGTTGTTCCT
ATACTTTCCTCCAACATTCTTGAAAATATAACCTCAGATTCAGAGTATTTTGTTGTTCCT
ATACTTTCCTCCAACATTCTTGAAAATATAACCTCAGATTCAGAGTATTTTGTTGTTCCT
ATACTTTCCTCCAACATTCTTGAAAATATAACCTCAGATTCAGAGTATTTTGTTGTTCCT
ATACTTTCCTCCAACATTCTTGAAAATATAACCTCAGATTCAGAGTATTTTGTTGTTCCT
************************************************************
GATTTACCCGATAGAGTCGAACTAACGAAAGCTCAGGTTTCAGGATCGACGAAAAATACT
GATTTACCCGATAGAGTCGAACTAACGAAAGCTCAGGTTTCAGGATCGACGAAAAATACT
GATTTACCCGATAGAGTCGAACTAACGAAAGCTCAGGTTTCAGGATCGACGAAAAATACT
GATTTACCCGATAGAGTTGAACTAACGAAAGCTCAGGTTTCAGGATCGACGAAAAATACT
GATTTACCCGATAGAGTCGAACTAACGAAAGCTCAGGTTTCAGGATCGACGAAAAATACT
***************** ******************************************
ACTTCTGTTAGTTCTTCTGTATTGAAAGAAGTTACTGAGCAAATCAGATTAGCCGAGGAA
ACTTCTGTTAGTTCTTCTGTATTGAAAGAAGTTACTGAGCAAATCAGATTAGCCGAGGAA
ACTTCTGTTAGTTCTTCTGTATTGAAAGAAGTTACTGAGCAAATCAGATTAGCCGAGGAA
ACTTCTGTTAGTTCTTCTGTATTGAAAGAAGTTACTGAGCAAATCAGATTAGCCGAGGAA
ACTTCTGTTAGTTCTTCTGTATTGAAAGAAGTTACTGAGCAAATCAGATTAGCCGAGGAA
************************************************************
TCATCATATGGTGTAATTGTTAATAGTTTTGAGGAGTTGGAGCAAGTGTATGAGAAAGAA
TCATCATATGGTGTAATTGTTAATAGTTTTGAGGAGTTGGAGCAAGTGTATGAGAAAGAA
TCATCATATGGTGTAATTGTTAATAGTTTTGAGGAGTTGGAGCAAGTGTATGAGAAAGAA
TCATCATATGGTGTAATTGTTAATAGTTTTGAGGAGTTGGAGCAAGTGTATGAGAAAGAA
TCATCATATGGTGTAATTGTTAATAGTTTTGAGGAGTTGGAGCAAGTGTATGAGAAAGAA
************************************************************
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TATAGGAAAGCTAGAGGGAAAAAAGTTTGGTGTGTTGGTCCTGTTTCTTTGTGTAATAAG
TATAGGAAAGCTAGAGGGAAAAAAGTTTGGTGTGTTGGTCCTGTTTCTTTGTGTAATAAG
TATAGGAAAGCTAGAGGGAAAAAAGTTTGGTGTGTTGGTCCTGTTTCTTTGTGTAATAAG
TATAGGAAAGCTAGAGGGAAAAAAGTTTGGTGTGTTGGTCCTGTTTCTTTGTGTAATAAG
TATAGGAAAGCTAGAGGGAAAAAAGTTTGGTGTGTTGGTCCTGTTTCTTTGTGTAATAAG
************************************************************
GAAATTGAAGATTTGGTTACAAGGGGTAATAAAACTGCAATTGATAATCAAGATTGCTTG
GAAATTGAAGATTTGGTTACAAGGGGTAATAAAACTGCAATTGATAATCAAGATTGCTTG
GAAATTGAAGATTTGGTTACAAGGGGTAATAAAACTGCAATTGATAATCAAGATTGCTTG
GAAATTGAAGATTTGGTTACAAGGGGTAATAAAACTGCAATTGATAATCAAGATTGCTTG
GAAATTGAAGATTTGGTTACAAGGGGTAATAAAACTGCAATTGATAATCAAGATTGCTTG
************************************************************
AAATGGTTAGATAATTTTGAAACAGAATCTGTGGTTTATGCAAGTCTTGGAAGTTTATCT
AAATGGTTAGATAATTTTGAAACAGAATCTGTGGTTTATGCAAGTCTTGGAAGTTTATCT
AAATGGTTAGATAATTTTGAAACAGAATCTGTGGTTTATGCAAGTCTTGGAAGTTTATCT
AAATGGTTAGATAATTTTGAAACAGAATCTGTGGTTTATGCAAGTCTTGGAAGTTTATCT
AAATGGTTAGATAATTTTGAAACAGAATCTGTGGTTTATGCAAGTCTTGGAAGTTTATCT
************************************************************
CGTTTGACATTATTGCAAATGGTGGAACTTGGTCTTGGTTTAGAAGAGTCAAATAGGCCT
CGTTTGACATTATTGCAAATGGTGGAACTTGGTCTTGGTTTAGAAGAGTCAAATAGGCCT
CGTTTGACATTATTGCAAATGGTGGAACTTGGTCTTGGTTTAGAAGAGTCAAATAGGCCT
CGTTTGACATTATTGCAAATGGTGGAACTTGGTCTTGGTTTAGAAGAGTCAAATAGGCCT
CGTTTGACATTATTGCAAATGGTGGAACTTGGTCTTGGTTTAGAAGAGTCAAATAGGCCT
************************************************************
TTTGTATGGGTATTAGGAGGAGGTGATAAATTAAATGATTTAGAGAAATGGATTCTTGAG
TTTGTATGGGTATTAGGAGGAGGTGATAAATTAAATGATTTAGAGAAATGGATTCTTGAG
TTTGTATGGGTATTAGGAGGAGGTGATAAATTAAATGATTTAGAGAAATGGATTCTTGAG
TTTGTATGGGTATTAGGAGGAGGTGATAAATTAAATGATTTAGAGAAATGGATTCTTGAG
TTTGTATGGGTATTAGGAGGAGGTGATAAATTAAATGATTTAGAGAAATGGATTCTTGAG
************************************************************
AATGGATTTGAGCAAAGAATTAAAGAAAGAGGAGTTTTGATTAGAGGATGGGCTCCTCAA
AATGGATTTGAGCAAAGAATTAAAGAAAGAGGAGTTTTGATTAGAGGATGGGCTCCTCAA
AATGGATTTGAGCAAAGAATTAAAGAAAGAGGAGTTTTGATTAGAGGATGGGCTCCTCAA
AATGGATTTGAGCAAAGAATTAAAGAAAGAGGAGTTTTGATTAGAGGATGGGCTCCTCAA
AATGGATTTGAGCAAAGAATTAAAGAAAGAGGAGTTTTGATTAGAGGATGGGCTCCTCAA
************************************************************
GTGCTTATACTTTCACACCCTGCAATTGGTGGAGTATTGACTCATTGCGGATGGAATTCT
GTGCTTATACTTTCACACCCTGCAATTGGTGGAGTATTGACTCATTGCGGATGGAATTCT
GTGCTTATACTTTCACACCCTGCAATTGGTGGAGTATTGACTCATTGCGGATGGAATTCT
GTGCTTATACTTTCACACCCTGCAATTGGTGGAGTATTGACTCATTGCGGATGGAATTCT
GTGCTTATACTTTCACACCCTGCAATTGGTGGAGTATTGACTCATTGCGGATGGAATTCT
************************************************************
ACATTGGAAGGTATTTCAGCAGGATTACCAATGGTAACATGGCCACTATTTGCTGAGCAA
ACATTGGAAGGTATTTCAGCAGGATTACCAATGGTAACATGGCCACTATTTGCTGAGCAA
ACATTGGAAGGTATTTCAGCAGGATTACCAATGGTAACATGGCCACTATTTGCTGAGCAA
ACATTGGAAGGTATTTCAGCAGGATTACCAATGGTAACATGGCCACTATTTGCTGAGCAA
ACATTGGAAGGTATTTCAGCAGGATTACCAATGGTAACATGGCCACTATTTGCTGAGCAA
************************************************************
TTTTGCAATGAGAAGTTAGTAGTCCAAGTGCTAAAAATTGGAGTGAGCCTAGGTGTGAAG
TTTTGCAATGAGAAGTTAGTAGTCCAAGTGCTAAAAATTGGAGTGAGCCTAGGTGTGAAG
TTTTGCAATGAGAAGTTAGTAGTCCAAGTGCTAAAAATTGGAGTGAGCCTAGGTGTGAAG
TTTTGCAATGAGAAGTTAGTAGTCCAAGTGCTAAAAATTGGAGTGAGCCTAGGTGTGAAG
TTTTGCAATGAGAAGTTAGTAGTCCAAGTGCTAAAAATTGGAGTGAGCCTAGGTGTGAAG
************************************************************
GTGCCTGTCAAATGGGGAGATGAGGAAAATGTTGGAGTTTTGGTAAAAAAGGATGATGTT
GTGCCTGTCAAATGGGGAGATGAGGAAAATGTTGGAGTTTTGGTAAAAAAGGATGATGTT
GTGCCTGTCAAATGGGGAGATGAGGAAAATGTTGGAGTTTTGGTAAAAAAGGATGATGTT
GTGCCTGTCAAATGGGGAGATGAGGAAAATGTTGGAGTTTTGGTAAAAAAGGATGATGTT
GTGCCTGTCAAATGGGGAGATGAGGAAAATGTTGGAGTTTTGGTAAAAAAGGATGATGTT
************************************************************

Figure 22 (continued on next page)
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AAGAAAGCATTAGACAAACTAATGGATGAAGGAGAAGAAGGACAAGTAAGAAGAACAAAA
AAGAAAGCATTAGACAAACTAATGGATGAAGGAGAAGAAGGACAAGTAAGAAGAACAAAA
AAGAAAGCATTAGACAAACTAATGGATGAAGGAGAAGAAGGACAAGTAAGAAGAACAAAA
AAGAAAGCATTAGACAAACTAATGGATGAAGGAGAAGAAGGACAAGTAAGAAGAACAAAA
AAGAAAGCATTAGACAAACTAATGGATGAAGGAGAAGAAGGACAAGTAAGAAGAACAAAA
************************************************************
GCAAAAGAGTTAGGAGAATTGGCTAAAAAGGCATTTGGAGAAGGTGGTTCTTCTTATGTT
GCAAAAGAGTTAGGAGAATTGGCTAAAAAGGCATTTGGAGAAGGTGGTTCTTCTTATGTT
GCAAAAGAGTTAGGAGAATTGGCTAAAAAGGCATTTGGAGAAGGTGGTTCTTCTTATGTT
GCAAAAGAGTTAGGAGAATTGGCTAAAAAGGCATTTGGAGAAGGTGGTTCTTCTTATGTT
GCAAAAGAGTTAGGAGAATTGGCTAAAAAGGCATTTGGAGAAGGTGGTTCTTCTTATGTT
************************************************************
AACTTAACATCTCTGATTGAAGACATCATTGAGCAACAAAATCACAAGGAAAAACTCGAG
AACTTAACATCTCTGATTGAAGACATCATTGAGCAACAAAATCACAAGGAAAAACTCGAG
AACTTAACATCTCTGATTGAAGACATCATTGAGCAACAAAATCACAAGGAAAAACTCGAG
AACTTAACATCTCTGATTGAAGACATCATTGAGCAACAAAATCACAAGGAAAAATAG--AACTTAACATCTCTGATTGAAGACATCATTGAGCAACAAAATCACAAGGAAAAATAGCTC
******************************************************
AATCACTAGT--AATCACTAGT--AATCACTAGT--------------GAGAATCACTAGT

Figure 22: Nucleotide Sequence Alignment of NtGT4 and pGEMT-SBIP68 Clones.
Clones C2, C15, C18, and C20. The arrow indicates the single nucleotide difference
between NtGT4 and pGEMT-SBIP68 clones.
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Figure 23: Amino Acid Sequence Alignment of NtGT4 and pGEMT-SBIP68 Clones,
C2 and C15. All sequences are identical.
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>SBIP68_Nucleotide
ATGGCAACTCAAGTGCACAAACTTCATTTCATACTATTCCCTTTAATGGCTCCAGGCCACATGATTCCTATGAT
AGACATAGCTAAACTTCTAGCAAATCGCGGTGTCATTACCACTATCATCACCACTCCAGTAAACGCCAATCGTT
TCAGTTCAACAATTACTCGTGCCATAAAATCCGGTCTAAGAATCCAAATTCTTACACTCAAATTTCCAAGTGTA
GAAGTAGGATTACCAGAAGGTTGCGAAAATATTGACATGCTTCCTTCTCTTGACTTGGCTTCAAAGTTTTTTGC
TGCAATTAGTATGCTGAAACAACAAGTTGAAAATCTCTTAGAAGGAATAAATCCAAGTCCAAGTTGTGTTATTT
CAGATATGGGATTTCCTTGGACTACTCAAATTGCACAAAATTTTAATATCCCAAGAATTGTTTTTCATGGTACT
TGTTGTTTCTCACTTTTATGTTCCTATAAAATACTTTCCTCCAACATTCTTGAAAATATAACCTCAGATTCAGA
GTATTTTGTTGTTCCTGATTTACCCGATAGAGTCGAACTAACGAAAGCTCAGGTTTCAGGATCGACGAAAAATA
CTACTTCTGTTAGTTCTTCTGTATTGAAAGAAGTTACTGAGCAAATCAGATTAGCCGAGGAATCATCATATGGT
GTAATTGTTAATAGTTTTGAGGAGTTGGAGCAAGTGTATGAGAAAGAATATAGGAAAGCTAGAGGGAAAAAAGT
TTGGTGTGTTGGTCCTGTTTCTTTGTGTAATAAGGAAATTGAAGATTTGGTTACAAGGGGTAATAAAACTGCAA
TTGATAATCAAGATTGCTTGAAATGGTTAGATAATTTTGAAACAGAATCTGTGGTTTATGCAAGTCTTGGAAGT
TTATCTCGTTTGACATTATTGCAAATGGTGGAACTTGGTCTTGGTTTAGAAGAGTCAAATAGGCCTTTTGTATG
GGTATTAGGAGGAGGTGATAAATTAAATGATTTAGAGAAATGGATTCTTGAGAATGGATTTGAGCAAAGAATTA
AAGAAAGAGGAGTTTTGATTAGAGGATGGGCTCCTCAAGTGCTTATACTTTCACACCCTGCAATTGGTGGAGTA
TTGACTCATTGCGGATGGAATTCTACATTGGAAGGTATTTCAGCAGGATTACCAATGGTAACATGGCCACTATT
TGCTGAGCAATTTTGCAATGAGAAGTTAGTAGTCCAAGTGCTAAAAATTGGAGTGAGCCTAGGTGTGAAGGTGC
CTGTCAAATGGGGAGATGAGGAAAATGTTGGAGTTTTGGTAAAAAAGGATGATGTTAAGAAAGCATTAGACAAA
CTAATGGATGAAGGAGAAGAAGGACAAGTAAGAAGAACAAAAGCAAAAGAGTTAGGAGAATTGGCTAAAAAGGC
ATTTGGAGAAGGTGGTTCTTCTTATGTTAACTTAACATCTCTGATTGAAGACATCATTGAGCAACAAAATCACA
AGGAAAAATAG

>SBIP68_Protein
MATQVHKLHFILFPLMAPGHMIPMIDIAKLLANRGVITTIITTPVNANRFSSTITRAIKSGLRIQILTLKFPSV
EVGLPEGCENIDMLPSLDLASKFFAAISMLKQQVENLLEGINPSPSCVISDMGFPWTTQIAQNFNIPRIVFHGT
CCFSLLCSYKILSSNILENITSDSEYFVVPDLPDRVELTKAQVSGSTKNTTSVSSSVLKEVTEQIRLAEESSYG
VIVNSFEELEQVYEKEYRKARGKKVWCVGPVSLCNKEIEDLVTRGNKTAIDNQDCLKWLDNFETESVVYASLGS
LSRLTLLQMVELGLGLEESNRPFVWVLGGGDKLNDLEKWILENGFEQRIKERGVLIRGWAPQVLILSHPAIGGV
LTHCGWNSTLEGISAGLPMVTWPLFAEQFCNEKLVVQVLKIGVSLGVKVPVKWGDEENVGVLVKKDDVKKALDK
LMDEGEEGQVRRTKAKELGELAKKAFGEGGSSYVNLTSLIEDIIEQQNHKEK

Figure 24: Full Length SBIP68 Sequence Cloned from Nicotiana tabacum. .
Nucleotide sequence. B. Translated amino acid sequence, a putative PSPG Box
(355-398) is highlighted.
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Figure 25: SBIP68 Protein BLAST Query. SBIP68 is a GTB_type protein with
putative GT1_Gtf and UDPGT conserved domains amongst others.
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Figure 26: Alignment of SBIP68 with Other Similar Glucosyltransferases. N.
tomentosiformis putative UDP-glycosyltransferase (NCBI reference sequence:
XP_009623864.12014), Lycium barbarum putative glucosyltransferase UGT73E5
(GenBank: BAG80535.1), Citrus paradisi putative flavonoid UDPglucosyltransferase 2 (GenBank: AIS39471.1), Nicotiana tabacum SA GTase
(GenBank: AAF61647.1).
PSPG box is underlined.
PCR Screening of pET-28a-SBIP68 Bacterial Clones
The pGEMT-SBIP68 (644 & 645) plasmids were restriction digested and the
fragments gel purified. The gel purified SBIP68 (644 & 645) were ligated into pET-28a
vector digested with the same set of enzymes. The resulting pET-28a-SBIP68
constructs were used to transform competent bacterial cells (BL21(DE3) pLysE)
capable of recombinant protein expression. The cells were plated and incubated, after
which several clones were tested for presence of the plasmids using colony PCR. The
PCR products were analyzed by agarose electrophoresis (Fig. 27).
83

1000 bp
ladder

3000 bp

SBIP68
(DK644)
~1491bp

1500 bp
500 bp
1

2

3

4

5

6

1000 bp
ladder

Lane #

3000 bp

SBIP68
(DK645)
~1491bp

1500 bp
500 bp
Lane #

1

2

3

4

5

6

Figure 27: Colony PCR Screening of pET28a-SBIP68 Clones. Agarose gel (0.8%)
showing PCR amplified SBIP68. All clones tested were positive for the presence of
insert. A. Colony PCR of 644, gene specific DK643 forward and DK644 reverse
primer were used for PCR. Lane numbers 2, 3, 4, 5, and 6 represent clones 1, 2, 3,
4, and 5, respectively. B. Colony PCR of 645, gene specific DK643 forward primer
and gene specific DK645 reverse primer were used for PCR. Lane numbers 2, 3, 4,
5, and 6 represent clones 6, 7, 8, 9, and 10, respectively.

Test for Recombinant pET-28a-SBIP68 Protein Expression
Clones which were positive for pET-28a-SBIP68 were used for protein
expression. To start the culture, 3 ml of LB with kanamycin were inoculated with a single
isolated colony and incubated in a shaker at 37 °C for 2 hours (see materials and
methods). Protein expression was induced by adding 1mM IPTG (final concentration)
and cultures were further incubated for 3 hours at 37°C. Pellets were collected and
processed as previously described. Samples were analyzed by SDS PAGE gel followed
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by coomassie blue staining (Fig. 28). It is not clear from the SDS-PAGE analysis which
of the expressed proteins are SBIP68 644 (expected size, ~58.5 kDa) or 645 (expected
size, ~59.6 kDa).

0 mM

0 mM

0 mM

Figure 28: SDS-PAGE of pET-28a-SBIP68 (644 & 645) Expressed in E. coli. In lane
1 is the low molecular weight marker, lanes 2 and 4 are pET-28a-SBIP68 (644) from
uninduced bacterial cultures. Lanes 3 and 5 contain pET-28a-SBIP68 (644) from
0.1mM and 1mM IPTG induced bacterial cultures respectively. Lane number 6
contains pET-28a-SBIP68 (645) from uninduced bacterial culture, while lane
numbers 7 and 8 contain pET-28a-SBIP68 645 from 0.1mM and 1mM IPTG induced
bacterial cultures respectively. ‘U’ in the figure stands for uninduced and ‘I’ is for
induced.

To specifically detect recombinant SBIP68, Western blot analysis using antipolyhistidine primary antibody was performed (Fig. 29A). Recombinant SBIP68 was
highly expressed in IPTG induced cultures (Lane #3, 5, 7, and 9) compared to
uninduced cultures (Lane #2, 4, 6, and 8). Recombinant SBIP68 was expressed at
higher levels in 645 (lane #2 - 5) compared to 644 (Lane #6 - 9). Low level recombinant
protein was also detected in uninduced cultures (lane #2, 3, 6, and 8). The extra bands
seen in lane #3, 5, 7, and 9 (Fig. 29A) could be as a result of degradation of SBIP68. It
is also possible that there are proteins indigenous to the expression host that have
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polyhistidine. To visualize the loaded proteins, the blot was later stained with coomassie
blue (Fig. 29B).
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Figure 29: Test for Expression of pET28a-SBIP68 (644) and (645) in E. coli. A.
Western Blot Analysis of pET-28a-SBIP68 (644 & 645) recombinant proteins
expression in E. coli. Lane 1 shows the low molecular weight marker, lanes 2 and 4
are pET-28a-SBIP68 644 from uninduced bacterial cultures, while lanes 3 and 5 are
pET-28a-SBIP68 644 from 0.1mM and 1mM IPTG induced bacterial cultures
respectively. Lane numbers 6 and 8 contain pET-28a-SBIP68 645 from uninduced
bacterial cultures, while lane numbers 7 and 9 contain pET-28a-SBIP68 645 from
0.1mM and 1mM IPTG induced bacterial cultures respectively. Lane 10 served as a
positive control for Western blot. B. Corresponding coomassie blue stained blot.
The membrane was stained after Western blot analysis. ‘U’ in the figures stand for
uninduced and ‘I’ for induced. The asterisk indicates SBIP68’s expected position on
the blot.

Recombinant pET-28a-SBIP68 Protein Solubility Test
A solubility test was performed to verify if SBIP68 was being expressed in the
soluble or insoluble protein fractions. pET-28a-SBIP68 (644) and 645 in E. coli cells
were cultured and the pellets derived following induction with IPTG were processed as
described in materials and methods. The supernatants (soluble) and pellet (insoluble)
fractions were analyzed by Western blot (Fig. 30A). Western blot analysis revealed that
pET-28a-SBIP68 (644) & (645) are both expressed mostly in the insoluble (lane # 3, 5,
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7, and 9) form but a small fraction was also expressed in the soluble form (lane # 4, 6,
8, and 10). The extra bands seen in lane # 3, 5, 7, 8, 9, and 10 (Fig. 30A), are either
degradation products of SBIP68 and/ or non-specific host proteins. Upon the completion
of Western blot, the membrane was stained with coomassie blue (Fig. 30B).
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Figure 30: Solubility Test of Expressed pET28a-SBIP68 (644) and (645). A.
Western blot analysis of 644 & 645 recombinant proteins. Lane#1 shows the low
molecular weight marker. Lane#2 is 644 from uninduced bacterial culture. Lanes 3
and 4 consist of insoluble and soluble cell fractions from 0.1mM IPTG induced 644
bacterial culture respectively, while lanes 5 and 6 are insoluble and soluble cell
fractions from 1mM IPTG induced 644 bacterial culture respectively. Lanes 7 and 8
contain insoluble and soluble cell fractions from 0.1mM IPTG induced 645 bacterial
culture respectively, while lanes 9 and 10 contain insoluble and soluble cell fractions
from 1mM IPTG induced 645 bacterial culture respectively. B. Corresponding
coomassie blue stained blot. The membrane was stained after Western blot
analysis. ‘U’ and ‘I’ in the figures stand for uninduced and induced respectively. ‘In’
and ‘S’ represent insoluble and soluble respectively. The asterisk indicates
SBIP68’s expected position on the blot.
.
Optimization of Conditions for Protein Solubility
In a bid to increase the amount of soluble SBIP68 recombinant protein, the
conditions for expression were fine-tuned by lowering the incubation temperature for
expression to 17 °C and different IPTG concentrations (1 mM, 0.1 mM, and 0.01 mM).
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Induction at 37 °C and 1 mM IPTG concentration was also performed simultaneously to
serve as a control. pET-28a-SBIP68 (644) and 645 in E. coli cells were cultured and
protein expression induced with IPTG. The pellets were processed as described in
materials and methods. The supernatants (soluble) and pellet (insoluble) fractions from
the 17 °C expression (Fig. 31A), and 37 °C expression (Fig. 31C), were analyzed by
Western blot. Western blot analysis revealed that there was no significant difference in
the amount of soluble pET-28a-SBIP68 (644) & (645) recombinant proteins expressed
at the different temperatures (17 °C and 37 °C). The membranes were stained with
coomassie blue after Western blot to visualize total protein loaded in the gel (Fig. 31B,
and Fig. 31D for 17 °C and 37 °C, respectively).
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Figure 31: Optimization of Protein Solubility. Solubility Test of Expressed pET28aSBIP68 (644) and (645). A. Western blot bnalysis of 644 & 645 recombinant protein
solubility at 17 °C. Lane one shows the low molecular weight marker. Lane 2 is 644
from uninduced bacterial culture. Lanes 3 and 4 consist of insoluble and soluble cell
fractions from 0.1mM IPTG induced 644 bacterial culture respectively, while lanes 5
and 6 are insoluble and soluble cell fractions from 0.01mM IPTG induced 645
bacterial culture respectively. B. Corresponding coomassie blue stained blot after
Western blot analysis. C. Western blot analysis of 644 & 645 recombinant protein
solubility at 37 °C. Lane one shows the low molecular weight marker. Lane 2 is 644
from uninduced bacterial culture. Lanes 3 and 4 consist of insoluble and soluble cell
fractions from 1mM IPTG induced 644 bacterial culture respectively. Lane 5 is 645
from uninduced bacterial culture while lanes 6 and 7 are insoluble and soluble cell
fractions from 1mM IPTG induced 645 bacterial culture respectively. D. Coomassie
blue stained blot after Western blot analysis. There appears to be no significant
difference in the amount of soluble SBIP68 produced at different temperatures. The
major difference here is the amount of insoluble protein being produced and this is
due to the different concentrations of IPTG used in inducing expression. The
asterisks indicate SBIP68’s expected position on the blots.
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Affinity Purification of Recombinant SBIP68 Protein
To purify the soluble recombinant SBIP68, large scale expression was
conducted. Bacterial cell pellets derived from 100 ml cultures from expression at 17 °C
and 37 °C were resuspended in 3 ml of 1 x Ni-NTA binding buffer containing PMSF
each. The cell lysates were collected and recombinant SBIP68 was purified using a NiNTA column. The column was washed with 15 ml of 1 x Ni-NTA wash / binding buffer
(containing 15 mM imidazole) at room temperature. Elution of 6xHis-tagged SBIP68
protein was achieved by 1 x Ni-NTA buffer containing 250 mM imidazole. The eluted
fractions (1 ml each) were analyzed by Western blot (Fig. 32A, Fig. 32C, Fig. 32E). After
Western blot, the membranes were stained with coomassie blue (Fig. 32B, Fig. 32D,
Fig. 32F). In lane # 3 of Figures 32A, 32C, and 32E, SBIP68 can be seen in the flow
through. This is probably as a result of the presence of 15 mM imidazole in the
wash/binding buffer. The pellets were resuspended in the binding buffer before lysis
with the French press. In other words, the binding buffer served as the lysis buffer, this
was done to minimize non-specific binding by non-target proteins. Another possibility is
that the Ni-NTA columns were saturated by the bound protein and could not hold any
more (their binding capacity was reached), so the excess proteins eluted in the flow
through. A combination of both factors, that is imidazole and binding capacity, could
also have been responsible for the elution of SBIP68 in the flow through.
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*

*

*

Figure 32 A-F: Ni-NTA Purification of SBIP68 Expressed in E. coli. A. Western blot
analysis of 644 expressed at 37 °C and 1 mM IPTG concentration. In lane 2 is the
cell lysate before purification, lane 3 is the flow through and lane 4 wash. Lanes 5 to
10 contain fraction numbers 2, 3, 4, 5, 6, and 8, respectively collected from the
purification process. B. Corresponding coomassie blue stained blot. C. Western blot
analysis of 645 expressed at 17 °C and 0.01 mM IPTG concentration. In lane 2 is the
cell lysate before purification, lane 3 is the flow through and lane 4 wash. Lanes 5 to
10 contain fraction numbers 1, 2, 3, 4, 5, and 6, respectively. D. Corresponding
coomassie blue stained blot. E. Western blot analysis of 645 expressed at 37 °C and
1 mM IPTG concentration. In lane 2 is the cell lysate before purification, lane 3 is the
flow through and lane 4 wash. Lanes 5 to 10 contain fraction numbers 2, 3, 4, 5, 6,
and 7, respectively. F. Corresponding coomassie blue stained blot. The asterisks
indicate SBIP68’s expected position on the blots.
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Figure 32 G-J: Ni-NTA Purification of SBIP68 Expressed in E. coli. G. Western blot
analysis of 645 expressed at 37 °C and 0.2 mM IPTG concentration. In lane 2 is the
cell lysate before purification, and lane 3 is the flow through. Lanes 4 to 9 contain
fraction numbers 2, 3, 4, 5, 6, and 7, respectively collected from the purification
process. H. Corresponding coomassie blue stained blot. I. Western blot analysis of
644 expressed at 37 °C and 0.2 mM IPTG concentration. In lane 2 is the cell lysate
before purification, and lane 3 is the flow through. Lanes 4 to 9 contain fraction
numbers 2, 3, 4, 5, 6, and 7, respectively collected from the purification process. J.
Corresponding coomassie blue stained blot. The asterisks indicate SBIP68’s
expected position on the blots.

HPLC Analysis of Glucosyltransferase Activity Assay Products
After determining that large scale expression of SBIP68 in E. coli produced some
soluble protein, SBIP68 was again expressed, purified, and used to test enzymatic
activity (Fig. 32G, Fig. 32I). HPLC analysis was performed to identify the products of the
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glucosyltransferase reactions using purified SBIP68 as described in the materials and
methods. The acceptor substrates tested were kaempferol, quercetin, hesperetin, and
naringenin (Fig. 33, Fig. 34). Kaempferol, kaempferol 3-O-glucoside, quercetin,
quercetin 3-O-glucoside, naringenin, naringenin 7-O-glucoside, and hesperetin were
used as standards in the identification of the reaction products.
The cloning and heterologous expression of SBIP68 in E. coli (prokaryote) and P.
pastoris (eukaryote) was performed simultaneously. This was done because there are
well known limitations to the expression of functional recombinant proteins with
eukaryotic origins in prokaryotic systems, and at the time of cloning there was no idea
as to just how much SBIP68 would be expressed in the soluble (functional) form in
E. coli. As can be seen from the results of the expression of SBIP68 in E. coli, a greater
percentage of expressed SBIP68 was present in the (non-functional) insoluble form
(Figs. 30 and 31).
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Figure 33 A-B: GT Assay using E. coli Expressed SBIP68 (645). . Top panel shows
retention time for kaempferol standard at 12.7 minutes, middle panel shows retention
time for kaempferol 3-O-glucoside standard at 9.2 minutes. The bottom panel shows
the products formed from the reaction with SBIP68-645, kaempferol 3-O-glucoside
and kaempferol, with retention times at 9.2 minutes and 12.8 minutes respectively. .
Top panel shows retention time for quercetin standard at 11.2 minutes, middle panel
shows retention time for quercetin 3-O-glucoside standard at 8 minutes. The bottom
panel shows the products formed from the reaction with SBIP68-645, quercetin 3-Oglucoside and quercetin, with retention times at 8 minutes and 11.2 minutes
respectively.
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Figure 33 C-D: GT Assay using E. coli Expressed SBIP68 (645). C. Top panel shows
retention time for naringenin standard at 12.2 minutes, middle panel shows retention
time for naringenin 7-O-glucoside standard at 9.2 minutes. The bottom panel shows
the products formed from the reaction with SBIP68-645, naringenin 7-O-glucoside
and naringenin, with retention times at 9.2 minutes and 12.2 minutes respectively. D.
Top panel shows retention time for hesperetin standard at 12.8 minutes.The bottom
panel shows the products formed from the reaction with SBIP68-645, hesperetin
glucoside and hesperetin, with retention times at 10.2 minutes and 12.8 minutes
respectively. It appears there is a second hesperetin glucoside with a retention time
of 9.7 minutes. There were no hesperetin glucoside standards available at the time of
this experiment.
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Figure 34 A-B: GT Assay using E. coli Expressed SBIP68 (644). . Top panel shows
retention time for kaempferol standard at 12.7 minutes, middle panel shows retention
time for kaempferol 3-O-glucoside standard at 9.2 minutes. The bottom panel shows
the products formed from the reaction with SBIP68-644, kaempferol 3-O-glucoside
and kaempferol, with retention times at 9.2 minutes and 12.8 minutes respectively. .
Top panel shows retention time for quercetin standard at 11.2 minutes, middle panel
shows retention time for quercetin 3-O-glucoside standard at 8 minutes. The bottom
panel shows the products formed from the reaction with SBIP68-644, quercetin 3-Oglucoside and quercetin, with retention times at 8 minutes and 11.2 minutes
respectively.
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Figure 34 C-D: GT Assay using E. coli Expressed SBIP68 (644). C. Top panel shows
retention time for naringenin standard at 12.2 minutes, middle panel shows retention
time for naringenin 7-O-glucoside standard at 9.2 minutes. The bottom panel shows
the products formed from the reaction with SBIP68-644, naringenin 7-O-glucoside
and naringenin, with retention times at 9.2 minutes and 12.2 minutes respectively. D.
Top panel shows retention time for hesperetin standard at 12.8 minutes.The bottom
panel shows the products formed from the reaction with SBIP68-644, hesperetin
glucoside and hesperetin, with retention times at 10.2 minutes and 12.8 minutes
respectively. It appears there is a second hesperetin glucoside with a retention time
of 9.7 minutes. There were no hesperetin glucoside standards available at the time of
this experiment.
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Cloning and Expression of SBIP68 in P. pastoris
PCR Amplification of SBIP68 with Modified Ends for Cloning into pPICZA
For cloning full length SBIP68 into P. pastoris, primers were synthesized and
used for PCR amplification. The pGEMT-SBIP68 plasmid (Clone# C2) was used as a
template for PCR, while DK639 and DK640 primers were used for amplification. Figure
35 below shows an ethidium bromide stained agarose gel of the PCR products.

Figure 35: PCR Amplification of SBIP68 for Cloning into pPICZA. Ethidium bromide
stained 0.8 % agarose gel picture of SBIP68’. Lane numbers 2, 3, 5, 6, and 7
contain replicates of the same PCR reaction.

The PCR products were gel purified and ligated into pGEMT forming a new set of
pGEMT-SBIP68’ constructs. Selected clones were tested for presence of the plasmids
using colony PCR. M13 forward and reverse primers were used in this PCR
amplification. PCR products were analyzed by electrophoresis using a 0.8 % agarose
gel (Fig. 36). Size of the amplified product is relatively large due to the amplification of
pGEMT fragments on both sides of SBIP68’. Several isolated positive colonies (C2, C3,
C5, C9, C10, C11, C12, C15, C17, C18) were chosen for plasmid DNA isolation.
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Figure 36: Verification of pGEMT-SBIP68’ clones. Ethidium bromide stained 0.8 %
agarose gel showing PCR amplified pGEMT-SBIP68’. For PCR amplification
pGEMT specific M13 forward and reverse primers were used. Lanes 2 – 18 are
representative of individual isolated clones from colonies C2, C3, C4, C5, C6, C7,
C8, C9, C10, C11, C12, C13, C14, C15, C16, C17, and C18, respectively. C8 in
lane 8 likely did not contain the SBIP68 insert of interest.

Sequencing of pGEMT-SBIP68’ Recombinant Plasmid
The plasmid DNA from several positive clones identified by colony PCR
screening (Fig. 36), were used for DNA sequencing. Ten clones (C2, C3, C5, C9, C10,
C11, C12, C15, C17, C18) were sequenced, of these, two of them (C11, and C18) were
a 100 % match to the pGEMT-SBIP68 used as template for PCR. The only difference
being the new restriction enzyme sites introduced for cloning into pPICZA by the new
primers. The other eight clones (C2, C3, C5, C9, C10, C12, C15, C17), showed greater
than 90 % identity (not shown) to the pGEMT-SBIP68 used as template for PCR. Figure
37 shows the sequence alignment of the new pGEMT-SBIP68’ clones (C11 and C18)
and the original pGEMT-SBIP68 from which they were derived. The different restriction
enzyme sites between pGEMT-SBIP68 and pGEMT-SBIP68’ can also be seen
highlighted in boxes.
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---GGATCCATGGCAACTCAAGTGCACAAACTTCATTTCATACTATTCCCTTTAATGGCT
CTCGAGGTCATGGCAACTCAAGTGCACAAACTTCATTTCATACTATTCCCTTTAATGGCT
CTCGAGGTCATGGCAACTCAAGTGCACAAACTTCATTTCATACTATTCCCTTTAATGGCT
*
****************************************************
CCAGGCCACATGATTCCTATGATAGACATAGCTAAACTTCTAGCAAATCGCGGTGTCATT
CCAGGCCACATGATTCCTATGATAGACATAGCTAAACTTCTAGCAAATCGCGGTGTCATT
CCAGGCCACATGATTCCTATGATAGACATAGCTAAACTTCTAGCAAATCGCGGTGTCATT
************************************************************
ACCACTATCATCACCACTCCAGTAAACGCCAATCGTTTCAGTTCAACAATTACTCGTGCC
ACCACTATCATCACCACTCCAGTAAACGCCAATCGTTTCAGTTCAACAATTACTCGTGCC
ACCACTATCATCACCACTCCAGTAAACGCCAATCGTTTCAGTTCAACAATTACTCGTGCC
************************************************************
ATAAAATCCGGTCTAAGAATCCAAATTCTTACACTCAAATTTCCAAGTGTAGAAGTAGGA
ATAAAATCCGGTCTAAGAATCCAAATTCTTACACTCAAATTTCCAAGTGTAGAAGTAGGA
ATAAAATCCGGTCTAAGAATCCAAATTCTTACACTCAAATTTCCAAGTGTAGAAGTAGGA
************************************************************
TTACCAGAAGGTTGCGAAAATATTGACATGCTTCCTTCTCTTGACTTGGCTTCAAAGTTT
TTACCAGAAGGTTGCGAAAATATTGACATGCTTCCTTCTCTTGACTTGGCTTCAAAGTTT
TTACCAGAAGGTTGCGAAAATATTGACATGCTTCCTTCTCTTGACTTGGCTTCAAAGTTT
************************************************************
TTTGCTGCAATTAGTATGCTGAAACAACAAGTTGAAAATCTCTTAGAAGGAATAAATCCA
TTTGCTGCAATTAGTATGCTGAAACAACAAGTTGAAAATCTCTTAGAAGGAATAAATCCA
TTTGCTGCAATTAGTATGCTGAAACAACAAGTTGAAAATCTCTTAGAAGGAATAAATCCA
************************************************************
AGTCCAAGTTGTGTTATTTCAGATATGGGATTTCCTTGGACTACTCAAATTGCACAAAAT
AGTCCAAGTTGTGTTATTTCAGATATGGGATTTCCTTGGACTACTCAAATTGCACAAAAT
AGTCCAAGTTGTGTTATTTCAGATATGGGATTTCCTTGGACTACTCAAATTGCACAAAAT
************************************************************
TTTAATATCCCAAGAATTGTTTTTCATGGTACTTGTTGTTTCTCACTTTTATGTTCCTAT
TTTAATATCCCAAGAATTGTTTTTCATGGTACTTGTTGTTTCTCACTTTTATGTTCCTAT
TTTAATATCCCAAGAATTGTTTTTCATGGTACTTGTTGTTTCTCACTTTTATGTTCCTAT
************************************************************
AAAATACTTTCCTCCAACATTCTTGAAAATATAACCTCAGATTCAGAGTATTTTGTTGTT
AAAATACTTTCCTCCAACATTCTTGAAAATATAACCTCAGATTCAGAGTATTTTGTTGTT
AAAATACTTTCCTCCAACATTCTTGAAAATATAACCTCAGATTCAGAGTATTTTGTTGTT
************************************************************
CCTGATTTACCCGATAGAGTCGAACTAACGAAAGCTCAGGTTTCAGGATCGACGAAAAAT
CCTGATTTACCCGATAGAGTCGAACTAACGAAAGCTCAGGTTTCAGGATCGACGAAAAAT
CCTGATTTACCCGATAGAGTCGAACTAACGAAAGCTCAGGTTTCAGGATCGACGAAAAAT
************************************************************
ACTACTTCTGTTAGTTCTTCTGTATTGAAAGAAGTTACTGAGCAAATCAGATTAGCCGAG
ACTACTTCTGTTAGTTCTTCTGTATTGAAAGAAGTTACTGAGCAAATCAGATTAGCCGAG
ACTACTTCTGTTAGTTCTTCTGTATTGAAAGAAGTTACTGAGCAAATCAGATTAGCCGAG
************************************************************
GAATCATCATATGGTGTAATTGTTAATAGTTTTGAGGAGTTGGAGCAAGTGTATGAGAAA
GAATCATCATATGGTGTAATTGTTAATAGTTTTGAGGAGTTGGAGCAAGTGTATGAGAAA
GAATCATCATATGGTGTAATTGTTAATAGTTTTGAGGAGTTGGAGCAAGTGTATGAGAAA
************************************************************
GAATATAGGAAAGCTAGAGGGAAAAAAGTTTGGTGTGTTGGTCCTGTTTCTTTGTGTAAT
GAATATAGGAAAGCTAGAGGGAAAAAAGTTTGGTGTGTTGGTCCTGTTTCTTTGTGTAAT
GAATATAGGAAAGCTAGAGGGAAAAAAGTTTGGTGTGTTGGTCCTGTTTCTTTGTGTAAT
************************************************************
AAGGAAATTGAAGATTTGGTTACAAGGGGTAATAAAACTGCAATTGATAATCAAGATTGC
AAGGAAATTGAAGATTTGGTTACAAGGGGTAATAAAACTGCAATTGATAATCAAGATTGC
AAGGAAATTGAAGATTTGGTTACAAGGGGTAATAAAACTGCAATTGATAATCAAGATTGC
************************************************************
TTGAAATGGTTAGATAATTTTGAAACAGAATCTGTGGTTTATGCAAGTCTTGGAAGTTTA
TTGAAATGGTTAGATAATTTTGAAACAGAATCTGTGGTTTATGCAAGTCTTGGAAGTTTA
TTGAAATGGTTAGATAATTTTGAAACAGAATCTGTGGTTTATGCAAGTCTTGGAAGTTTA
************************************************************

Figure 37 (continued on next page)
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TCTCGTTTGACATTATTGCAAATGGTGGAACTTGGTCTTGGTTTAGAAGAGTCAAATAGG
TCTCGTTTGACATTATTGCAAATGGTGGAACTTGGTCTTGGTTTAGAAGAGTCAAATAGG
TCTCGTTTGACATTATTGCAAATGGTGGAACTTGGTCTTGGTTTAGAAGAGTCAAATAGG
************************************************************
CCTTTTGTATGGGTATTAGGAGGAGGTGATAAATTAAATGATTTAGAGAAATGGATTCTT
CCTTTTGTATGGGTATTAGGAGGAGGTGATAAATTAAATGATTTAGAGAAATGGATTCTT
CCTTTTGTATGGGTATTAGGAGGAGGTGATAAATTAAATGATTTAGAGAAATGGATTCTT
************************************************************
GAGAATGGATTTGAGCAAAGAATTAAAGAAAGAGGAGTTTTGATTAGAGGATGGGCTCCT
GAGAATGGATTTGAGCAAAGAATTAAAGAAAGAGGAGTTTTGATTAGAGGATGGGCTCCT
GAGAATGGATTTGAGCAAAGAATTAAAGAAAGAGGAGTTTTGATTAGAGGATGGGCTCCT
************************************************************
CAAGTGCTTATACTTTCACACCCTGCAATTGGTGGAGTATTGACTCATTGCGGATGGAAT
CAAGTGCTTATACTTTCACACCCTGCAATTGGTGGAGTATTGACTCATTGCGGATGGAAT
CAAGTGCTTATACTTTCACACCCTGCAATTGGTGGAGTATTGACTCATTGCGGATGGAAT
************************************************************
TCTACATTGGAAGGTATTTCAGCAGGATTACCAATGGTAACATGGCCACTATTTGCTGAG
TCTACATTGGAAGGTATTTCAGCAGGATTACCAATGGTAACATGGCCACTATTTGCTGAG
TCTACATTGGAAGGTATTTCAGCAGGATTACCAATGGTAACATGGCCACTATTTGCTGAG
************************************************************
CAATTTTGCAATGAGAAGTTAGTAGTCCAAGTGCTAAAAATTGGAGTGAGCCTAGGTGTG
CAATTTTGCAATGAGAAGTTAGTAGTCCAAGTGCTAAAAATTGGAGTGAGCCTAGGTGTG
CAATTTTGCAATGAGAAGTTAGTAGTCCAAGTGCTAAAAATTGGAGTGAGCCTAGGTGTG
************************************************************
AAGGTGCCTGTCAAATGGGGAGATGAGGAAAATGTTGGAGTTTTGGTAAAAAAGGATGAT
AAGGTGCCTGTCAAATGGGGAGATGAGGAAAATGTTGGAGTTTTGGTAAAAAAGGATGAT
AAGGTGCCTGTCAAATGGGGAGATGAGGAAAATGTTGGAGTTTTGGTAAAAAAGGATGAT
************************************************************
GTTAAGAAAGCATTAGACAAACTAATGGATGAAGGAGAAGAAGGACAAGTAAGAAGAACA
GTTAAGAAAGCATTAGACAAACTAATGGATGAAGGAGAAGAAGGACAAGTAAGAAGAACA
GTTAAGAAAGCATTAGACAAACTAATGGATGAAGGAGAAGAAGGACAAGTAAGAAGAACA
************************************************************
AAAGCAAAAGAGTTAGGAGAATTGGCTAAAAAGGCATTTGGAGAAGGTGGTTCTTCTTAT
AAAGCAAAAGAGTTAGGAGAATTGGCTAAAAAGGCATTTGGAGAAGGTGGTTCTTCTTAT
AAAGCAAAAGAGTTAGGAGAATTGGCTAAAAAGGCATTTGGAGAAGGTGGTTCTTCTTAT
************************************************************
GTTAACTTAACATCTCTGATTGAAGACATCATTGAGCAACAAAATCACAAGGAAAAACTC
GTTAACTTAACATCTCTGATTGAAGACATCATTGAGCAACAAAATCACAAGGAAAAAGGG
GTTAACTTAACATCTCTGATTGAAGACATCATTGAGCAACAAAATCACAAGGAAAAAGGG
*********************************************************
GAG
CCC
CCC

Figure 37: Alignment of Cloned SBIP68’ in pGEMT with Reference Gene. The
sequences match perfectly except for the new restriction enzyme sites at 5’ (Xho 1)
and 3’ (Apa 1) ends of pGEMT-SBIP68’. The restriction enzyme sites are highlighted
in boxes.
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PCR Screening of pPICZA-SBIP68’ Transformed Bacterial Clones
The positive clones (pGEMT-SBIP68’) were digested with restriction enzymes
(Xho 1 and Apa 1) and ligated into pPICZA digested with same set of enzymes as
described in material and methods. The ligated pPICZA-SBIP68’ products were used to
transform competent bacterial cells. Selected clones were tested for presence of the
pPICZA-SBIP68’ plasmid by colony PCR using the vector specific 5’ AOX1 (DK 641)
forward and 3’ AOX1 (DK 642) reverse primers. Figure 39 shows the agarose gel
electrophoresis of the PCR amplified products.

Figure 38: Colony PCR to Verify Presence of SBIP68’ in pPICZA Plasmid. Colony
PCR was performed using pPICZA specific AOX1 primers. Ethidium bromide
stained 0.8 % Agarose gel picture of pPICZA-SBIP68’. Lanes 2 – 20 are
representative of individual clones C1, C2, C3, C4, C5, C6, C7, C8, C9, C10, C11,
C15, C16, C17, C18, C23, C26, C28, and C30, respectively. Positive clones have
been underlined.

Sequencing of pPICZA-SBIP68’ Recombinant Clones
Clones that tested positive in colony PCR analyses were used for plasmid DNA
isolation. Plasmid DNA samples were sent for sequencing. Sequencing was important
to ensure that the SBIP68 gene (in the recombinant pPICZA-SBIP68’ plasmid) was in-
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frame with the rest of the plasmid. This would ensure that the stop codon, fusion tags
and other sequences necessary for expression and purification of the protein are in
place. Fifteen clones were sequenced, out of which fourteen showed 100 % identity to
the reference (expected sequence), and one sequence showed 99 % identity with a
single nucleotide difference. Figure 39 shows one of the sequenced clones (C4) as a
representative of the clones that showed 100 % identity to the reference (expected)
sequence, together with the reference sequence. Figure 40 shows the translated amino
acid sequence. The c-myc epitope and 6xHis-tag necessary for detection and
purification of the recombinant SBIP68’ protein are shown in blue and red respectively
(Fig. 40).
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TCGGATCGGTACCTCGAGGTCATGGCAACTCAAGTGCACAAACTTCATTTCATACTATTC
TCGGATCGGTACCTCGAGGTCATGGCAACTCAAGTGCACAAACTTCATTTCATACTATTC
************************************************************
CCTTTAATGGCTCCAGGCCACATGATTCCTATGATAGACATAGCTAAACTTCTAGCAAAT
CCTTTAATGGCTCCAGGCCACATGATTCCTATGATAGACATAGCTAAACTTCTAGCAAAT
************************************************************
CGCGGTGTCATTACCACTATCATCACCACTCCAGTAAACGCCAATCGTTTCAGTTCAACA
CGCGGTGTCATTACCACTATCATCACCACTCCAGTAAACGCCAATCGTTTCAGTTCAACA
************************************************************
ATTACTCGTGCCATAAAATCCGGTCTAAGAATCCAAATTCTTACACTCAAATTTCCAAGT
ATTACTCGTGCCATAAAATCCGGTCTAAGAATCCAAATTCTTACACTCAAATTTCCAAGT
************************************************************
GTAGAAGTAGGATTACCAGAAGGTTGCGAAAATATTGACATGCTTCCTTCTCTTGACTTG
GTAGAAGTAGGATTACCAGAAGGTTGCGAAAATATTGACATGCTTCCTTCTCTTGACTTG
************************************************************
GCTTCAAAGTTTTTTGCTGCAATTAGTATGCTGAAACAACAAGTTGAAAATCTCTTAGAA
GCTTCAAAGTTTTTTGCTGCAATTAGTATGCTGAAACAACAAGTTGAAAATCTCTTAGAA
************************************************************
GGAATAAATCCAAGTCCAAGTTGTGTTATTTCAGATATGGGATTTCCTTGGACTACTCAA
GGAATAAATCCAAGTCCAAGTTGTGTTATTTCAGATATGGGATTTCCTTGGACTACTCAA
************************************************************
ATTGCACAAAATTTTAATATCCCAAGAATTGTTTTTCATGGTACTTGTTGTTTCTCACTT
ATTGCACAAAATTTTAATATCCCAAGAATTGTTTTTCATGGTACTTGTTGTTTCTCACTT
************************************************************
TTATGTTCCTATAAAATACTTTCCTCCAACATTCTTGAAAATATAACCTCAGATTCAGAG
TTATGTTCCTATAAAATACTTTCCTCCAACATTCTTGAAAATATAACCTCAGATTCAGAG
************************************************************
TATTTTGTTGTTCCTGATTTACCCGATAGAGTCGAACTAACGAAAGCTCAGGTTTCAGGA
TATTTTGTTGTTCCTGATTTACCCGATAGAGTCGAACTAACGAAAGCTCAGGTTTCAGGA
************************************************************

Figure 39 (continued on next page)
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TCGACGAAAAATACTACTTCTGTTAGTTCTTCTGTATTGAAAGAAGTTACTGAGCAAATC
TCGACGAAAAATACTACTTCTGTTAGTTCTTCTGTATTGAAAGAAGTTACTGAGCAAATC
************************************************************
AGATTAGCCGAGGAATCATCATATGGTGTAATTGTTAATAGTTTTGAGGAGTTGGAGCAA
AGATTAGCCGAGGAATCATCATATGGTGTAATTGTTAATAGTTTTGAGGAGTTGGAGCAA
************************************************************
GTGTATGAGAAAGAATATAGGAAAGCTAGAGGGAAAAAAGTTTGGTGTGTTGGTCCTGTT
GTGTATGAGAAAGAATATAGGAAAGCTAGAGGGAAAAAAGTTTGGTGTGTTGGTCCTGTT
************************************************************
TCTTTGTGTAATAAGGAAATTGAAGATTTGGTTACAAGGGGTAATAAAACTGCAATTGAT
TCTTTGTGTAATAAGGAAATTGAAGATTTGGTTACAAGGGGTAATAAAACTGCAATTGAT
************************************************************
AATCAAGATTGCTTGAAATGGTTAGATAATTTTGAAACAGAATCTGTGGTTTATGCAAGT
AATCAAGATTGCTTGAAATGGTTAGATAATTTTGAAACAGAATCTGTGGTTTATGCAAGT
************************************************************
CTTGGAAGTTTATCTCGTTTGACATTATTGCAAATGGTGGAACTTGGTCTTGGTTTAGAA
CTTGGAAGTTTATCTCGTTTGACATTATTGCAAATGGTGGAACTTGGTCTTGGTTTAGAA
************************************************************
GAGTCAAATAGGCCTTTTGTATGGGTATTAGGAGGAGGTGATAAATTAAATGATTTAGAG
GAGTCAAATAGGCCTTTTGTATGGGTATTAGGAGGAGGTGATAAATTAAATGATTTAGAG
************************************************************
AAATGGATTCTTGAGAATGGATTTGAGCAAAGAATTAAAGAAAGAGGAGTTTTGATTAGA
AAATGGATTCTTGAGAATGGATTTGAGCAAAGAATTAAAGAAAGAGGAGTTTTGATTAGA
************************************************************
GGATGGGCTCCTCAAGTGCTTATACTTTCACACCCTGCAATTGGTGGAGTATTGACTCAT
GGATGGGCTCCTCAAGTGCTTATACTTTCACACCCTGCAATTGGTGGAGTATTGACTCAT
************************************************************
TGCGGATGGAATTCTACATTGGAAGGTATTTCAGCAGGATTACCAATGGTAACATGGCCA
TGCGGATGGAATTCTACATTGGAAGGTATTTCAGCAGGATTACCAATGGTAACATGGCCA
************************************************************
CTATTTGCTGAGCAATTTTGCAATGAGAAGTTAGTAGTCCAAGTGCTAAAAATTGGAGTG
CTATTTGCTGAGCAATTTTGCAATGAGAAGTTAGTAGTCCAAGTGCTAAAAATTGGAGTG
************************************************************
AGCCTAGGTGTGAAGGTGCCTGTCAAATGGGGAGATGAGGAAAATGTTGGAGTTTTGGTA
AGCCTAGGTGTGAAGGTGCCTGTCAAATGGGGAGATGAGGAAAATGTTGGAGTTTTGGTA
************************************************************
AAAAAGGATGATGTTAAGAAAGCATTAGACAAACTAATGGATGAAGGAGAAGAAGGACAA
AAAAAGGATGATGTTAAGAAAGCATTAGACAAACTAATGGATGAAGGAGAAGAAGGACAA
************************************************************
GTAAGAAGAACAAAAGCAAAAGAGTTAGGAGAATTGGCTAAAAAGGCATTTGGAGAAGGT
GTAAGAAGAACAAAAGCAAAAGAGTTAGGAGAATTGGCTAAAAAGGCATTTGGAGAAGGT
************************************************************
GGTTCTTCTTATGTTAACTTAACATCTCTGATTGAAGACATCATTGAGCAACAAAATCAC
GGTTCTTCTTATGTTAACTTAACATCTCTGATTGAAGACATCATTGAGCAACAAAATCAC
************************************************************
AAGGAAAAAGGGCCCGAACAAAAACTCATCTCAGAAGAGGATCTGAATAGCGCCGTCGAC
AAGGAAAAAGGGCCCGAACAAAAACTCATCTCAGAAGAGGATCTGAATAGCGCCGTCGAC
************************************************************
CATCATCATCATCATCATTGAGTTTTAGCCTTA
CATCATCATCATCATCATTGAGTTTTAGCCTTA
*********************************

Figure 39: Nucleotide Sequence Alignment of Cloned SBIP68’ in pPICZA. C4 is a
pPICZA-SBIP68’ clone, and ref is the reference sequence. The reference sequence
was derived from a combination of the SBIP68 and pPICZA sequences. The
underlined nucleotides are part of the pPICZA vector, which include the c-myc and
6xHis tag coding sequences.
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MATQVHKLHFILFPLMAPGHMIPMIDIAKLLANRGVITTIITTPVNANRFSSTITRAIKSGLRIQIL
TLKFPSVEVGLPEGCENIDMLPSLDLASKFFAAISMLKQQVENLLEGINPSPSCVISDMGFPWTTQI
AQNFNIPRIVFHGTCCFSLLCSYKILSSNILENITSDSEYFVVPDLPDRVELTKAQVSGSTKNTTSV
SSSVLKEVTEQIRLAEESSYGVIVNSFEELEQVYEKEYRKARGKKVWCVGPVSLCNKEIEDLVTRGN
KTAIDNQDCLKWLDNFETESVVYASLGSLSRLTLLQMVELGLGLEESNRPFVWVLGGGDKLNDLEKW
ILENGFEQRIKERGVLIRGWAPQVLILSHPAIGGVLTHCGWNSTLEGISAGLPMVTWPLFAEQFCNE
KLVVQVLKIGVSLGVKVPVKWGDEENVGVLVKKDDVKKALDKLMDEGEEGQVRRTKAKELGELAKKA
FGEGGSSYVNLTSLIEDIIEQQNHKEKGPEQKLISEEDLNSAVDHHHHHH Stop

Figure 40: Amino Acid Sequence of pPICZA-SBIP68’ Clone # C4. Underlined and
highlighted in blue and red are the c-myc epitope and the 6xHis-tag for detection
and purification of the recombinant protein respectively.

Transformation of pPICZA-SBIP68’ Plasmid DNA into Pichia pastoris
For transforming P. pastoris, both linear and circular plasmids can be used.
However it is desirable to linearize the plasmid before using it to transform P. Pastoris.
Linearized plasmids are believed to produce more stable transformants. Figure 41
shows the picture of a 0.8 % agarose gel with both linearized (~4800 bp) and circular
pPICZA-SBIP68’ plasmids. The restriction enzyme Pme I was used in linearization.

SBIP68’+pPICZA
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Figure 41: Agarose Gel Electrophoresis of pPICZA-SBIP68’ Plasmid DNA. Ethidium
bromide stained 0.8 % gel shows cicular (uncut) and linearized pPICZA-SBIP68’
plasmid DNAs. In lanes 2 and 4 are uncut circular plasmids while lanes 3 and 5 are
plasmids that have been cut using the enzyme Pme I, making them linear.
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Competent Pichia pastoris strain X-33 Mut+ cells were prepared for electroporation.
Both linearized and circular pPICZA-SBIP68’ DNAs were used in two separate
transformation reactions. The transformed cells were plated on YPDS/zeocin plates.
Screening of P. pastoris Clones
Selected clones after 3.5 days were verified by colony PCR for successful
incorporation of SBIP68’ into the P. pastoris genome. PCR was performed using 5’
AOX1 (DK 641) forward primer, and 3’ AOX1 (DK 642) reverse primer. The result of the
colony PCR is shown in Fig. 42. In this picture (Fig. 42), two distinct bands are
noticeable. P. pastoris has an AOX1 gene in its genome which is ~2.2 kb.
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Figure 42: Agarose Gel Showing Colony PCR of P. pastoris Clones. The upper
band is the AOX1 gene (2.2 Kb) native to P. pastoris while the lower band (1.8 Kb)
is a combination of the SBIP68’ gene (~1.5 kb) and the AOX1 sites (325 bp) of the
pPICZA-SBIP68’ construct used to transform P. pastoris.

The pPICZA plasmid also has 5’ and 3’ AOX1 priming sites, and the SBIP68’
gene is actually cloned in between the 5’ and 3’ AOX1 priming sites of the pPICZA
plasmid. The 5’ and 3’ AOX1 primers used in PCR therefore amplified both the AOX1
106

native to P. pastoris and the AOX1 sites (and everything in between which includes
SBIP68’) introduced by the plasmid. The lower of the two bands in the picture is ~1.8 kb
and comprises the SBIP68’ gene (~1.5 kb) and the AOX1 sites of the plasmid (325 bp)
Expression of Recombinant SBIP68’ in Pichia pastoris
Pichia-SBIP68’ was initially grown in BMGY medium to generate biomass and
later transferred during log-phase growth to BMMY medium for the recombinant protein
expression. Samples were taken regularly at various time points (0, 24, 48, and 72 hr)
to determine the optimal recombinant SBIP68’ protein expression. The collected Pichia
samples were centrifuged and the supernatants discarded. Pellets were stored at -80°C
until ready for analyses. The pellets were resuspended in breaking buffer and lysed as
described in the materials and methods section. A Western blot analysis was performed
to specifically detect expression of recombinant SBIP68’ (Fig. 43A).
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Figure 43: Recombinant SBIP68’ expression in P. pastoris. Both linear (Colony 4 or
C4) and circular (Colony 17 or C17) pPICZA-SBIP68’ DNA’s were used to transform
P. pastoris and both transformant have been analyzed for expression of the
recombinant protein. A. Western blot analysis of SBIP68’ recombinant protein (57.6
kDa) expression in P. Pastoris. In lanes 2, 3, 4, and 5 are 0 hr, 24 hr, 48 hr, and 72
hr time point expression samples derived from C4. In lanes 6, 7, 8, and 9 are 0 hr,
24 hr, 48 hr, and 72 hr time point expression samples derived from C17. B.
Corresponding coomassie blue stained blot. The membrane was stained after
Western blot analysis.

Due to the presence of multiple bands (other than SBIP68’) in Figure 43A, a
second expression was performed in which samples were collected at earlier time
points (6 hr, 12 hr, 24 hr) following induction with methanol. An uninduced sample
(SBIP68’ in BMGY) was also maintained. These put together would help in determining
if some of the extra immunopositive bands seen in Figure 43A were due to degradation
of SBIP68’ over time, or these are other proteins present in the expression system. The
result of the uninduced sample and the shorter time points are shown in Figure 44A.
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Figure 44: Time Course Expression of Recombinant SBIP68’. Linear pPICZASBIP68’ DNA transformed colony C4 was used. A. Western blot analysis of SBIP68’
recombinant protein (57.6 kDa) expression in P. Pastoris. In lane 1 is an uninduced
sample (C4 in BMGY), lane 2 the low molecular weight ladder, lanes 3, 4, 5, and 6
are 0 hr, 6 hr, 12 hr, and 24 hr time point expression samples derived from C4. U
stands for uninduced, and UPP means unidentified Pichia protein. B.
Corresponding coomassie blue stained blot. The membrane was stained after
Western blot analysis.

It can be deduced from the Western blot in Figure 44A that the bright band (UPP)
directly below SBIP68’ in lanes 4, 5, and 6 is not a degradation product of SBIP68’ as it
is seen to be strongly expressed in the uninduced sample in lane 1. The lowest band
(just above 30 kDa) in lane 6 (24 hr) is likely a degradation product of SBIP68’ due to
proteases present in the expression host. This band is not seen in the 12 hr and 6 hr
time points, the amount of SBIP68’ in the 24 hr time point (lane 6) also appears to be
less than the amount of SBIP68’ in the 12 hr time point (lane 5). It may be desirable to
express SBIP68’ for no longer than 12 hours for subsequent applications. This will
reduce the extent of degradation and also gives less room for other undesirable proteins
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to be expressed to a great extent. It will also result in better purification of SBIP68’ with
less non-specific bands.
Large Scale Expression and Purification of Recombinant SBIP68’ Protein
Approximately 500 ml culture of Pichia-SBIP68’ in BMMY media was used for
large scale expression. After 96 hrs of induction, the cell pellets were harvested and
pellets were saved at – 80 °C until they were processed for purification of recombinant
protein. To lyse Pichia cells, a French press was utilized. The cell lysate was collected
and the recombinant SBIP68’ was purified using a Ni-NTA column. The bound 6xHistagged SBIP68’ protein was eluted with 150 mM imidazole in 1 x Ni-NTA elution buffer
at 4 °C. The eluted samples were collected as 1 ml fractions, and the fractions with the
highest concentration of proteins were pooled and concentrated before testing the
enzyme for activity. Figure 45A shows a Western blot analysis of selected fractions after
purification.
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Figure 45: Ni-NTA Affinity Chromatography Purification of SBIP68’. A. Western Blot
Analysis of SBIP68’ recombinant protein present in P. pastoris. In lane 1 is the
concentrated sample, lane 2 the low molecular weight ladder. Lanes 3 to 8 contain
fraction numbers 8, 7, 6, 5, 4, and 3, respectively, collected from the purification
process. B. Corresponding coomassie blue stained blot. The membrane was
stained after Western blot analysis.
Purification of recombinant SBIP68’ using Anion Exchange Chromatography
In an attempt to optimize the purification of SBIP68’, a new batch of 200 ml (96 hr
induction) culture of Pichia-SBIP68’ was used. Initial purification was achieved by NiNTA column using AKTA purifier 10 (Fig. 46). Fractions 7 to 13 containing SBIP68’ were
pooled, desalted, and purified on a Mono-Q anion exchange column using AKTA purifier
10 (Figure 47-48). Bound proteins were eluted with a linear gradient of 0-500 mM NaCl
in potassium phosphate buffer pH 7.5. Western blot analysis was performed on the
eluted fractions to detect SBIP68’ (Fig. 48).
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Figure 46: Ni-NTA Affinity Chromatography Purification of SBIP68’. A. Western Blot
analysis of SBIP68’ recombinant protein present in P. pastoris. In lane 1 is the cell
lysate before purification, lane 2 is the flow through, and lane 3 the wash. Lane 4
contains the low molecular weight ladder. Lane numbers 5 to 10 contain fractions 5,
6, 7, 8, 10, and 12 respectively. The extra bands seen to coelute with SBIP68’ in
fractions 7 and 8 are likely Pichia proteins with polyhistidine-like sequences and
therefore bind to the column. Expression of SBIP68’ at shorter time points should
minimize the appearance of some of the bands as previously demonstrated. B.
Corresponding coomassie blue stained blot. The membrane was stained after
Western blot analysis. The asterisk indicates SBIP68’s expected position on the
blot.

Coomassie blue staining of the blots (Fig. 48B and Fig. 48D) revealed that
proteins other than SBIP68’ were still present in the eluted fractions and that SBIP68’
was not the major protein present in the samples. One of the major contaminating
protein (~40 kDA) was eluted in earlier fractions. One option to further purify SBIP68’
will be to perform size-exclusion chromatography.
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Electrical conductivity

Volume / fraction

Figure 47: Chromatogram Showing Purification of SBIP68’ on MonoQ Column. The
vertical axis represents electrical conductivity; the horizontal axis represents the
volume of eluted sample. The red lines on the horizontal axis represent the eluted
(0.5 ml) fractions. The blue line represents the absorbance of the protein sample at
280 nm, the green line represents the salt concentration, and the dark brown line
represents salt conductivity.
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Figure 48: MonoQ Anion Exchange Chromatography Purification of SBIP68’. A. Western
Blot Analysis of SBIP68’ recombinant protein. Lanes 2 to 10 represent fractions 4, 5, 6, 7, 8,
9, 10, 11, and 12 derived from MonoQ anion exchange chromatography. B. Corresponding
coomassie blue stained blot of A. C. Lanes 2 to 7 represent fractions 13, 14, 15, 22, 23,
and 24 derived from MonoQ anion exchange chromatography. Lanes 8, 9, and 10
represent the flow-through, the input ( Ni-NTA purified, desalted sample), and the undesalted sample respectively. D. Corresponding coomassie blue stained blot of C. The

asterisks indicate SBIP68’s expected position on the blots.

Analysis of Glucosyltransferase Activity of SBIP68’ using Radioactive Method
A radioactive assay was performed to test for glucosyltransferase activity of
purified recombinant SBIP68 as described in the materials and methods section
(McIntosh et al., 1990). UDP-[U- 14C] glucose was the donor substrate while a total of
14 different aglycones were each used as potential acceptor substrates. The
incorporation of 14C glucose (CPM, counts per minute) for each of the substrates tested
is represented in Table 2 below. SBIP68’ showed highest activity with kaempferol.
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Figure 49 and Table 2 show the relative activity (kaempferol was considered100%) for
each substrate tested. Two independent reactions were performed for each substrate
tested and the average of the values are also shown (Table 2). This radioactive assay
method was developed for the detection of flavonoid glucosides that are soluble in ethyl
acetate (see materials and methods), and may not be suitable for testing
glucosyltransferase activity with salicylic acid and other simple phenols, as the solubility
of their glucosides in ethyl acetate could not be ascertained at the time of this
experiment.

Table 2: ctivity Screening of S IP68’ using UDP-14C-glucose
Substrate
Kaempferol

Cpm/rxn Cpm/rxn Average
1
2
cpm/rxn
7599
7467
7533

Quercetin

5326

5674

5500

73

Hesperetin

4295

4909

4602

61

Naringenin

4277

4208

4243

56

Gossypetin

2051

2067

2059

27

4-acetone-7 Hydroxy-6methoxy-Isoflavone

1325

1263

1294

17

Luteolin

1171

1221

1196

16

Apigenin

991

966

979

13

Fisetin

565

462

514

7

MeSA

269

244

257

3

Benzoic acid

260

234

247

3

Azelaic acid

216

257

237

3

Salicylic acid

235

232

234

3

p-hydroxybenzoic acid

217

192

205

3

Blank

59

47

53

1
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Figure 49: Relative Activity of SBIP68’ with Different Potential Acceptor Substrates.
Radioactive UDP glucose was used as the donor substrate. The CPM for each
reaction was measured with a scintillation counter. All reactions were in duplicates
and the average was taken.

Analysis of Glucosyltransferase Activity using HPLC
An HPLC based method (Owens and McIntosh, 2009) was used to identify the
products formed from five different reactions involving kaempferol, quercetin,
naringenin, hesperetin, and salicylic acid as acceptor substrates (Fig. 50). The
glucosyltransferase reaction using purified SBIP68’ was performed as described in the
materials and methods. HPLC grade kaempferol 3-O-glucoside, kaempferol, quercetin,
quercetin 3-O-glucoside, naringenin, naringenin 7-O-glucoside, hesperetin, and salicylic
acid were also used as standards in the identification of the reaction products.
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Figure 50 A-B: Identification of Reaction Products by HPLC. . Top panel shows
retention time for kaempferol standard at 12.7 minutes, middle panel shows retention
time for kaempferol 3-O-glucoside standard at 9.2 minutes. The bottom panel shows
the products formed from the reaction with SBIP68, kaempferol 3-O-glucoside and
kaempferol, with retention times at 9.2 minutes and 12.8 minutes respectively. . Top
panel shows retention time for quercetin standard at 11.2 minutes, middle panel
shows retention time for quercetin 3-O-glucoside standard at 8 minutes. The bottom
panel shows the products formed from the reaction with SBIP68, quercetin 3-Oglucoside and quercetin, with retention times at 8 minutes and 11.2 minutes
respectively.
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Figure 50 C-D: Identification of Reaction Products by HPLC. C. Top panel shows
retention time for naringenin standard at 12.2 minutes, middle panel shows retention
time for naringenin 7-O-glucoside standard at 9.2 minutes. The bottom panel shows
the products formed from the reaction with SBIP68, naringenin 7-O-glucoside and
naringenin, with retention times at 9.2 minutes and 12.2 minutes respectively. D. Top
panel shows retention time for hesperetin standard at 12.8 minutes.The bottom panel
shows the products formed from the reaction with SBIP68, hesperetin glucoside and
hesperetin, with retention times at 10.2 minutes and 12.8 minutes respectively. It
appears there is a second hesperetin glucoside with a retention time of 9.7 minutes.
There were no hesperetin glucoside standards available at the time of this
experiment.
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Figure 50 E: Identification of Reaction Products by HPLC. E. Top panel shows
retention time for salicylic acid standard at 17.2 minutes.The bottom panel shows the
product(s) from the SBIP68 reaction involving salicylic acid as a potential acceptor
substrate. SA is seen to have a retention time of 17.2 minutes, no SA glucosides are
observed. There were no salicylic acid glucoside standards available at the time of
this experiment.
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CHAPTER 4
DISCUSSION
Salicylic acid is a well-established signal molecule when it comes to defense
responses in plants (Chen et al., 2009). The exogenous application of SA has been
known to induce the expression of plant pathogenesis-related genes (Ward et al.,
1991), and disease resistance (White, 1979). SA is not only involved in inducing
hypersensitive response in infected areas of the plant but also systemic acquired
resistance (SAR) in uninfected and distal parts (Malamy et al., 1990; Yalpani et al.,
1991; Yalpani et al., 1993). The majority of the SA produced by plants undergoes
glucosylation and/or methylation (Rivas-San Vicente and Plasencia, 2011).
Glucosylation of SA at the hydroxyl group produces SA 2-O-β-D-glucoside (SAG), while
glucosylation at the carboxyl group produces the SA glucose ester in large and minute
amounts respectively (Rivas-San Vicente and Plasencia, 2011). SA
glucosyltransferases are responsible for these glucosylation reactions which are
induced upon the application of SA or during response to pathogen attack in tobacco
and Arabidopsis (Lee and Raskin, 1999; Song, 2006). SAG stored in the vacuole may
serve as an inactive form of SA capable of releasing free SA when required (Dean and
Mills, 2004; Dean et al., 2005).
The methylation of SA by SA carboxyl methyltransferase produces methyl
salicylate (MeSA), a volatile SA derivative that plays a crucial role serving as a long
distance signal during systemic acquired resistance in tobacco and Arabidopsis
(Shulaev et al., 1997; Chen et al., 2003; Park et al., 2007; Vlot et al., 2008). Tobacco
SABP2 is the enzyme responsible for converting the volatile methyl salicylate into
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salicylic acid in the distal parts of the plant to induce SAR (Park et al., 2007; Tripathi et
al., 2010). An improved knowledge of SABP2 functionality would be a great
achievement in the quest to understand how plants respond to stress. In a bid to
achieve this, a yeast two-hybrid screening was performed with tobacco SABP2 as a bait
and total expressed tobacco leaf proteins as prey. This led to the identification of
several interacting proteins including SBIP68. Computational analysis revealed that
SBIP68 belongs to the Family 1 of plant GTs (UGT), and it has the C-terminal PSPG
signature motif characteristic of this group. The PSPG box is predicted to be involved in
the binding of the UDP moiety of the sugar-donor substrate in the glycosylation reaction
(Hughes and Hughes, 1994).
As mentioned previously, SABP2 has high affinity for salicylic acid and is
important for the induction of SAR in the event of a pathogen attack (Kumar and
Klessig, 2003). Since SBIP68 possessed the characteristics of a potential
glucosyltransferase as determined by bioinformatics, and it interacts with SABP2, it is
logical to hypothesize that SBIP68 might be a UGT involved in the glucosylation of
salicylic acid during plant stress signaling.
UGTs have been known to participate in the detoxification of metabolites
produced by plant-pathogens (Schweiger et al., 2013), or detoxification of harmful
compounds including herbicides (Kreuz et al., 1996). They also enhance the solubility of
low molecular weight compounds in water (Hrazdina, 1988), and are involved in the
regulation of the action of essential compounds like indole acetic acid and cytokinins
(Dixon et al., 1989; Szerszen et al., 1994).
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As previously mentioned, a number of glucosyltransferases have been found to
glucosylate salicylic acid, and their expression has been induced by SA. In Oryza
sativa, probenazole (an agrochemical) induced the expression of OsSGT1, a UDPglucose:SA glucosyltransferase involved in catalyzing the conversion of SA into SA O-βglucoside (SAG) (Umemura et al., 2009). RNAi silencing of OsSGT1 was observed to
reduce to a large extent, the probenazole-dependent resistance to blast disease
(Umemura et al., 2009). This strengthens the suggestion that OsSGT1 is a key player in
the development of chemically induced disease resistance in rice (Umemura et al.,
2009). OsSGT1 may be involved in the SA signaling pathway by inducing the upregulation of SAG in rice (Umemura et al., 2009).
In tobacco plants possessing the ‘N’ resistance protein, bacterial or viral
pathogens were observed to induce tobacco UDP-glucose:salicylic acid
glucosyltransferase (SA GTase) mRNA expression (Lee and Raskin, 1999). This
observed induction of SA GTase mRNA expression corresponded to an increase in
endogenous SA found in the inoculated tissue (Lee and Raskin, 1999). Also, treatment
of plant with SA was found to activate SA GTase mRNA expression, implying that
induction of the SA GTase gene is through the SA-mediated signal transduction
mechanism (Lee and Raskin, 1999).
The aim of the present study was to determine what role SBIP68 plays in
tobacco and more importantly what kind of relationship exists between SBIP68 and
SABP2. To gain more insight into the role of SBIP68, it was cloned, expressed and
characterized functionally in vitro.
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In silico subcellular localization analysis using various computer software
predicted SBIP68 to be either present in the cytoplasm, or targeted to the endoplasmic
reticulum membrane (Fig. 14 and 16), or may be transported (Fig. 15) to some other
organelle where it exerts its effect. Protein BLAST analyses revealed that SBIP68 has a
GTB topology, one of two protein topologies found in nucleotide-sugar-dependent
glycosyltransferases (Marchler-Bauer et al., 2015). GTB proteins are known to have N
and C terminal domains that are distinct each possessing a typical Rossmann fold
(Marchler-Bauer et al., 2015). Both domains exhibit high structural homology even
though they have very little sequence homology (Marchler-Bauer et al., 2015).
Separating both domains is a large cleft which contains the catalytic center and allows a
high degree of flexibility (Marchler-Bauer et al., 2015). SBIP68 was also shown to
possess a putative GT1_Gtf_like conserved protein domain (Marchler-Bauer et al.,
2015). Gtfs are a group of homologous glycosyltransferases that are involved in the last
steps of the biosynthesis of vancomycin and related chloroeremomycin (Marchler-Bauer
et al., 2015). They catalyze the transfer of sugars from activated NDP-sugar donors to
the heptapeptide core of vancomycin group of antibiotics (Marchler-Bauer et al., 2015).
In contrast, SBIP68 has a PSPG motif (Fig. 26) characteristic of plant GT’s which binds
the sugar donor substrate (Hughes and Hughes, 1994).
SBIP68 was cloned and expressed in E. coli. Solubility results revealed that
recombinant SBIP68 in E. coli were mostly expressed in the insoluble form, and only a
minor fraction was present in the soluble form (Fig. 30). The construct with C-terminal
6xHis tag (pET-28a-SBIP68-645) seemed to be better expressed in the soluble form
compared to one with N-terminal 6xHis tag (pET-28a-SBIP68-644) (Fig. 30). There are
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certain limitations to expression of recombinant proteins in a prokaryotic system such as
E.coli, one of which is the formation of densely packed denatured proteins in the form of
particles referred to as inclusion bodies(Singh and Panda, 2005). They occur as a
stress response upon the high level expression of recombinant proteins (Sorensen and
Mortenson, 2005) and they do not have a defined structure (Carrio et al., 2000).
Formation of inclusion bodies in recombinant systems could be reduced by altering
certain expression conditions including but not limited to temperature, rate of
expression, and target protein engineering (Jonasson et al., 2002). In an attempt to
produce more soluble SBIP68 recombinant protein, the amount of IPTG used in
inducing expression, the expression temperature, and the duration of time used in
expression were altered. The altering of these parameters, did not bring about
significant improvement in the amount of soluble SBIP68 recombinant protein that was
being produced (Fig. 31). The affinity purified soluble protein, however, showed
glucosyltransferase activity when tested using four flavonoid acceptor substrates and
UDP-glucose (Fig. 33, Fig. 34).
SBIP68 was also cloned into the pPICZA (a yeast expression) plasmid to be
expressed in P. pastoris, a eukaryotic system. Some important characteristics that
make yeast cells desirable for protein expression include the ability to proper protein
folding and post-translational modifications because they are eukaryotes (Mattanovich
et al., 2012). Presently, Saccharomyces cerevisiae, Hansenula polymorpha, and Pichia
pastoris are being used in the large scale expression of heterologous proteins. These
appear to be the most promising yeast strains at the moment (Mattanovich et al., 2012).
P. pastoris is a methylotrophic yeast capable of growing on simple, inexpensive medium
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and is appropriate for small as well as large scale heterologous expression of proteins
(Daly and Hearn, 2005). It has two alcohol oxidase genes, AOX1 and AOX2, whose
promoters are methanol inducible (Daly and Hearn, 2005). Usually, the gene for the
heterologous protein to be expressed is placed under the control of the AOX1 promoter,
which is strongly induced by methanol. Molecular manipulations like gene targeting,
high efficiency of DNA transformation, and cloning for the purpose of functional
complementation are similar to those obtainable with S. cerevisiae (Cereghino and
Cregg, 2000). In addition to the above, P. pastoris has the ability to integrate
heterologous DNA into the host chromosome easily, has promoters that are very tightly
controlled, and is capable of generating more posttranslational modifications, making it
preferable to S. cerevisiae (Yesilirmak and Sayers, 2009).
Cloning of SBIP68 into the pPICZA vector resulted in the formation of the
pPICZA-SBIP68’ construct which was used to transform P. pastoris. Because pPICZA
has the AOX1 promoter, and SBIP68 had been cloned behind this promoter, expression
of the SBIP68 gene was made possible by induction of the AOX1 promoter with
methanol. Recombinant SBIP68 had a c-myc epitope as well as a C-terminal
6xHistidine tag which facilitated identification and purification, respectively. The Pichia
pastoris expression system proved to be a preferable alternative to E. coli system in the
expression of SBIP68 as a large proportion of the protein was present in the soluble
form. Time point expression studies showed that the amount of SBIP68 produced from
0 – 96 hours continued to increase, however, after about 6 hours of induction, what
appears to be a degradation product of SBIP68 starts to form and some other unwanted
host proteins started accumulating (Figs. 43 and 44). Expression of SBIP68 for more
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than 6 hours but no longer than 12 hours may be best as this may reduce the extent of
degradation seen in 24 hour and above time points and also reduces the chances of
expression of some of the non-specific proteins that appear during detection by Western
blot analysis and also bind to the column during purification (Fig. 45).
Recombinant SBIP68 from Pichia pastoris was purified by affinity
chromatography using Ni- NTA. Purification with Ni-NTA got rid of most but not all of the
unwanted host proteins (Fig. 45). Ni-NTA purified samples were subsequently purified
using anion exchange chromatography. Anion exchange chromatography further
purified to a great extent, still several unwanted proteins co-purified as was visualized
by coomassie blue staining (Fig. 48). It may be desirable to perform a purification using
size-exclusion chromatography or other available chromatography matrix.
Based on our hypothesis of SBIP68 being a salicylic acid GT, and bioinformatics
analysis predicting it to be a flavonoid GT, the purified SBIP68 was screened for GT
activity with fourteen potential acceptor substrates using UDP-glucose as the sugar
donor substrate. The acceptor substrates tested included a number of flavonoids,
simple phenolics, and azelaic acid, a compound known to induce the accumulation of
salicylic acid in plants after infection (Jung et al., 2009; Everts, 2011).
In testing the recombinant enzyme for glucosyltransferase activity, a radioactive
assay (McIntosh et al., 1990) involving radiolabeled UDP-glucose, was employed.
Recombinant SBIP68 glucosylated flavonols (kaempferol, quercetin, gossypetin, fisetin),
flavanones (hesperetin, naringenin), flavones (apigenin, luteolin,), and isoflavones (4acetone-7 Hydroxy-6-methoxy-isoflavone), displaying broad substrate specificity.
SBIP68 barely showed activity in the reactions involving azelaic acid and the simple
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phenolic compounds benzoic acid, salicylic acid, p-hydroxybenzoic acid, and MeSA, as
acceptor substrates. Of the fourteen substrates tested, the reaction with kaempferol had
the highest activity with 7,533 cpm, and quercetin was next with 5,500 cpm. Reactions
involving hesperetin, naringenin, gossypetin, 4-acetone-7 hydroxy-6-methoxyisoflavone, luteolin, apigenin, fisetin, methyl salicylic acid, benzoic acid, azelaic acid,
and salicylic acid had 4602 cpm, 4243 cpm, 2059 cpm, 1294 cpm, 1196 cpm, 979 cpm,
514 cpm, 257 cpm, 247 cpm, 237 cpm, and 234 cpm respectively. The reaction with phydroxybenzoic acid had the lowest with 200 cpm (Fig. 49 and Table 2). Because the
radioactive method was developed for detecting flavonoid glucosides that are soluble in
the organic ester ethyl acetate (see materials and methods), this method may not be
suitable for testing glucosyltransferase activity with salicylic acid and other simple
phenols as the solubility of their glucosides in ethyl acetate could not be ascertained.
An HPLC based method (Owens and McIntosh, 2009) was used to identify the
products formed from separate reactions involving kaempferol, quercetin, naringenin,
hesperetin and salicylic acid as acceptor substrates (Fig. 33, Fig. 34, Fig. 50).
Kaempferol, kaempferol 3-O-glucoside, quercetin, quercetin 3-O-glucoside, naringenin,
naringenin 7-O-glucoside, hesperetin, and salicylic acid were also used as standards in
an attempt to identify the products formed from the reactions with each of the acceptor
substrates, there were no hesperetin glucoside and salicylic acid glucoside standards
available at the time of the experiment. These reactions, when analyzed by HPLC, had
distinct peaks for substrate and products formed. The reactions involving kaempferol as
acceptor substrate had retention times of 9.2 minutes and 12.8 minutes for kaempferol3-0-glucoside and kaempferol, respectively (Fig. 33A, Fig. 34A, Fig. 50A). The reaction
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with quercetin had retention times of 8 minutes and 11.2 minutes for quercetin 3-Oglucoside and quercetin, respectively (Fig. 33B, Fig. 34B, Fig. 50B). The reaction
involving naringenin as acceptor substrate had retention times of 9.2 minutes and 12.2
minutes for naringenin-7-0-glucoside and naringenin, respectively (Fig. 33C, Fig. 34C,
Fig. 50C). The reaction with hesperetin had retention times of 9.7 minutes, 10.2
minutes, and 12.8 minutes for two unidentified hesperetin glucosides and hesperetin,
respectively (Fig. 33D, Fig. 34D, Fig. 50D), while that with salicylic acid only showed a
retention time for salicylic acid at 17.2 minutes (Fig. 50E). These results suggest that
SBIP68 is a UDP-glucose: flavonoid glucosyltransferase, and probably not a salicylic
acid glucosyltransferase.
Flavonoids are secondary metabolites synthesized by plants with known
biological activities, they are involved in the interactions of plants with other organisms
as well as their environment (Mierziak et al., 2014). Flavonoids undergo modification
reactions such as methylation and glycosylation by methyltransferases and
glycosyltransferases respectively (Mierziak et al., 2014). These reactions are known to
alter their reactivity, solubility, and stability (Mierziak et al., 2014). Due to their diverse
chemical structures and variety arising from the attached substituent groups, flavonoids
have various important roles in plants, the most significant of which is UV protection
(Treutter, 2005; Mierziak et al., 2014). They are involved in plant protection against both
abiotic and biotic stresses, and they also maintain a redox state in cells arising from
their antioxidative properties (Mierziak et al., 2014). Fat-soluble flavonoids could distort
microbial membranes, alter their fluidity and damage the respiratory chain (Haraguchi et
al., 1998; Mishra et al., 2009). The B ring of flavonoids are capable of intercalating or
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forming hydrogen bonds with the stacking of nucleic acid bases causing an inhibition of
DNA and RNA synthesis in bacteria and also enhance the activity of DNA gyrase (Wu et
al., 2013). This feature is also considered to be the basis of their antiviral properties, as
they are known to inhibit viral polymerase enzymes and bind to the nucleic acids or
capsid proteins viruses (Selway, 1986). Flavonols (quercetin, kaempferol, myricetin)
have also been shown to strongly promote pollen germination frequency, pollen
development, and pollen tube growth in cultures of tobacco (Nicotiana tabacum L.)
immature pollen in vitro (Ylstra et al., 1992). Low concentrations of these flavonols
produced the best results, indicative of a signaling function (Ylstra et al., 1992).
Cucumber mosaic virus containing satellite RNA (CMV sat) which causes
catastrophic necrotic tomato disease and is capable of infecting Arabidopsis was used
in an experiment involving three groups of Arabidopsis plants; control plants which were
untreated, wounded plants which were treated with buffer, and infected plants which
were treated with CMV sat (Likić et al., 2014). As mentioned earlier, flavonoids
participate in the detoxification of ROS in plants after wounding (León et al., 2001; Apel
and Hirt, 2004). A decrease in kaempferol aglycone levels observed in the treated
plants confirmed a putative role for kaempferol in the detoxification of ROS (Likić et al.,
2014). Also, based on a model suggesting that H2O 2 induces SA accumulation
(Summermatter et al., 1995), detoxification of ROS by kaempferol and quercetin would
inhibit the accumulation of SA in inoculated leaves (Likić et al., 2014). Observed
changes in the concentrations of kaempferol and SA during the first four time points
after inoculation with CMVsat were in accordance with the model (Likić et al., 2014).
Significantly smaller concentrations of kaempferol present in the upper leaves of all
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CMVsat infected plants as compared to the controls also indicated an important role for
kaempferol in defense responses induced by CMVsat (Likić et al., 2014). Results from
the experiment indicate a plausible regulatory function of kaempferol as a part of a
proposed kaempferol-indole acetic acid dependent defense response where the
systemic spread of CMVsat is curtailed through the joint action of kaempferol and IAA
(Likić et al., 2014). This response is believed to be activated prior to the activation of
well known salicylic acid defense response (Likić et al., 2014).
Quercetin is known to induce resistance in response to infection by virulent strain
Pseudomonas syringae pv. tomato DC3000 (Pst) in Arabidopsis, via H2O2 burst and the
involvement of SA and non-pathogenesis related 1 (NPR1) (Jia et al., 2010). Defense
responses such as callose deposition, H2O2 burst, cell death, pathogenesis-related 1
(PR1) and Phenylalanine ammonia-lyase 1 (PAL1) gene expression were observed in
quercetin-pretreated Pst-inoculated Arabidopsis Col-0 and a strong defense response
against virulent Pst was found to occur in quercetin-pretreated Arabidopsis (Jia et al.,
2010). In the presence of the enzyme catalase however, the anti-pathogenic effects of
quercetin on virulent Pst in Arabidopsis was observed to disappear (Jia et al., 2010).
This suggests that H2O2 is also important in the defense response against Pst (Jia et al.,
2010). Quercetin was shown to have no beneficial effect on pathogen-free leaves in
Arabidopsis, indicating that pathogen challenge is necessary to induce the defense
responses observed to occur in quercetin-pretreated Arabidopsis (Jia et al., 2010).
Two new isoflavones and seven other known isoflavones were isolated from the
stems and roots of Nicotiana tabacum and their anti-tobacco mosaic virus (anti-TMV)
activities were evaluated using the half-leaf method (Yan et al., 2010; Chena et al.,
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2012). Two of the tested isoflavones, licoisoflavone and 6-hydroxy-7,3′,4′,5′tetramethoxy-isoflavone showed high (48.4%) anti-TMV activity and moderate (22.2%)
anti-TMV activity respectively by inhibiting replication of the virus (Chena et al., 2012).
The other seven compounds, 7-hydroxy-6,3′,4′,5′-tetramethoxy-isoflavone, irigenin,
genistein, glycitein, 8-hydroxyglycitein, 2′,4′,5′,6,7-pentamethoxyisoflavone, and
2′,3′,4′,6,7-pentamethoxy isoflavone, all displayed weak (< 10%) anti-TMV activities
(Chena et al., 2012). Ningnanmycin, a commercial product used in controlling plant
diseases showed 33% inhibition rate and served as a positive control (Chena et al.,
2012).
Under natural conditions, most flavonoids are present in form of their respective
glycosides (Bohm, 1998; Forkmann and Heller, 1999). Glycosylation is one key
mechanism that functions in regulating the storage and bioactivity of phytochemicals
and the detoxiﬁcation of xenobiotics in plants (Mackenzie et al., 1997; Bowles et al.,
2005). Flavonoids are most commonly glycosylated by UGTs with one sugar group or
more (Harborne and Baxter, 1999), and glucose happens to be the most common sugar
found in naturally occurring ﬂavonoid glycosides (Noguchi et al., 2009). Certain plants
however, possess characteristic ﬂavonoids in conjugation with speciﬁc sugars as their
specialized metabolites (Noguchi et al., 2009).
UGT707B1 a glucosyltransferase found in the cytoplasm and the nucleus of
stigma and tepal cells of Crocus sativus (saffron) is absent in the tepals of certain
species (Trapero et al., 2012). Analysis of the glucosylated ﬂavonoids present in the
tepals of Crocus revealed two main ﬂavonoid compounds present in saffron, these are
kaempferol-3-O-β-D-glucopyranosyl-(1-2)-β-D-glucopyranoside and quercetin-3-O-β-D-
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glucopyranosyl-(1-2)-β-D-glucopyranoside (Trapero et al., 2012). Both of these
flavonoid glucosides were not found in the tepals of Crocus species that did not express
UGT707B1 (Trapero et al., 2012). Transgenic Arabidopsis plants constitutively
expressing UGT707B1 under the control of the cauliﬂower mosaic virus 35S promoter
showed a number of phenotypic changes similar to those observed in previously
described lines in which ﬂavonoid levels had been altered (Trapero et al., 2012). The
plants displayed thicker stems, hyponastic leaves, delay in ﬂowering, and a lesser
amount of trichomes (Trapero et al., 2012). Flavonoid levels present in extracts of the
transgenic plants varied in their ﬂavonol content as compared to wild-type plants
(Trapero et al., 2012). Extracts obtained from the stems and ﬂowers showed an
increase in 3-sophoroside ﬂavonol glucosides (Trapero et al., 2012). A new flavonol
compound not found in Arabidopsis ecotype col-0 wild-type plants was found in all the
tissues and this was identiﬁed to be kaempferol-3-O-sophoroside-7-O-rhamnoside
(Trapero et al., 2012). All of these put together indicate that UGT707B1 is involved in
the biosynthesis of ﬂavonol-3-O-sophorosides and that the overexpression of a
flavonoid glucosyltransferase could bring about signiﬁcant changes in ﬂavonoid
homeostasis in a plant (Trapero et al., 2012).
UGT73A10 (49 % similarity to SBIP68) a glycosyltransferase cloned from
Chinese wolfberry (Lycium barbarum L.) was heterologously expressed in E. coli and
found to show outstanding regiospeciﬁc glucosyltransferase activity towards ﬂavan-3-ols
(e.g., (+)-catechin and epigallocatechin gallate), which are known to occur rarely in
nature as glucosides (Noguchi et al., 2008). UGT73A10 showed high speciﬁcity for the
donor substrate UDP-glucose and displayed broad acceptor substrate speciﬁcity with
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the highest preference for naringenin (Noguchi et al., 2008). The enzyme glucosylated
the 7 hydroxyl position of naringenin and was shown to be phylogenetically related to
ﬂavonoid 7-O-glucosyltransferases (Noguchi et al., 2008). UGT73A10 displayed high
glucosyltransferase activity, up to 83% glucosyl transfer to (+)-catechin was observed.
Spectroscopic analyses revealed that the transfer product was 4’-O-β-Dglucopyranoside, and not the 7-O-β-D-glucoside, of (+)-catechin (Noguchi et al., 2008).
Stability studies also revealed that this glucoside product had better stability than (+)catechin when subjected to alkaline conditions and high temperatures (Noguchi et al.,
2008). The glucosylation of flavonoids by SBIP68 may serve to maintain ﬂavonoid
homeostasis in tobacco as well as play a protective role in the plant during abiotic or
biotic stress conditions (Fig. 51).
As part of an ongoing project intended to elucidate the SA defense pathway in
plants, and the SA-SABP2 relationship in tobacco, this research aimed at characterizing
functionally the role of SBIP68 as a glucosyltransferase in the SA-SABP2 interaction.
Recombinant SBIP68 activity screening performed with fourteen potential acceptor
substrates and UDP-glucose as the donor substrate revealed SBIP68 to have broad
substrate specificity, glucosylating flavonols, flavanones, and isoflavones. Kaempferol,
quercetin, and naringenin appeared to be the preferred substrates, however, further
experiments will have to be performed to determine SBIP68’s substrate of choice.
HPLC analysis and comparison with available commercial standards confirmed the
formed glucosides from the reactions with kaempferol, quercetin, and naringenin, to be
kaempferol 3-0-glucoside, quercetin 3-0-glucoside, and naringenin 7-0-glucoside,
respectively.
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Results from this study, as well as information available in the database indicate
that SBIP68 is a UDP-glucose: flavonoid glucosyltransferase with broad substrate
specificity. As earlier mentioned, flavonoids may be involved in plants defense against

Figure 51: Model Suggesting SBIP68 Function in planta. SBIP68 may serve to
maintain ﬂavonoid homeostasis in tobacco plants during abiotic or biotic stress
conditions, and consequently prevent excessive to the plants.
pathogens and most flavonoids occur naturally in their glycosylated forms. Glycosylation
of flavonoids may function in regulating their storage and bioactivity (Fig. 51).
The reactions with azelaic acid, benzoic acid, and MeSA have to be repeated
and optimized, and the reaction products analyzed in order to determine if SBIP68 is
involved in the glucosylation of any of these. Bacterial infections lead to an increased
accumulation of azelaic acid, which is known to confer local and systemic resistance
against the pathogen Pseudomonas syringae in plants. It is required for the
accumulation of salicylic acid and systemic immunity upon pathogen infection (Jung et
al., 2009). Methyl salicylate (MeSA) is the in planta substrate of SABP2. SABP2
converts MeSA into SA, a requirement for the onset of systemic acquired resistance
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(SAR) in systemic tissues (Park et al., 2007). Infection of tobacco (Nicotiana tabacum cv
Samsun NN) plants with TMV or elicitation of tobacco cell suspensions with βmegaspermin brings about a rapid de novo synthesis and accumulation of a conjugated
form of benzoic acid, benzoyl-glucose, which is a likely involved in the biosynthesis of
SA (Chong et al., 2001).
This entire experiment was performed in vitro, and as a result we do not have
information regarding the substrates of SBIP68 in planta. What we do know from this
study is that SBIP68 is a glucosyltransferase. This information will be used in attempts
to determine SBIP68’s natural substrates and its role in planta, and more significantly its
interaction with SABP2 and its role in the SA induced defense pathway, if any.

135

Future Directions
The characterization of SBIP68 is only a piece of the puzzle intended at
deciphering the SA pathway in tobacco. Based on what is known about the
glucosylation of salicylic acid, and available information indicating that SBIP68 is a
glucosyltransferase that interacts with SABP2, it was proposed that SBIP68 is likely
involved in the glucosylation of salicylic acid. Based on the results obtained in this study
using in vitro enzyme assay, recombinant SBIP68 failed to glucosylate salicylic acid, but
several potential flavonoid substrates were identified. Further experiments should be
performed to determine SBIP68’s most preferred substrate, as well as various kinetic
studies to determine its rate of glucosylation, effect of temperature, pH, metal ions, etc.
To study the effect of SABP2’s interaction with SBIP68, the glucosyltransferase activity
assay with flavonoid substrates should be conducted in the presence of SABP2.
To further study the role of SBIP68 in plant defense, transgenic plants either
silenced in SBIP68 expression or overexpressing SBIP68 should be generated and
used. These SBIP68 transgenic plants could be used for a range of experiments
including challenging with viral pathogens such as tobacco mosaic virus (TMV) or
bacterial plant pathogens such as Pseudomonas syringae. The results from all these
proposed experiments is likely to help in understanding the role of SBIP68 in tobacco
plants, and determine if it is involved in defense against pathogens.
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APPENDICES
Appendix A – Abbreviations
SABP2 - Salicylic acid binding protein 2
SBIP68 - SABP2 Interacting Protein-68
HR - Hypersensitive response
SA - Salicylic acid
JA - Jasmonic acid
ET - Ethylene
SAR - Systemic acquired resistance
MeSA - Methyl salicylate
SDS PAGE - Sodium dodecyl sulphate-polyacrylamide gel electrophoresis
TMV - Tobacco mosaic virus
PR - Pathogenesis-related
βME - Beta mercaptoethanol
EFalpha1 - Elongation Factor alpha 1
TAE - Tris-Acetate EDTA
KDa - Kilo Dalton
OD - Optical Density
UV - Ultra violet
µg – micro gram
μl – micro litre
ml – milli litre
mM – milli Molar
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Appendix B – Buffers, Reagents, and Media
0.8 % Agarose Gel
Agarose = 0.40 g
1x TAE Buffer = 50 ml
Dissolve the agarose in the TAE buffer by heating in a microwave for ~ 60
seconds.
Place the mixture in a water bath ~ 60 °C to dissolve the agarose completely.
Add 2.5 μl (10 mg/mL) ethidium bromide
20% APS (Ammonium Persulfate) (1 ml)
Ammonium persulfate = 0.2 g
Water = 1 ml
500X B (0.02% Biotin)
Biotin = 20 mg
Dissolve in100 ml distilled water
Filter sterilize solution
Store at 4 °C
Breaking Buffer (500 mL)
Monobasic Sodium Phosphate Monohydrate = 3.45 g
EDTA (non-salt) = 145 mg
100 % Glycerol = 25 ml
Dissolve ingredients in 500 mL dH2O
Add 10μl of 0.1M PMSF per ml of breaking buffer immediately before use
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BMGY Medium (1 L)
1% Yeast extract = 10 g
2 % Peptone = 20 g
Dissolve in 700 ml sterile distilled water
Autoclave for 20 min on liquid cycle
Cool to room temperature
Add the following
1M Potassium Phosphate Buffer (pH=6.0) = 100 ml
1M 10X Yeast Nitrogen Base = 100 ml
10X Glycerol = 100 ml
500X Biotin = 2 ml
Store at 4 °C
BMMY Medium (1 L)
Yeast extract = 10 g
Peptone = 20 g
Dissolve in 700 ml distilled water
Autoclave for 20 minutes on liquid cycle
Cool to room temperature
Add the following
1M Potassium Phosphate Buffer (pH=6.0) = 100 ml
1M 10X Yeast Nitrogen Base = 100 ml
10X Methanol = 100 ml
500X Biotin = 2 ml
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Store at 4°C
Coomassie brilliant blue destaining solution (1 L)
500 ml distilled water
400 ml methanol
100 ml acetic acid
Coomassie Brilliant Blue staining solution (1 L)
500ml Methanol
100 ml acetic acid
400 ml H2O
Dissolve 1 g of Coomassie Brilliant Blue in the solution.
10X D (20% Dextrose) (500 ml)
Dextrose (D-glucose) = 100 g
Dissolve in 500 ml distilled water
Autoclave for 15 min on liquid cycle
Store at room temperature
0.1% DEPC (Diethyl Pyrocarbonate) Treated Water (0.1 L)
Diethyl pyrocarbonate = 0.1 ml
Distilled water = 100 ml
Mix the above constituents by pipetting the DEPC into the distilled water,
incubate the mixture at 37°C for ~12 hours. Autoclave at 121°C and 15 psi
atmospheric pressure for 20 minutes and allow to cool to room temperature.
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10X GY (10 % Glycerol) (500 ml)
100 % Glycerol = 50 ml
Add 450 ml distilled water
Sterilize by autoclaving for 20 minutes on liquid cycle
Store at room temperature
LB/ampicillin/IPTG/X-Gal Plates
LB Broth = 2.5 g
Agar = 1.5 g
Make up to 100 ml with distilled water
Sterilize by autoclaving for 20 minutes on liquid cycle
Cool to ~ 50 °C and add 100 µl of ampicillin (100 mg/ml)
Pour plates to solidify
Add 20 µl of 0.5 M IPTG and 40 µl of 20 mg/ml X-Gal to each plate and spread
using glass beads
LB Medium (1 L)
LB Broth = 25 g
Make up to 1000 ml with distilled water
Sterilize by autoclaving for 15 minutes on liquid cycle
Store at room temperature
Low Salt LB-Agar Plates (200 mL) with 25mg/l Zeocin
0.5 % Yeast Extract = 1 g
1 % Tryptone = 2 g
1 % Sodium Chloride = 2 g
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Dissolve in 150 ml distilled water
Adjust to pH 7.5 with 1M NaOH
Make up volume to 200 ml with distilled water
Add 1.5 % Agar = 3 g
Autoclave for 20 minutes
Allow to cool to ~55 °C
Add 50 μl of filter sterilized zeocin (100 mg/ml)
Pour plates to solidify
Store at 4°C in the dark
Low Salt LB Medium (200 ml) with 25 mg/l Zeocin
0.5 % Yeast Extract = 1 g
1 % Tryptone = 2 g
1 % Sodium Chloride = 2 g
Dissolve in 150 ml distilled water
Adjust to pH 7.5 with 1M NaOH
Make up volume to 200 ml with distilled water
Autoclave for 20 minutes
Allow to cool to room temperature
Add 50 μl filter sterilized zeocin (100 mg/ml)
Store at 4°C in the dark
10X M (5% Methanol) (500 ml)
100 % Methanol = 25 ml
Add 475 ml of distilled water
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Filter sterilize
Store at 4 °C
Ni-NTA Binding Buffer (1 L)
Sodium phosphate monobasic (M.W: 137.99 g/mol) = 6.89 g,
final concentration = 50 mM
Sodium chloride (M.W: 58.44 g/mol) = 17.53 g, final concentration = 300 mM
Imidazole (M.W: 68.08) = 0.6808, final concentration = 10 mM
Ni-NTA Elution Buffer (1 L)
Sodium phosphate monobasic (M.W: 137.99 g/mol) = 6.896 g,
final concentration = 50 mM
Sodium chloride (M.W: 58.44 g/mol) = 17.53 g, final concentration = 300 mM
Imidazole (M.W: 68.08) = 17.02 g, final concentration = 250 mM
10X PBS (Phosphate Buffer Saline) (1L)
Sodium Phosphate dibasic (M.W: 141.96 g/mol) = 10 g, final conc. = 70mM
Sodium Phosphate monobasic (M.W: 119.96 g/mol) = 4.1g, final conc.= 30mM
Sodium Chloride (58.44g/mol) = 76 g, final concentration = 1.3M
Dissolve the above listed in 500 ml distilled water, adjust the volume to 1L with
distilled water.
1X PBS (1 L)
10X PBS = 100 ml
Distilled water = 900 ml
Mix the above.
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1X PBS Plus 3% Tween Twenty (1 L)
10X PBS = 100 ml
Distilled water = 870 ml
Tween twenty = 30 ml
Mix the above.
Ponceau S Stain (0.1 L)
Ponceau S = 0.1 g, final concentration = 0.1%
Acetic acid = 5 ml, final concentration = 5%
Distilled water = 95 ml
1M Potassium Phosphate Buffer (500 ml)
Potassium Phosphate Dibasic = 11.5 g
Potassium Phosphate Monobasic = 59.08 g
Dissolve in 450 ml distilled water (Final pH=6.0)
Allow to cool to room temperature
Make up to 500 ml with distilled water
Sterilize by autoclaving for 20 minutes on liquid cycle
Store at 4 °C
10x SDS-PAGE Running Buffer (1 L)
Tris base (M.W: 121.1 g/mol) = 30 g
Glycine (M.W: 75.07 g/mol) = 144 g
SDS = 10 g
1x SDS-PAGE Running Buffer (1 L)
10x SDS-PAGE Running Buffer = 100 ml
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Distilled water = 900 ml
4x SDS-PAGE Separating Gel Buffer (500mL)
Tris base (M.W: 121.1 g/mol) = 90.85 g, final concentration = 1.5M
Adjust pH to 8.8
Add SDS to a final concentration of 0.04% = 0.2 g
4x SDS-PAGE Stacking Gel Buffer (500mL)
Tris base (M.W: 121.1 g/mol) = 30.28 g, final concentration = 0.5M
Adjust pH to 6.8
Add SDS to a final concentration of 0.04% = 0.2 g
3M Sodium Acetate (100 mL)
CH3COONa.3H2O = 40.82 g
Dissolve in 50 ml dd H2O
Adjust pH to 5.2 with glacial acetic acid
Adjust volume to 100 ml with dd H2O
Filter and sterilize by autoclaving
50X TAE (Tris Acetate EDTA) Buffer (500mL)
Tris base (M.W: 121.1 g/mol) = 121.0 g
Glacial acetic acid = 28.55 ml
0.5 M EDTA (pH 8.0) = 50.0 ml
Bring volume up to 500 ml with distilled water
5X TBS (Tris Buffered Saline) Buffer (1L)
NaCl = 40 g
KCl = 1 g
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Tris base = 15 g
Dissolve in 900 ml distilled water
Adjust to pH=7.4 with concentrated HCl
Allow the solution to cool to room temperature before final adjustment of pH
Make up to a final volume of 1L with distilled water
Store at room temperature
1X TBS Buffer (1L)
5X TBS Buffer = 100 ml
Distilled water= 400 ml
Western Blotting Blocking Buffer 1(100 ml)
Fat-free Milk Powder = 5 g
1X TBS= 100 ml
Add 100 µl of 20% Sodium azide
Western Blotting Blocking Buffer 2 (100 ml)
1X PBS buffer = 100 ml
Fat-free Milk Powder = 1 g
BSA = 3 g
10x Western Blotting Transfer Buffer (1L)
Tris base (M.W: 121.1 g/mol) = 30.3 g, final concentration = 125 mM
Glycine (M.W: 75.07 g/mol) = 72.06 g, final concentration = 960 mM
Dissolve in 500 ml distilled water and make up to 1000 ml.
1x Western Blotting Transfer Buffer (1L)
10x Western blotting transfer buffer = 100 ml
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100% methanol = 100 ml
Cold distilled water = 800 ml
10X YNB (500 ml)
Yeast nitrogen base (YNB) = 17 g
Ammonium sulfate = 50 g
Dissolve in 500 ml distilled water
Heat slightly to dissolve completely
Filter sterilize solution and store at 4 °C
YPD (Yeast extract Peptone Dextrose) Medium (200 ml)
1 % Yeast Extract = 2 g
2 %Peptone = 4 g
Dissolve in 180 ml distilled water
Autoclave for 20 minutes
Cool to room temperature
Add 20 ml of 10X D (final concentration = 2%)
YPD Medium with Zeocin (200 ml)
Prepare YPD medium as above
Add 200 μl of filter sterilized Zeocin (100 mg/ml)
Store in the dark at 4 °C
YPD Plate with Zeocin (200 ml)
1 % Yeast Extract = 2 g
2 % Peptone = 4 g
Dissolve in 180 ml distilled water
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Add 2 % Agar = 4 g
Autoclave for 20 minutes
Cool to ~ 55°C
Add the following
10X D = 20 ml (final concentration = 2%)
Zeocin (100 mg/ml) = 200μl
Mix properly by swirling
Pour medium into plate to solidify
Store plates in the dark at 4 °C
YPDS Plates with Zeocin (200 ml)
1 % Yeast Extract = 2 g
2 % Peptone = 4 g
Sorbitol = 36.44 g
Dissolve in 120 ml distilled water and make up to 180 ml
Add 2 % Agar = 4 g
Autoclave for 20 minutes
Cool to ~ 55°C
Add the following
10X D = 20 ml (final concentration = 2%)
Zeocin (100 mg/ml) = 200μl
Mix properly by swirling
Pour medium into plate to solidify
Store plates in the dark at 4 °C

165

Zeocin (100 mg/ml) Stock Solution (10 ml)
1g zeocin
Dissolve in 10 ml distilled water
Filter sterilize solution
Store at - 20°C in the dark.
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